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Zusammenfassung
Amphibien sind sta¨rker gefa¨hrdet als irgendeine andere Wirbeltierklasse
(Stuart et al., 2004; Hoffmann et al., 2010). Gru¨nde fu¨r diese Gefa¨hrdung
sind vor allem U¨bernutzung und Habitatsverlust (Stuart et al., 2004). Erst
ku¨rzlich tauchte eine weitere Bedrohung auf, die zum Ru¨ckgang von Popu-
lationen beitra¨gt und diese sogar zum Aussterben bringt: die sich ausbre-
itende infektio¨se Krankheit Chytridiomykose (Berger et al., 1998; Daszak
et al., 2000; Stuart et al., 2004; Skerratt et al., 2007).
Der Infektionserreger der Chytridiomykose ist der Chytridpilz Batracho-
chytrium dendrobatidis (Bd), welcher 1998 entdeckt und 1999 beschrieben
wurde (Longcore et al., 1999). Der Pilz geho¨rt zur Abteilung der Chytrid-
iomycota, eine Gruppe von nicht Hyphen bildenden Pilzen (Longcore et al.,
1999). Bd kann sich sowohl sexuell als auch asexuell fortpflanzen (Schloegel
et al., 2012). Wa¨hrend des asexuellen Lebenszyklus bilden sich frei be-
wegliche infektio¨se Zoosporen, welche die Amphibienhaut besiedeln und
Thalli bilden, welche sich zu Zoosporangien entwickeln. In diesen Zoospo-
rangien werden neue Zoosporen produziert, welche durch einen Schlauch aus
der Haut ins Wasser entlassen werden. Hier ko¨nnen sie einen neuen Wirt in-
fizieren oder ihren bisherigen Wirt wieder infizieren. (Longcore et al., 1999;
Berger et al., 2005).
Bd infiziert keratinisierte Teile der Amphibienhaut, was zu einer Verdick-
ung jener Hautschichten fu¨hrt, die fu¨r viele Stoffe undurchla¨ssig sind. Dies
beeintra¨chtigt die osmoregulatorischen Hautfunktion des infizierten Indi-
viduums, was zu Dehydration, einem Ungleichgewicht im Elektrolythaushalt
und letztendlich zum Tod fu¨hren kann (Voyles et al., 2009).
Heute ist man sich einig, dass Chytridiomykose Verursacherin ist von
raschen Populationsru¨ckga¨ngen und lokalem Aussterben. Im “Amphibian
Conservation Action Plan“ der Weltnaturschutzorganisation IUCN wir Chy-
tridiomykose charakterisiert als “die schlimmste Infektionskrankheit, die je
bei Wirbeltieren festgestellt wurde hinsichtlich der Anzahl betroffener Arten
und der Fa¨higkeit, diese Arten zum Aussterben zu bringen“ (Gascon et al.,
2007). Es ist daher wichtig, dass die Gemeinschaft der Wissenschaftler und
Naturschutzbeho¨rden die Bedrohung durch die Chytridiomykose erkennt
und Massnehmen dagegen entwickeln. Allerdings fehlen uns Methoden zur
Beka¨mpfung dieser noch wenig bekannten Krankheit, was bedeutet, dass
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hunderte von Amphibienarten demna¨chst aussterben werden (Stuart et al.,
2004). Der Schlu¨ssel fu¨r einen erfolgreichen Amphibienschutz ist daher,
neben der Verringerung der U¨bernutzung und der Wiederherstellung von
Lebensra¨umen, die wirksame Beka¨mpfung der Chytridiomykose.
Bisher wurden drei verschiedene Ansa¨tze als Beka¨mpfungsmassnahmen
gegen Bd formuliert: Ein Ansatz ist, die Menschverursachte Verbreitung
von Bd zu stoppen, mittels Kontrollen des Amphibien Welthandels (Fisher
and Garner, 2007) und die Verbreitung von Bd auf kleinem Raum zu ver-
hindern mittels der Entwicklung von Standard Biosicherheits Protokollen
(Schmidt et al., 2009a). Ein zweiter Ansatz ist das Einrichten von Erhal-
tungszuchtprogrammen. Dieser Ansatz ist keine Beka¨mpfungsmassnahme
gegen Bd, aber er schu¨tzt empfindliche Arten vor dem Krankheitsbedingten
Aussterben (Zippel et al., 2011). Der dritte Ansatz ist die Entwicklung von
Beka¨mpfungsmassnahmen gegen Bd.
Dazu wurden vielerlei Ideen vorgeschlagen und experimentell getestet
und wertvolle Resultate wurden generiert. Eine Idee war, Mikro Flora der
Amphibienhaut und antimikrobielle Peptide mit Bd-hemmender Aktivita¨t
zu verwenden, um Chytridiomykose zu beka¨mpfen (Woodhams et al., 2011).
Die meist versprechenden Strategien sind in diesem Zusammenhang Bakte-
rien in den Boden einzusetzen, welche verhindern, dass Bd die Amphibi-
enhaut besiedelt (Muletz et al., 2012). Zudem wurden Bakterien und an-
timikrobielle Peptide gefunden, welche die Krankheit bei einigen Amphibien
unterdru¨cken (Woodhams et al., 2011). Eine weitere Idee war es, natu¨rliche
Feinde von Bd zu finden oder o¨kologische Faktoren, welche sich ungu¨nstig
auf das Pathogen auswirken (Woodhams et al., 2003). In diesem Zusam-
menhang waren Behandlungen mit erho¨hter Temperatur sehr erfolgreich.
Wenn Amphibien bei erho¨hter Temperatur gehalten werden, kann dies die
Infektion drastisch reduzieren oder das Tier sogar ganz von der Infektion
befreien (Woodhams et al., 2011). Eine weitere Idee war schlussendlich der
Einsatz von chemischen Fungiziden (Woodhams et al., 2011). In diesem
Bereich haben Garner et al. (2009a) eine sehr erfolgreiche Behandlung ge-
funden, mit welcher Kaulquappen mit dem Fungizid Itraconazol von der Bd
Infektion befreit wurden.
Was vorerst fehlt, ist eine Strategie mit welcher Bd in natu¨rlichen Lebens-
ra¨umen beka¨mpft werden kann. Gut wa¨re eine Methode, die nicht nur
die Bd Infektion reduziert, sondern auch die U¨bertragung des Pathogens
von infizierten auf un-infizierte Tiere. Die meisten der bisher entwickel-
ten Beka¨mpfungsmethoden wurden im Labor durchgefu¨hrt und keine der
Methoden erwies sich in natu¨rlichen Lebensra¨umen als durchfu¨hrbar und
wirksam. Einige der Methoden wurden noch gar nicht im Feld getestet,
ha¨tten aber durchaus das Potential, sehr wirksam zu sein. Andere Meth-
oden mo¨gen aber als Beka¨mpfungsmethode in natu¨rlichen Lebensra¨umen
ungeeignet sein.
Das Problem ist, dass eine Beka¨mpfungsmethode in natu¨rlichen Lebens-
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ra¨umen gewisse Kriterien erfu¨llen muss: Zuallererst sollte die Methode die
Bd Infektion reduzieren und wenn mo¨glich die U¨bertragung von Bd verhin-
dern und dies nicht nur unter den kontrollierten Bedingungen im Labor,
sondern auch im komplexen Netzwerk eines natu¨rlichen O¨kosystems. Des
Weiteren sollte die Behandlung keine Nebeneffekte haben weder auf Amphi-
bien noch auf nicht-Zielorganismen im O¨kosystem. Eine Behandlung sollte
zudem einfach in der Anwendung sein, da sie wahrscheinlich in abgelege-
nen Gebieten angewendet wird. Schlussendlich sollte es mo¨glich sein, eine
grosse Anzahl an Tieren zu behandeln, weil wir ganze Populationen oder
zumindest Teile einer Population behandeln mu¨ssen. Es ist somit wichtig,
dass neue Beka¨mpfungsmethoden entwickelt werden, die erfolgversprechend
sind fu¨r die Anwendung in natu¨rlichen Populationen. Dies war das Ziel
meiner Doktorarbeit: Die Entwicklung von Beka¨mpfungsmethoden gegen
Chytridiomykose in natu¨rlichen Lebensra¨umen.
Der Ansatz, den ich hierbei verfolgte war einerseits die Anwendung
von Fungiziden, andrerseits testete ich o¨kologische Faktoren, welche fu¨r das
Pathogen unvorteilhaft sind. Ich wa¨hlte dazu ein Vorgehen in drei Schrit-
ten: in einem ersten Schritt testete ich verschiedene Methoden im Labor. In
einem zweiten Schritt testete ich diese Methoden in halbnatu¨rlichen Teichen
(sogenannten Meskosmen). Hierbei analysierte ich den Effekt des Fungizides
auf die Infektion mit Bd und auch auf die U¨bertragung von Bd. Wesentlich
war aber vor allem das Fungizid auf Nebeneffekte auf Amphibien und auf
Nicht-Zielorganismen zu testen. In einem dritten und letzten Schritt wur-
den die erfolgreichsten Methoden ausgewa¨hlt fu¨r die Tests in natu¨rlichen
Teichen. Ziel war hier zu pru¨fen, ob die Beka¨mpfungsmethoden gegen Bd
ihre Wirksamkeit in einem komplexen O¨kosystem aufrechterhalten.
Meine Studienart war hauptsa¨chlich die Geburtshelferkro¨te (Alytes ob-
stetricans) weil bekannt ist, dass diese sehr anfa¨llig ist auf Chytridiomykose
und weil sie deshalb beachtliche Populationsru¨ckga¨nge erlitten hat (Bosch
et al., 2010). In den meisten Experimenten arbeitete ich mit Amphibien im
Kaulquappen Stadium. Grund dafu¨r ist, dass die Infektion bei Kaulquappen
auf die keratinhaltigen Mundfelder beschra¨nkt ist, was nicht zum Ausbruch
der Krankheit fu¨hrt. Die Anfa¨lligkeit der Tiere steigt erst an, wenn sich Ker-
atin in der Haut zu bilden beginnt und wenn das Immunsystem geschwa¨cht
ist, was beides kurz nach der Metamorphose der Fall ist (Rollins-Smith,
1998). Wenn also die Infektion bei Kaulquappen eliminiert wird, oder zu-
mindest die Intensita¨t der Infektion reduziert wird, ko¨nnte das die Mortalita¨t
von metamorphosierenden Tieren reduzieren (Briggs et al., 2010; Vreden-
burg et al., 2010; Tobler and Schmidt, 2010).
In Kapitel 1 beschreibe ich ein Experiment, in welchem ein o¨kologischer
Faktor als Beka¨mpfungsmassnahme verwendet wurde. Bd ist empfindlich
gegen hohe Temperaturen (Piotrowski et al., 2004). Ich setzte Kaulquap-
pen der Geburtshelferkro¨te niedriger, mittlerer und hoher Temperatur aus
und habe dabei herausgefunden, dass Kaulquappen die Infektion verlieren,
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wenn sie fu¨nf Tage lang bei mindestens 26◦C gehalten werden. Als Schutz-
massnahme empfehle ich daher, die Abschirmung der Sonne durch Ba¨ume
zu reduzieren und Flachwasserzonen anzulegen, was zu einer Erho¨hung der
Wassertemperatur fu¨hrt (Skelly et al., 2002) und sehr wahrscheinlich zu
einem Ru¨ckgang der Bd Pra¨valenz. Warme Teiche beschleunigen zudem die
Entwicklung der Amphibien Larven, wodurch weniger Tiere im Larvensta-
dium u¨berwintern (Thiesmeier, 1992), was die Wachstumsrate der Popula-
tion steigert (Govindarajulu et al., 2005). Warme Teiche ko¨nnten somit das
Populationswachstum steigern und gleichzeitig die Bd Pra¨valenz verringern.
In Kapitel 2 verwendete ich chemische Mittel um infizierten Kaulquap-
pen gegen Bd zu behandeln. Dazu hielt ich Kaulquappen der Geburtshel-
ferkro¨te sieben Tage lang individuell in Lo¨sungen mit jeweils einem der
zwei chemischen Mittel General Tonic® oder Virkon Aquatic® . General
Tonic® war sehr wirksam in der Reduktion der Infektion wa¨hrend Virkon
Aquatic® keinen Effekt auf Bd zeigte. Kapitel 2 zeigt, dass chemische Mittel
durchaus verwendet werden ko¨nnen, um Kaulquappen gegen Infektion mit
Bd zu behandeln, jedoch sind weitere Experimente no¨tig, um Nebeneffekte
der Mittel auf Amphibien und auf das O¨kosystem zu testen.
Das war das Ziel im Kapitel 3: Im dritten Kapitel berichte ich u¨ber
ein Experiment, in welchem ich halbnatu¨rliche Mesokosmen einrichtete, um
die chemischen Mittel in einem etwas weiteren Kontext zu testen. Ich set-
zte Mollusken, Insekten, Pflanzen, Krebsartige, Plankton und sowohl in-
fizierte, als auch un-infizierte Kaulquapen der Geburtshelferkro¨te und un-
infizierte Kaulquappen anderer Amphibienarten in die Mesokosmen ein.
Danach gab ich jeweils eines von drei Mitteln mit fungizider Wirkung (Gen-
eral Tonic® , Virkon Aquatic® oder PIP Pond Plus® ) zum Mesokos-
mos Wasser dazu. Ich pru¨fte dann, ob die Mittel die Infektion der in-
fizierten Kaulquappen reduzieren und ob sie die U¨bertragung von Bd von
infizierten auf un-infizierte Tiere stoppen. Zudem testete ich, ob die Mit-
tel Nebenwirkungen auf Amphibien, Mollusken oder andere Faktoren im
O¨kosystem haben. PIP Pond Plus® hatte keinen Effekt auf die Infek-
tion, hatte aber auch keine Nebeneffekte. General Tonic® reduzierte die
Infektion und hatte einige kurzfristige Nebeneffekte auf Mollusken und auf
die Struktur des O¨kosystems wie z. B. Planktondichte. Die Funktion des
O¨kosystems war nicht messbar beeintra¨chtigt, z. B. blieb der Abbau von or-
ganischem Material unvera¨ndert. Virkon Aquatic® hatte keinen Effekt auf
Sta¨rke der Infektion oder Pra¨valenz, aber es blockierte die U¨bertragung des
Pathogens. Virkon Aquatic® verursachte keine kurzfristigen Nebeneffekte
auf das O¨kosystem, aber la¨ngerfristig hatte es einen Effekt auf die Struktur
des O¨kosystems, was sich in einem Anstieg der Schneckenreproduktion und
Planktonzahl niederschlug. Die entscheidende Frage ist jedoch: Was sind
die Kosten und was ist der Nutzen der Behandlung? Wa¨hrend der Nutzen
fu¨r die Amphibien klar zu sein scheint, wissen wir, dass es Kosten gibt, die
jedoch viel schwieriger zu quantifizieren sind. In solchen Situationen emp-
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fiehlt man daher einen vorsichtigen Ansatz zu wa¨hlen, der da wa¨re, dass
chemische Mittel nur dann in natu¨rlichen Lebensra¨umen verwendet werden,
wenn der erwartete Nutzen gross ist und die Kosten wett gemacht werden.
Der Nutzen ko¨nnte z. B. gross sein bei einem katastrophalen krankheits-
bedingten Ru¨ckgang einer Population. In Situationen, wo Bd keine katas-
trophalen Effekte zu haben scheint z. B. Tobler et al. (2012), ist der Ge-
brauch von chemischen Mitteln nicht zu empfehlen. In simplen Habitat-
stypen ko¨nnten die Kosten einer Behandlung eher tragbar sein, wie z. B. in
den Felsschluchten, die von der Mallorkanischen Geburtshelferkro¨te Alytes
muletensis besiedelt werden oder in mensch-gemachten Habitaten wie Kies-
gruben. In einem na¨chsten Experiment testete ich die Behandlungsmetho-
den mit chemischen Mitteln in natu¨rlichen Lebensra¨umen.
In Kapitel 4 beschreibe ich drei Experimente, in welchen ich die Be-
handlung mit den chemischen Mitteln Itraconazol und General Tonic® in
natu¨rlichen Teichen testete. Ich mischte das Mittel aber nicht ins Teich-
wasser, sondern fing die Kaulquappen heraus und behandelte diese in Becken
neben dem Teich. So wurden Nebeneffekte auf Nicht-Zielorganismen ver-
mieden. Nach der Behandlung wurden die Kaulquappen wieder in ihrem ur-
spru¨nglichen Teich freigelassen. Diese Prozedur fu¨hrte ich zuerst in Mesokos-
men durch unter der Verwendung von Itraconazol (Garner et al., 2009a;
Tobler and Schmidt, 2010). Dabei fand ich heraus, dass die Behandlung
wa¨hrend des Larvenstadiums die Infektion senkt und danach u¨ber die Meta-
morphose hinweg auf tiefem Niveau bleibt, was dann eine verringerte Mor-
talita¨t unter metamorphosierenden Tieren bewirkt. Diese Behandlungsmeth-
ode testete ich daraufhin in einem weiteren Experiment in natu¨rlichen Te-
ichen, wobei die Tiere ein einziges Mal behandelt wurden. Im letzten Experi-
ment behandelte ich die Kaulquappen dann monatlich und benutzte das Mit-
tel General Tonic® anstatt Itraconazol. Nach beiden Teich Experimenten
habe ich die Infektion der Kaulquappen im Teich ein Jahr lang beobachtet.
Dabei zeigte sich, dass eine chemische Behandlung von Kaulquappen in
Becken ausserhalb des Teiches, eine kurzfristige Reduktion der Infektion be-
wirkt. Dieser Effekt verschwand allerdings wieder nach zwei Monaten. Ein
Teil der Kaulquappen wurde nicht gefangen und wurde somit auch nicht be-
handelt. Bei diesen unbehandelten Kaulquappen wurde die Infektion eben-
falls reduziert, was mo¨glicherweise auf die reduzierte Dichte an infizierten
Tieren im Teich zuru¨ckzufu¨hren ist. Ein weiteres Resultat war, dass die In-
fektion im Herbst am tiefsten ist, verglichen mit dem Rest des Jahres. Eine
Behandlung im Herbst ko¨nnte somit ein neuer Ansatz sein, welcher erlaubt,
dass die Infektion auf diesem tiefen Herbst-Niveau gehalten wird. Insgesamt
zeigen diese Resultate, dass Fungizide die Infektion reduzieren ko¨nnen, dass
sie das Pathogen jedoch nicht ga¨nzlich eliminieren. Die Behandlung ist aber
wirksam fu¨r eine kurze Zeit und ko¨nnte somit als Notfallstrategie dienen im
Falle eines krankheitsbedingten Massensterbens.
Kapitel 5 ist eine Sammlung von Behandlungen, die nicht wirksam waren.
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Das Kapitel beinhaltet Behandlungen mit Itraconazol, antimikrobiellen Pep-
tiden, Bakterien und mit erho¨hter Temperatur. Die Behandlungen waren
nicht wirksam hinsichtlich erho¨hter U¨berlebenswahrscheinlichkeit. Dennoch
sind diese Resultate wichtig, weil sie zuku¨nftige Forschung voran bringen,
indem sie die Grenzen und Mo¨glichkeiten bestimmter Methoden dokumen-
tieren. Aus “gescheiterten“ Versuchen lernen ist essentiell, weil die Zeit, die
wir verlieren, wenn Fehler mehrmals gemacht werden, ist verlorene Zeit, die
wir dringend brauchen fu¨r die Entwicklung von wirksamen Beka¨mpfungs-
methoden gegen Bd.
Kapitel 6 ist eine Notiz u¨ber die Beobachtung, dass sich Bd und Bak-
terien auf dem resorbierenden Schwanz von metamorphosierenden Tieren
anha¨ufen. Bisher war es schwierig Bd Infektion auf metamorphosierenden
Individuen zu entdecken, weil man nicht wusste, welche Hautstellen Bd bei
Tieren in diesem Lebensstadium hauptsa¨chlich besiedelt. Die Notiz in Kapi-
tel 6 hilft, Bd auch auf metamorphosierenden Tieren zu finden.
Zusammenfassend vermittelt meine Doktorarbeit Methoden, Bd in natu¨r-
lichen Teichen zu beka¨mpfen. Einige der Methoden wurden in natu¨rlichen
Teichen getestet. Wir wissen daher, wie diese Methoden im komplexen Net-
zwerk eines O¨kosystems funktionieren. Ein neuer und o¨kologisch vertra¨g-
licher Ansatz ko¨nnte sein, bei Teichen die Abschirmung durch Ba¨ume zu
reduzieren und Flachwasserzonen zu schaffen, was zu einer Erwa¨rmung des
Wassers fu¨hrt. Dies ko¨nnte die Pra¨valenz von Bd reduzieren und zudem eine
erho¨hte Wachstumsrate der Population bewirken. Eine andere neue Ent-
deckung war, dass die U¨bertragung der Krankheit mit Fungiziden gestoppt
werden kann.
Neu ist auch, dass auf dem Markt erha¨ltliche Fungizide sowohl die Sta¨rke
der Infektion als auch die Pra¨valenz reduzieren ko¨nnen. Allerdings haben
sie Nebeneffekte auf das O¨kosystem. Ich wu¨rde daher empfehlen, chemis-
che Mittel nur im Falle von katastrophalen krankheitsverursachten Popula-
tionsru¨ckga¨ngen einzusetzen. Ich empfehle auch, Kosten und Nutzen einer
Behandlung im Vornherein sorgfa¨ltig abzuscha¨tzen. Wenn der Nutzen die
Kosten nicht klar aufwiegt wu¨rde ich von einer Behandlung des Teichwassers
mit chemischen Mitteln unbedingt abraten. Dann empfiehlt sich eher, die
Tiere zu fangen und ausserhalb des natu¨rlichen Gewa¨ssers gruppenweise
in Becken zu behandeln. Dies bringt uns zu einem weiteren neuen Ergeb-
nis meiner Doktorarbeit: Das Herausfangen und chemische Behandeln von
Kaulquappen in Becken neben dem Teich reduziert nicht nur die Infektion
der behandelten, sondern auch die Pra¨valenz der unbehandelten Kaulquap-
pen, die im Teich geblieben sind. Interessant ist auch die Beobachtung, das
die Infektion im Herbst am tiefsten ist. Eine Behandlung im Herbst ko¨nnte
daher dazu beitragen, die Infektion auf tiefem Niveau zu halten.
Probleme ko¨nnten entstehen, wenn sich neue und virulentere Sta¨mme
von Bd entwickeln oder einwandern oder wenn sich bei Bd Resistenzen gegen
ein Mittel etnwickeln. Umgekehrt ko¨nnen aber auch anfa¨lligen Amphibien-
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arten Resistenzen gegen Bd entwickeln.
Etwas ernu¨chternd ist natu¨rlich, dass Bd hartna¨ckig bestehen bleibt.
Was wir in der Hand haben, sind ein paar Notfallmassnahmen, mit welchen
wir das Pathogen u¨ber kurze Zeit einda¨mmen ko¨nnen. Was wir tun ko¨nnen,
ist weiterforschen, um Beka¨mpfungsmethoden zu finden, mit welchen In-
fektionen mit Bd reduziert und die U¨bertragung in ganzen Populationen
gestoppt werden ko¨nnen. Dies z. B. mittels Impfung, Zu¨chten von an-
timikrobiellen Hautbakterien und im Wesentlichen auch mittels ganzheitlichen
Ansa¨tzen, die auch Wiederherstellung von Habitaten einbeziehen. Was uns
bleibt ist Hoffnung; die Hoffnung, dass mit unseren Beka¨mpfungsmethoden
das Aussterben anfa¨lliger Arten vorerst verhindert werden kann so dass Zeit
gewonnen wird, um Beka¨mpfungsmethoden mit permanenter Wirkung zu
entwickeln, so dass Chytridiomykose eines Tages verschwindet von der lan-
gen Liste der Bedrohungen der Amphibien.
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Summary
Amphibians are more threatened than any other vertebrate taxon (Stu-
art et al., 2004; Hoffmann et al., 2010). Reasons for this threat are mainly
overutilization and habitat loss (Stuart et al., 2004). Only recently a new se-
vere threat to amphibians appeared which contributes to population declines
and drives species to extinction: the emerging infectious disease chytridiomy-
cosis (Berger et al., 1998; Daszak et al., 2000; Stuart et al., 2004; Skerratt
et al., 2007).
The causative agent of chytridiomycosis is the chytrid fungus Batracho-
chytrium dendrobatidis (hereafter Bd) which has been detected in 1998 and
was formally described in 1999 (Longcore et al., 1999). The fungus belongs
to the Chytridiomycota, a phylum of non-hyphal fungi (Longcore et al.,
1999). Bd can reproduce sexually and asexually (Schloegel et al., 2012).
During its asexual life cycle Bd has a motile infective zoospore-stage that
colonizes amphibian skin where it forms thalli that develop into zoospo-
rangia. New infective zoospores are produced within the zoosporangia and
released through a tube into the water where they can be transmitted to
new hosts or re-infect the individual (Longcore et al., 1999; Berger et al.,
2005). Bd infects the keratinized amphibian skin inducing thickening of im-
permeable skin layers which interferes with osmoregulatory functions of the
skin and results in dehydration, electrolyte imbalance and eventually in the
death of the infected individual (Voyles et al., 2009).
Nowadays it is widely accepted that the amphibian skin disease chytrid-
iomycosis causes rapid population extirpations and declines. In the IUCN
Amphibian Conservation Action Plan chytridiomycosis was characterized as
“the worst infectious disease ever recorded among vertebrates in terms of
the number of species impacted, and its propensity to drive them to ex-
tinction” (Gascon et al., 2007). It is thus of great importance that the
scientific community and conservation agencies recognize and manage the
threat of chytridiomycosis. However, the lack of mitigation methods against
this poorly understood disease means that hundreds of amphibian species
may face extinction (Stuart et al., 2004). Hence, beside habitat restora-
tion and reduction of amphibian exploitation a new key factor in successful
amphibian conservation is the effective mitigation of chytridiomycosis.
So far, three different approaches were considered as mitigation strategies
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against Bd: One approach is to stop the human induced dissemination of Bd
by controlling the world trade in amphibians (Fisher and Garner, 2007) or by
developing standard biosafety protocols to avoid spreading Bd on a smaller
scale (Schmidt et al., 2009a). A second approach is the establishment of
captive breeding programs. This approach is not a mitigation method but
it preserves the most susceptible species from disease-induced extinction
(Zippel et al., 2011). The third approach is the development of a mitigation
strategy against Bd.
Multiple ideas were suggested and tested experimentally as mitigation
strategies against Bd and valuable results were achieved: One idea was to use
amphibian skin microbiota and antimicrobial peptides with Bd inhibitory
activity to combat chytridiomycosis (Woodhams et al., 2011). Here, the
most promising strategies are mitigation by introduction of bacteria into
the soil which inhibits colonization by Bd on the skin of the amphibian
(Muletz et al., 2012). Moreover bacteria and antimicrobial skin peptides
were found to suppress disease in some amphibians (Woodhams et al., 2011).
A further idea was to find natural enemies of Bd or ecological conditions
that are unfavorable for the pathogen (Woodhams et al., 2003). In this
context treatments with elevated temperature were very successful. Keeping
amphibians in elevated temperature has the potential to clear or drastically
reduce infection burdens (Woodhams et al., 2011). Finally, an idea was to
use chemical antifungal agents (Woodhams et al., 2011). In this regard a
very successful treatment was found by Garner et al. (2009a), who cleared
tadpoles with the antifungal agent Itraconazole.
What has been missing until now is a strategy to mitigate Bd in natural
habitats potentially including a method which not only reduces Bd infec-
tion but also transmission of the pathogen from infected to non-infected
individuals. Most of the mitigation methods that were developed so far
were conducted in the laboratory and none of them proved to be an imple-
mentable and effective strategy to mitigate Bd in natural habitats. Some
of these methods were simply not tested yet in natural habitats but have
the potential to be very effective. Other strategies might not satisfy the
demands of a mitigation method in natural habitats.
Problems could arise because a mitigation method against Bd in natu-
ral habitats has to fulfill multiple objectives: First and foremost it should
reduce Bd infection and possibly Bd transmission not only under controlled
conditions in the laboratory but importantly also in the complex framework
of a natural ecosystem. Furthermore a treatment should be safe for amphib-
ians as well as for non-target organisms in the environment. A treatment
should also be simple to implement because it might be applied in remote
areas. Finally, as we need to treat whole or parts of a population it should
be possible to treat large numbers of amphibians. Hence, we need to explore
new treatments that seem promising for use in natural populations. This
was exactly the goal of my dissertation: Developing methods to mitigate
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chytridiomycosis in natural habitats.
The approach I persuaded was on the one hand the use of antifungal
agents as a treatment against Bd on the other hand I tested ecological con-
ditions that are unfavorable for the pathogen. In the search for a mitigation
method against Bd I followed a three-step approach: in the first step I tested
several mitigation methods in the laboratory. In a second step I tested these
methods in semi-natural ponds (mesocosms). Here I tested the effect of the
antifungal agent on Bd infection and transmission and importantly also side
effects on amphibians and non-target organisms. In the third and final step
the best methods were selected for tests in natural ponds. The goal was here
to verify whether the Bd mitigation methods maintain their effectiveness in
the complex framework of a natural ecosystem.
My study species was mainly the midwife toad Alytes obstetricans be-
cause it is known to be highly susceptible to chytridiomycosis and has suf-
fered substantial declines (Bosch et al., 2010). I used in all the experiments
amphibians in the tadpole stage. The reason is that Bd infection in tadpoles
is restricted to the keratinized mouthparts, which does not cause disease.
Susceptibility to Bd is highest when the skin becomes keratinized and when
the amphibian immune system is depressed, which happens both shortly af-
ter metamorphosis (Rollins-Smith, 1998). Clearing infection in tadpoles or
at least reducing pathogen loads shortly before metamorphosis might thus
reduce mortality among metamorphosing individuals (Briggs et al., 2010;
Vredenburg et al., 2010; Tobler and Schmidt, 2010).
In chapter 1 I describe an experiment in which an ecological condition
was used as mitigation method against Bd. As Bd is sensitive to high tem-
perature (Piotrowski et al., 2004), I exposed tadpoles of Alytes obstetricans
to low, medium and high temperatures. I found that most tadpoles lost
the infection, when they were kept for 5 days at temperatures higher than
26◦C. As conservation measures I suggest to reduce canopy cover and to
construct shallow water zones which results in the rise of temperatures in
the ponds (Skelly et al., 2002) and perhaps prevalence will drop. Addition-
ally warmer water speeds up larval development which implies that fewer
tadpoles will hibernate (Thiesmeier, 1992) and therefore population growth
rate will increase (Govindarajulu et al., 2005). Warmer ponds may thus
boost population growth rate and reduce Bd prevalence. In chapter 2 I
used chemical agents to treat infected tadpoles against Bd. I kept tadpoles
of Alytes obstetricans for seven days individually in solutions of the two
chemical agents General Tonic® and Virkon Aquatic® . General Tonic® re-
duced Bd infection efficiently while Virkon Aquatic® showed no effect on
Bd infections. Chapter 2 shows that chemical agents may be used to treat
amphibian larvae against Bd infection but further experiments are necessary
to test side effects of this agent on the amphibians and the pond ecosystem.
This was the goal in chapter 3. In chapter 3 I describe an experiment
in which I set up semi-natural mesocosms to test for the effects of antifun-
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gal chemicals in a broader ecological context. I introduced mollusks, in-
sects, plants, crustaceans, plankton and infected and uninfected tadpoles of
Alytes obstetricans and uninfected tadpoles of other species into the meso-
cosms. I added three different chemical agents (General Tonic® , Virkon
Aquatic® and PIP Pond Plus® ) to the mesocosms. I checked for the effi-
ciency of these compounds in reducing Bd infection of infected tadpoles and
transmission from infected to uninfected tadpoles. Furthermore, I also tested
for side effects of the antifungal treatment on amphibians, mollusks and on
different responses of the ecosystem. PIP Pond Plus® had no effect on Bd
infections and I did not detect side effects. General Tonic® reduced Bd
infection and had some negative short-term effects on mollusks and on the
structure of the ecosystem like plankton density. Function of the ecosystem
was unaffected returning no effects of the agent on litter breakdown. Virkon
Aquatic® had no effect on Bd loads and Bd prevalence of infected individu-
als, but it blocked Bd transmission. Virkon Aquatic® caused no short-term
side effects on the ecosystem, but in the long run ecosystem structure was
affected by Virkon Aquatic® , returning an increase in snail reproduction
and plankton numbers. However, the crucial question is: what are the costs
and the benefits? While the benefit for amphibians seems clear, we know
that there are costs but the costs are much harder to quantify. In such a sit-
uation, a precautionary approach is recommended. That is, one should only
use antifungal agents in natural habitats when the expected benefit is large
and likely outweighs the costs. A benefit may be large if one is witnessing
a catastrophic Bd-induced population decline. In situations, where Bd does
not appear to have immediate catastrophic effects, e.g. Tobler et al. (2012),
the use of antifungal agents might not be recommended. Moreover costs of
antifungal treatments may be more admissible in simple habitat types like
the gorges inhabited by the Mallorcan midwife toad Alytes muletensis or
man-made habitats such as gravel pits. In a next experiment I tested the
treatment with antifungal agents in natural habitats.
In chapter 4 I report on three experiments in which I tested chemical
antifungal treatments with Itraconazole and General Tonic® in mesocosms
and in natural ponds. I did not add the agent directly to the water. Instead I
caught tadpoles out and treated them in tanks next to the pond to avoid side
effects on non-target organisms. After the treatment tadpoles were released
into the pond. I did this procedure first in mesocosms using the chemical
agent Itraconazole (Garner et al., 2009a; Tobler and Schmidt, 2010). Here
I found that a treatment in the tadpole stage reduced Bd infection. Bd
infection stayed on a low level throughout metamorphosis and reduced the
mortality of metamorphosed individuals. Subsequently I tested this method
in the second experiment in natural ponds by treating tadpoles once with
the chemical agent Itraconazole; in a last experiment I treated tadpoles
monthly with General Tonic® . Both experiments in ponds were followed
by a monitoring of Bd infection over the period of one year. I found that
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treating tadpoles with chemical agents outside the pond and releasing them
after the treatment reduced Bd infection in the short term. However the
effect disappeared after two months. A part of the tadpoles were not caught
out and thus not treated. These untreated tadpoles showed as well reduced
Bd infection. Finally I found that Bd infection is lowest in fall. A treatment
in fall might thus be a new approach in order to keep Bd infection in a low
level. These results suggest that antifungal agents can reduce infection but
cannot eradicate Bd from natural environments. However, treatments are
effective for a short time and thus might serve as an emergency measure in
the case of a Bd-induced mass die-off.
Chapter 5 is a conglomeration of treatments that were not considered as
successful. The chapter includes treatments with itraconazole, antimicrobial
peptides, bacteria, and elevated temperature to treat amphibians against Bd
infection. None of these new experimental treatments were considered suc-
cessful in terms of improving survival; however, these results may advance
future research by indicating the limits and potential of the various proto-
cols. Learning from failed treatments’ is essential because the time we lose
by doing the same failures twice is valuable time we lose in the development
of an urgently needed mitigation method against Bd.
Chapter 6 is a notice about the observation that Bd and bacteria ac-
cumulate on the reabsorbing tail of metamorphosing animals. So far it
was difficult to detect Bd infection on metamorphosing individuals because
of lack of information about the position of Bd on the animal during this
developmental stage. The notice in chapter 6 helps to find Bd also on meta-
morphosing individuals.
In conclusion, my dissertation provides methods to mitigate Bd in natu-
ral ponds. Some of these methods were tested in natural ponds and we thus
know how they work in the complex framework of a natural ecosystem. A
new and ecologically compatible approach might be to reduce canopy cover
and to create shallow water zones in order to provide warmer water which
may result in lower Bd prevalence and higher population growth rate. An-
other new finding was that transmission can be blocked by adding antifungal
agents to the water.
A new findig was, that commercially available antifungal agents have
the potential to reduce Bd loads and Bd prevalence although they have a
number of side effects on the ecosystem. I thus recommend chemical treat-
ments of ponds exclusively if a catastrophic Bd-induced population decline
is foreseeable and I also recommend to careful assess the costs and benefits
of such a treatment in advance. If the benefits do not clearly outweigh the
costs, I advise against adding the chemicals directly into the pond water. I
rather recommend catching animals and treating them outside the pond in
groups. This leads us to a further new outcome of my dissertation: catching
tadpoles out of a pond and treating them with a chemical agent in tanks
next to the pond reduces not only Bd loads of the treated tadpoles but
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also prevalence of those tadpoles that remained in the pond and were never
treated. Interesting was the observation that Bd infection is lowest in fall.
A treatment in fall might thus help to keep Bd infection on a low level.
Problems could arise through development of new and more virulent
strains of Bd or through resistances of Bd against the treatments. Re-
sistances however might also be developed among susceptible amphibian
species to Bd.
The drawback of course is that Bd will persist. What we have in hand
are some emergency strategies to confine the pathogen for a short term on
a limited area. What we can do is go on with research to find mitigation
strategies that reduce Bd infection and transmission in whole populations,
like blocking transmission, vaccination, culturing antimicrobial skin bacteria
and importantly also more integrated strategies including habitat restora-
tion. What remains finally is hope; the hope that our mitigation strategies
help to avoid extinction of susceptible species so that we get more time
to develop mitigation methods against Bd with permanent effects and one
day, hopefully, chytridiomycosis disappears from the long list of threats to
amphibians.
General Introduction
Pathogens are ubiquitous. We all know the cold viruses that causes a run-
ning nose, coughs and aches. And we are all frightened by other pathogens
that cause more serious diseases such as AIDS, cholera, typhus, tuberculosis
or malaria, which kill millions of people each year. But pathogens affect
much more than our own health. Beekeepers are concerned with the global
collapse of honey bee colonies associated with the spread of viruses most
probably driven by mites that act as a viral reservoir and incubator. As
a consequence, farmers are alarmed as the honey bee is economically one
of the most important insects, providing crop pollination services (Martin
et al., 2012). Cereal growers struggle with virulent and aggressive fungi
that attack their crops which now poses a severe threat to the world’s wheat
supply (Hovmoller et al., 2010; Fisher et al., 2012).
However the importance of diseases should not be limited to threats in
agriculture or human health, which was historically the case. Nowadays,
the threat of wildlife diseases is taken more seriously because new outbreaks
of diseases were recently registered not only among humans, domesticated
animals and plants but also among endangered species (Daszak et al., 2000).
This global emergence of infectious diseases raised concerns among sci-
entists, politicians, conservation managers, and the public that global health
is deteriorating. A change in the pattern of occurrence and transmission dy-
namics of infectious diseases was observed, raising concerns among scientists
and stimulating intense reflection on the factors involved in this emergence
of diseases. Mirroring the recent advancements in disease awareness and re-
search, the term “emerging infectious disease” (EID) was coined by Joshua
Lederberg (Drotman, 1998) in the early 1990s. Emerging infectious dis-
eases can be defined as infections that have newly appeared in a population
or have existed but are rapidly increasing in incidence or geographic range
(Morse, 1995). Nowadays it is widely accepted that emerging infectious dis-
eases (EIDs) are one of the most severe threats to biodiversity and wildlife
and this threat is even increasing (Daszak et al., 2000, 2001; Greger, 2007;
Smith et al., 2009).
What are the reasons for this new emergence of infectious diseases? Dis-
eases have been with us for millennia and pandemics occurred already many
times before. Historical records reveal reports of Egyptian plagues 2000
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years ago (Gummow, 2010), the black death raged in Asia and entered Sicily
in 1347 from where it spread across Europe (Beran, 2008), and the Spanish
conquistadors introduced measles and smallpox into America with disas-
trous consequences for the native populations who were never confronted
with that pathogen, i.e. they were nave to it (Gummow, 2010). These pan-
demics of the past were often linked to human migration across the globe.
This movement of people and their animals has resulted in dissemination of
exotic pathogens into nave populations and is therefore an important driver
for the emergence of diseases (Daszak et al., 2000; Gummow, 2010).
However, human-mediated dispersal is not the only factor that drives
the emergence of infectious diseases. Pathogens interact with other driving
factors, such as habitat destruction, climate change, overharvesting, invasive
species and environmental pollution, enforcing the emergence of infectious
diseases and related local and global extinctions (Smith et al., 2009). It is
thus a combination of many factors that boosts the emergence of infectious
diseases. A good part of these factors have only recently appeared and
emerged which might explain the emergence of infectious diseases. A new
devastating EID that has appeared recently is the amphibian skin disease
chytridiomycosis. The causative agent of chytridiomycosis is the chytrid
fungus Batrachochytrium dendrobatidis (hereafter Bd) which was described
formally in 1999 by Longcore et al. (1999).
The fungus belongs to the Chytridiomycota, a phylum of non-hyphal
fungi (Longcore et al., 1999). Bd can reproduce sexually and asexually
(Schloegel et al., 2012). During its asexual life cycle Bd has a motile infec-
tive zoospore-stage that colonizes amphibian skin where it forms thalli that
develop into zoosporangia. New infective zoospores are produced within the
zoosporangia and released through a tube into the water where they can be
transmitted to new hosts or re-infect the individual (Longcore et al., 1999;
Berger et al., 2005). An infection with Bd induces proliferation of keratina-
ceous cells (hyperplasia) and the fusion of the keratin layers (keratosis) in
the amphibian skin (Kilpatrick et al., 2010). In adult amphibians this thick-
ening of impermeable skin layers interferes with osmoregulatory functions
of the skin resulting in dehydration, electrolyte imbalance and eventually in
the death of the infected individual (Voyles et al., 2009).
First signs of this disastrous disease were declines in amphibian popu-
lations in ecologically pristine areas like the montane tropical rain forests
of Central America and Australia (Daszak et al., 1999). Based on long-
term data, scientists showed catastrophic amphibian population declines
that eventually resulted in the complete loss of amphibian species (Richards
et al., 1993; Mahony, 1996; Pounds et al., 1997; Lips, 1998, 1999). The causal
link between the disease chytridiomycosis and these population crashes was
not obvious from the beginning on. Historical data indicate that declines
began in the early 1970s in the United States Puerto Rico and northeast-
ern Australia (Stuart et al., 2004). In 2004 Stuart et al. (2004) reported
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that many declines among amphibian populations were due to habitat loss
and overutilization while 48% of the declines were defined as “enigmatic de-
clines”. These enigmatic decline species are rapidly declining species that
have shown dramatic declines, even where suitable habitat remains, for rea-
sons that are not fully explained. Finally, in 2007 Skerratt et al. (2007)
presented evidence that chytridiomycosis, is by far the most likely primary
cause of most of these enigmatic” declines of frogs.
Nowadays it is widely accepted that the amphibian skin disease chytrid-
iomycosis causes rapid population extirpations and declines. In the IUCN
Amphibian Conservation Action Plan chytridiomycosis was characterized as
“the worst infectious disease ever recorded among vertebrates in terms of
the number of species impacted, and its propensity to drive them to ex-
tinction” (Gascon et al., 2007). It is thus of great importance that the
scientific community and conservation agencies recognize and manage the
threat of chytridiomycosis. However, the lack of mitigation methods against
this poorly understood disease means that hundreds of amphibian species
may face extinction (Stuart et al., 2004). Hence, beside habitat restora-
tion and reduction of amphibian exploitation a new key factor in successful
amphibian conservation is the effective mitigation of chytridiomycosis.
Developing mitigation methods is a challenging issue because it requires
a deep understanding of the dynamics of the disease. Disease dynamics are
affected by dynamics of the host, pathogen, and vectors, which transport the
pathogen between hosts. Host, pathogen and vector are embedded within
ecological communities, ecosystems and landscapes which gives a complex
framework of countless components of which many have an influence on
disease dynamics. Finding a mitigation method against a disease in natural
habitats requires that we find the components with the biggest impact on
the dynamics of the disease so that we can change them.
Important is information about diversity of hosts and vectors, informa-
tion about pathogen transmission, pathogen spread on a large scale and in-
formation about how the pathogen persists at a site. We also need knowledge
about the effects of ecological factors on the disease dynamics for instance
disease dynamics under different temperatures or effects of natural preda-
tors of the pathogen. Thanks to scientific activities and research valuable
insights into these features became apparent.
Host diversity was found to be extremely high: Bd is a generalist pathogen
and infects keratinized amphibian skin of over 500 species distributed in at
least 54 countries (Fisher et al., 2009). But infection does not necessarily
cause disease. Some species are resistant to chytridiomycosis and others
suffer mass die-offs (Fisher et al., 2009; Kilpatrick et al., 2010). Multiple
asymptomatically infected amphibian species serve as vectors and may be
implicated in the transmission and spread of the fungus (Daszak et al., 2001;
Weldon et al., 2004; Picco and Collins, 2008). Other factors may also be
involved in transmission and spread: there is strong evidence that the am-
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phibian trade is contributing to the spread of Bd by the global dissemination
of infected animals, by introductions of non-native infected individuals into
the wild and by the untreated discharge of zoospores into landscape water
regimes (Fisher and Garner, 2007). Additionally, Bd is attracted to the
keratinous toes of aquatic birds on which they can adhere and even prolif-
erate. This suggests that waterfowl are potential vectors or environmental
reservoirs for Bd (Garmyn et al., 2012).
Once the pathogen is transmitted to a new site, it might persist. Even
though persistence of this pathogen is currently poorly understood some
patterns became apparent: The fungus can survive up to three months in
moist sterile river sand and grows on sterile feathers, dead algae and arthro-
pod exoskeletons (Johnson and Speare, 2005). An important reservoir for
Bd is the tadpole stage: Because Bd infects only keratinized cells infection
in tadpoles is restricted to the keratinized mouthparts, which does not cause
disease. One important reservoir for Bd is thus the tadpole stage: A long-
lived tadpole stage that can become infected but not succumb to infection
also can promote pathogen persistence (Briggs et al., 2010). How long Bd
persists at a site is unclear. In some areas it is even suggested to be native
(enzootic) (Longo et al., 2010; Tobler et al., 2012). In areas where Bd is
enzootic population declines do not necessarily occur but they might have
occurred in the past when Bd arrived. At that time population may have
declined to lower abundance and remained stationary at a smaller size after
Bd became enzootic (Tobler et al., 2012). In areas where Bd is new (i.e.
Bd is epizootic) it spreads in a wave-like fashion and causes populations to
collapse (Lips et al., 2006; Wake and Vredenburg, 2008). To successfully
protect amphibians from Bd we need thus to develop mitigation methods
against this pathogen.
This brings us back to the question: how can we protect amphibians from
Bd? So far, three different approaches were suggested: One approach is to
stop the human induced dissemination of Bd by controlling the world trade
in amphibians (Fisher and Garner, 2007) or by developing standard biosafety
protocols to avoid spreading Bd on a smaller scale (Schmidt et al., 2009a).
A second approach is the establishment of captive breeding programs to
preserve the most susceptible species from extinction (Zippel et al., 2011).
The third approach is the development of a mitigation strategy against Bd.
Bd mitigation is a difficult task considering the enormous diversity of hosts
and vectors, the numerous reservoirs for the pathogen as well as the different
ways of transmission and spread. Hitherto, different ideas were suggested
and tested experimentally: One idea is to use amphibian skin microbiota
with Bd inhibitory activity to combat chytridiomycosis (Woodhams et al.,
2011). Another idea is to find antimicrobial peptides that make amphibians
resistant to Bd (Woodhams et al., 2011). A further idea is to find natural
enemies of Bd or ecological conditions that are unfavorable for the pathogen
(Woodhams et al., 2003). And finally, an idea is borrowed from agriculture
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where fungal diseases of crops are treated using chemical antifungal agents
(Woodhams et al., 2011).
Multiple experiments and studies were undertaken to test these strate-
gies resulting in a series of extremely valuable results. To date, it is possible
to treat captive amphibians successfully against infection with Bd (Garner
et al., 2009a). However, treating amphibian populations in their natural en-
vironments remains a challenge (Woodhams et al., 2011). Here is where my
dissertation comes in: The utmost goal of my dissertation was the develop-
ment of a mitigation strategy against Bd in natural habitats. The methods
I tested were mostly chemical antifungal agents as well as ecological factors.
My study species was mainly the midwife toad Alytes obstetricans because
it is known to be highly susceptible to chytridiomycosis and has suffered
substantial declines (Bosch et al., 2010).
My dissertation followed a three-step approach: in the first step I tested
several mitigation methods in the laboratory. The aim was, to check whether
the methods works in principle under controlled conditions and I also tested
for side effects on the amphibian. In a second step I tested these methods in
semi-natural ponds (mesocosms). Here I was interested in the effectiveness
of the mitigation method under controlled yet more natural conditions. This
included not only to test whether the method is reducing infection intensity
of animals but also transmission of Bd from infected to uninfected individ-
uals. A very important feature were side effects: I tested side effects on
amphibians including histology, behavior and body condition as well as side
effects on other aquatic organisms by measuring body condition, activity,
survival or development of mollusks, insects, crustaceans and plants. An
essential part was also testing side effects on the function of the ecosystem
like decomposition of organic material, ability to metamorphose or repro-
duction. In a third and final step the best mitigation methods were selected
for tests in natural ponds. The goal was here to verify whether the Bd mit-
igation methods maintain their effectiveness in the complex framework of a
natural ecosystem. An important feature of this last study was the record
of ecological variables to draw conclusions on how the mitigation method
works under different ecological conditions.
For all the experiments I used amphibians in the tadpole stage. The
reason for this approach is that Bd infection in tadpoles is restricted to the
keratinized mouthparts, which does not cause disease. Susceptibility to Bd
is highest when the skin becomes keratinized and when the amphibian im-
mune system is depressed, which happens both shortly after metamorphosis
(Rollins-Smith, 1998). Clearing infection in tadpoles or at least reducing
pathogen loads shortly before metamorphosis might thus reduce mortality
among metamorphosing individuals (Briggs et al., 2010; Vredenburg et al.,
2010; Tobler and Schmidt, 2010). Moreover tadpoles are often better ac-
cessible than adult individuals. A further reason is that population models
lead us to expect that enhancing juvenile survival should increase popula-
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tion viability (Lampo and De Leo, 1998; Hels and Nachman, 2002; Conroy
and Brook, 2003).
In chapter 1 I describe an experiment with elevated temperature as mit-
igation method against Bd. In chapter 2 an experiment was done with
chemical agents to treat infected tadpoles against Bd. In chapter 3 I set up
semi-natural mesocosms to test for the effects of chemicals in a broader eco-
logical context. In chapter 4 I report on three experiments in which I tested
chemical treatments with Itraconazole and General Tonic® in mesocosms
and in natural ponds. Chapter 5 is a conglomeration of treatments that were
not considered as successful. Chapter 6 is a notice about the observation
that Bd and bacteria accumulate on the reabsorbing tail of metamorphosing
animals.
Taken together, a mitigation method against Bd in natural habitats has
to fulfill multiple objectives: First and foremost, the treatment strategy
should reduce Bd infection and possibly reduce transmission of the pathogen
from infected to non-infected individuals. Furthermore a treatment should
be safe for individual amphibians as well as for non-target organisms in the
environment. And last but not least, a treatment is only effective if we
apply it, hence it should be simple to implement. The aim of the three-step
approach is to select for those methods which meet these criteria. The three-
step approach was based on methods that proved to be efficient in simple
and controlled systems in the laboratory. With experiments in more complex
systems in mesocosms I gained a more differentiated picture of the methods
in terms of effectiveness in reducing Bd infection, in terms of transmission
as well as of side effects on the ecosystem. In the course of the experiments
in natural ponds the methods had to withstand the rigorous demands of a
complex ecosystem. Methods that went through this three-step assessment
are methods which might be effective strategies to mitigate Bd in natural
habitats.
Chapter 1
Elevated temperature clears
chytrid fungus infections
from tadpoles of the midwife
toad, Alytes obstetricans
(Amphibia-Reptilia 32: 276-280 DOI:10.1163/017353711X556970)
Corina C. Geiger, Eliane Ku¨pfer, Sa¨mi Scha¨r, Sarah Wolf, Benedikt R.
Schmidt
Abstract The amphibian chytrid fungus Batrachochytrium dendrobatidis
(Bd) is sensitive to high temperature. Hence, exposing amphibians to high
temperature may be a method to clear Bd infection. However, the effect of
exposure to elevated temperature has never been tested in larval stages or
temperate species. We experimentally exposed tadpoles of the toad Alytes
obstetricans to low, medium and high temperatures and found that most,
but not all, tadpoles lost the infection when exposed to temperatures higher
than 26◦C for 5 days. Thus, exposure to elevated temperatures can be used
to treat tadpoles against Bd infection.
Keywords chytridiomycosis, disease, infection, temperature, treatment.
1.1 Introduction
Pathogenic chytrid fungi can drive host population dynamics(Ibelings et al.,
2004). The chytrid fungus Batrachochytrium dendrobatidis (hereafter Bd)
causes the amphibian disease chytridiomycosis that was characterized in
the IUCN Amphibian Conservation Action Plan as ”the worst infectious
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disease ever recorded among vertebrates in terms of the number of species
impacted, and its propensity to drive them to extinction” (Gascon et al.,
2007). Chytridiomycosis is thought to be one of the main reasons for the
global decline of amphibians (Houlahan et al., 2000, 2001; Stuart et al., 2004;
Skerratt et al., 2007; Collins and Crump, 2009).
Because chytridiomycosis can lead to high mortality of amphibians both
in captivity and in the field, there is a great need for methods that can be
used to treat amphibians both against chytridiomycosis and Bd infection
(Young et al., 2007; Pessier, 2008). Antifungal drugs have been used suc-
cessfully to clear infection with Bd (Nichols and Lamiranda, 2000; Parker
et al., 2002; Garner et al., 2009a; Tobler and Schmidt, 2010), but there
are concerns that these drugs may have unwanted side effects (Nichols and
Lamiranda, 2000; Woodhams et al., 2003; Garner et al., 2009a). For ex-
ample, when treating tadpoles of the toad Alytes muletensis against Bd
infection using Itraconazole (De Beule and Van Gestel, 2001), Garner et al.
(2009a) reported depigmentation of the tadpoles. Therefore, Garner et al.
(2009a) did not generally recommend Itraconazole as an anti-Bd treatment
because of suspected hepatotoxicity. However, Tobler and Schmidt (2010)
used Itraconazole to treat tadpoles of Alytes obstetricans and observed no
depigmentation. Furthermore, Young et al. (2007) report that no treat-
ment using antifungal drugs is consistently effective across species. Hence, a
treatment against Bd that has no such side effects would be of great benefit.
Because growth and survival of Bd are highly sensitive to high temper-
ature (Piotrowski et al., 2004), Woodhams et al. (2003) and Retallick and
Miera (2007) exposed adult frogs to elevated temperature (37◦C and 32◦C,
respectively). After being exposed to elevated temperature, frogs were no
longer infected with Bd. Keeping frogs at high temperature may thus be
a treatment against Bd infection that may be free of undesirable side ef-
fects. The use of elevated temperature to clear Bd infection requires further
testing (Berger et al., 2010). Here, we test whether tadpoles can also be
treated against Bd infection by keeping them at an elevated temperature.
In many species, tadpoles carry infections and may be an intraspecific reser-
voir (Brunner et al., 2004). Additionally, tadpoles of many species are more
easily accessible than adults. Hence, mitigation strategies may focus on tad-
poles rather than adults (Lubick, 2010). We used tadpoles of the locally en-
dangered midwife toad (Alytes obstetricans) (Schmidt and Zumbach, 2005)
in our experiment because the species is known to be highly susceptible to
chytridiomycosis and carries Bd infections in many parts of its range, often
at high infection prevalence and infection loads (Bosch et al., 2001; Garner
et al., 2005; Tobler and Schmidt, 2010).
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1.2 Material and Methods
Study site Alytes obstetricans tadpoles where caught in a pond near
Zunzgen (canton Baselland, Switzerland) with dip nets. The site was se-
lected because we knew that Bd prevalence was high (Tobler and Schmidt,
2010). Standard hygiene recommendations were followed during field work
(Schmidt et al., 2009b,a). For transport to the University of Zu¨rich, tad-
poles were individually packed in small plastic containers (1.5 L) filled up
to two thirds with pond water. Before the experiment began, they were
kept indoors at 19◦C. Water was changed twice a week, followed by feeding
(Spirulina suspended in tap water).
Procedure in the laboratory After capture, and again 6-10 days after
the experimental treatments, each tadpole was swabbed with a sterile rayon
tipped plain swab with a plastic applicator (Copan, Italy) in the mouthpart
to test for infection with the fungus Batrachochytrium dendrobatidis (Bd).
Metamorphs (post Gosner stage 42Gosner (1960)) were swabbed on each
foot and on the belly. Bd DNA extraction and subsequent real-time PCR
followed standard protocols (Boyle et al., 2004; Tobler and Schmidt, 2010).
We ran each sample twice (Tobler and Schmidt, 2010). If the two results of
one sample were different, the analysis was repeated. For the experiment, we
only used tadpoles that tested positive for Bd. One tadpole metamorphosed
on the penultimate day of the experiment.
Experimental treatment To test if warm water cures Bd infection in
tadpoles of Alytes obstetricans, we conducted a factorial experiment in which
we manipulated temperature. Tadpoles were exposed to one of three dif-
ferent treatments: a ”low” temperature treatment with a constant water
temperature of 21.4◦C, a ”medium” temperature treatment with a constant
water temperature of 26.2◦C, and a ”high” temperature treatment. While
the cold and warm treatment were kept at a constant temperature over the
whole time of the experiment (5 days or 120 hours), tadpoles in the high
treatment were treated differently. The containers were kept at approxi-
mately 30◦C twice for 8 hours, followed by room temperature for 16 hours.
Afterwards they were kept at approximately 30◦C for 43 hours. Then they
were kept at room temperature until the end of the experiment. Thus, in
the ”high” treatment, tadpoles were exposed to a mean of 29.7◦C for 59
hours, while the mean temperature across the 5 days was 27.1◦C. Heating
was done by placing experimental containers on two different heating mats
(a 25 cm by 35 cm 15 watt Thermolux heat basis and a 51.6 cm by 27.4 cm
28 watt Lucky Reptile thermo mat). The ”low” treatment was kept at room
temperature without heating or cooling. Temperatures in each experimental
unit were measured daily.
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For the experiment, we used small round plastic containers. Each con-
tained 500 ml tap water and one tadpole each. Tadpoles were fed 2.5 ml of
Spirulina suspension (1¯20 mg dry food) at the beginning of the experiment
and after three days. The plastic containers were placed on a laboratory
table next to a window with closed shutters. Since water evaporated, we
added water after three days to reach the original volume. 10 tadpoles were
kept in the ”low”, 9 tadpoles in the ”medium” and 10 tadpoles in the ”high”
treatment. All tadpoles were assigned randomly to treatments.
After the experiment, all tadpoles and metamorphs that tested positive
for Bd were treated using Itraconazole (Garner et al., 2009a; Tobler and
Schmidt, 2010) and all survivors released at the site of capture.
Response variables and statistical analysis The response variable for
the statistical analyses was the infection status after the experimental treat-
ment (all tadpoles were initially infected). We conducted two tests. First,
we used the experimental treatment levels (”low”, ”medium”, ”high”) as
categorical explanatory variables and a Fisher’s exact test to test the null hy-
pothesis of no difference among treatment levels. Second, because there was
some variation in temperature among experimental units within treatment
levels, we used the mean temperature that a tadpole experienced as a con-
tinuous explanatory variable in a logistic regression (Dalgaard, 2008). Sta-
tistical analyses were done using the program R (RDevelopmentCoreTeam,
2012). Type I error probability was 5%.
1.3 Results
Three tadpoles died in the ”medium” and ”high” treatments (one and two,
respectively). Loss of Bd infection depended on the temperature treatment.
At low, medium and high temperature 2, 5 and 7 out of 10, 8 and 8 tad-
poles, respectively, lost the Bd infection (proportions: 0.2, 0.625, 0.875, re-
spectively). The difference among treatments was significant (Fisher’s exact
test: p = 0.0262). The logistic regression based on the mean temperature
experienced by tadpoles also showed a highly significant decline of the prob-
ability to remain infected with increasing temperature (p = 0.00825; Fig.
1.1).
1.4 Discussion
Growth of the amphibian chytrid fungus Batrachochytrium dendrobatidis is
maximal at 17-25 ◦C (Piotrowski et al., 2004). Based on this knowledge,
Woodhams et al. (2003) and Retallick and Miera (2007) showed that adult
frogs can clear Bd-infection when kept for some time at high temperature.
Our results (Fig.1.1) show that tadpoles also clear infection when kept at
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Figure 1.1: Relationship between mean temperature that tadpoles expe-
rienced during the experiment and the probability of losing Bd infection.
Circles represent individual tadpoles. The equation for the logistic regres-
sion line is logit(”probability of remaining infected”) = 12.356 - 0.507*mean
temperature. Standard errors for intercept and mean are 4.797 and 0.192,
respectively.
temperatures that are above the fungus’ optimal temperature. It may be
possible that tadpoles did not clear infection but rather that infection level
was below the detection threshold after the treatments. However, Briggs
et al. (2010) showed that fungal load dynamics probably explain mortality
associated with Bd infection. Hence, even if our treatments only reduced
infection loads (as opposed to clearing infection), then this would probably
lead to reduced Bd-associated mortality because mortality depends on Bd
infection loads (Tobler and Schmidt, 2010).
While there was a clear effect of temperature on the rate of loss of the
Bd infection, 2 out of 10 tadpoles that were kept at a mean temperature of
20-21◦C also lost the infection. Such a loss of infection was not observed
in Alytes obstetricans tadpoles in another laboratory experiment where tad-
poles were kept at 19◦C (Tobler and Schmidt, 2010). A spontaneous loss of
infection (and re-infection) was observed, however, in other species (Briggs
et al., 2010). Hence, not all losses of infection at higher temperatures ob-
served in our experiment may be due to temperature. Nevertheless, the rate
of loss is much higher at elevated temperatures.
Because prolonged exposure to high temperatures cleared most Bd in-
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fections, exposure to high temperature may be a simple and inexpensive
way to treat large numbers of tadpoles against Bd infections in relatively
short time (as it is possible in adult frogs: (Woodhams et al., 2003). We did
not measure costs associated with exposure to elevated temperature but we
believe that the benefits of the treatment outweigh costs due to side effects.
Temperature does not seem to be as efficient (in terms of clearing rates)
as antifungal drugs. For instance, Tobler and Schmidt (2010) reported that
100% of the tadpoles were free of Bd after treatment with Itraconazole. Yet,
while antifungal drugs may have unwanted side effects (e.g., Garner et al.
(2009a)), temperature probably has no such strong side effect because the
temperatures that we used are well below the critical thermal maxima re-
ported for tadpoles (usually >38◦C; (Ultsch et al., 1999). Hence, one may
test the efficacy of higher temperatures or longer exposure times such that
Bd infection is eliminated from all tadpoles. Based on the logistic regres-
sion equation, less than 1% of the tadpoles is predicted to remain infected
at 34◦C. When temperature is used to treat tadpoles against Bd infection,
we recommend some acclimatization of the tadpoles before the treatment.
When novel species are treated, then a pilot study with a small number of
tadpoles would be important. Exposure to temperatures that tadpoles oc-
casionally experience in natural ponds ((Thiesmeier, 1992; Indermaur et al.,
2010), S. Bo¨ll, pers. comm.) cleared most, but not all, Bd infections. It
may be possible to use this piece of information to design a mitigation strat-
egy. In some habitats, it may be possible to reduce canopy cover, especially
when there are no closed-canopy specialists and when canopy closure is the
results of shrub and tree encroachment in the wetland. In a natural experi-
ment where beaver reduced canopy cover, the entire amphibian community
benefited (Dalbeck et al., 2007). As a result of reduced canopy cover, tem-
peratures would rise (Skelly et al., 2002) and perhaps prevalence may drop.
It may drop to a level that the population may be able to compensate, for
example through density dependent processes (Boyce et al., 1999). Such a
strategy may have additional benefits in a species with overwintering larvae,
such as Alytes obstetricans. If warmer water speeds up development such
that fewer tadpoles hibernate (Thiesmeier, 1992), then population growth
rate is predicted to increase (Govindarajulu et al., 2005). If this reasoning
is correct, then warmer ponds may be beneficial for amphibians because Bd
prevalence may be lower and population growth rate higher.
Chapter 2
Laboratory tests of
antifungal agents
(Diseases of Aquatic Organisms 103: 191-197 DOI:10.3354/dao02576)
Corina C. Geiger and Benedikt R. Schmidt
Abstract The fungus Batrachochytrium dendrobatidis (hereafter Bd), which
is the etiological agent of the disease chytridiomycosis, is threatening am-
phibians both in nature and in captivity. While there are some methods to
treat amphibians in captivity, there is no method yet that has been shown
to be a promising treatment for amphibian populations in natural habitats.
Here we present the results of an experiment in which we tested two anti-
fungal agents that might be used to treat amphibians in the field. As a first
step towards the goal of developing mitigation methods, we tested the effi-
ciency of these agents in reducing Bd prevalence and loads in the laboratory.
We exposed naturally infected tadpoles of the midwife toad Alytes obstet-
ricans for seven days to different concentrations of the antifungal agents.
We found that Virkon Aquatic® had no effect neither on Bd prevalence nor
loads (zoospore counts). At 0.625 ml L−1 General Tonic® , prevalence was
reduced to 60% and infected animals had greatly reduced burdens. However,
tadpole length was reduced by 19 % and mass by 32 % on average compared
to the control group, suggesting a negative effect on fitness. Survival was
not affected at 0.625 ml L−1 or 1.25 ml L−1 but was reduced to 60 % at 2.5
ml L−1 . Keeping animals in a dilution of General Tonic® for seven days at
a concentration of 0.625 ml L−1 might be an easy way to reduce zoospore
counts in large numbers of animals at relatively low costs.
Keywords amphibian, Alytes obstetricans, Batrachochytrium dendroba-
tidis, treatment, General Tonic® , mitigation, Virkon Aquatic® .
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2.1 Introduction
Newly emerging diseases can pose serious threats to humans, wildlife and
biodiversity (Daszak et al., 2000; Jones et al., 2008; Fisher et al., 2012). Even
though it is unusual that a pathogen drives its host to extinction, there are
some examples where an emerging pathogen caused host extinction (Smith
et al., 2009). One of the most fatal diseases for wildlife capable of driving
hosts to extinction is chytridiomycosis, a disease of amphibians caused by the
fungus Batrachochytrium dendrobatidis (hereafter Bd) (Berger et al., 1998;
Lips et al., 2006; Skerratt et al., 2007). Chytridiomycosis is now considered
a major threat to amphibian species and populations. Hence, successful
amphibian conservation depends on effective disease treatment (Woodhams
et al., 2011).
While it is possible to treat captive amphibians against infection with
Bd, treating amphibians in the wild remains a challenge (Woodhams et al.,
2011). A treatment protocol should meet different demands to be successful
in the field (Berger et al., 2010; Speare and Young, 2010): 1) a treatment
should be highly effective against Bd, 2) a treatment should be effective after
a single application, 3) a treatment should act rapidly, 4) as we need to treat
whole populations in the field, we need to be able to treat large numbers of
amphibians, 5) a method should have a high safety margin, 6) a treatment
should be inexpensive, 7) the equipment for a treatment method has to be
readily available and 8) a suitable method should cure amphibians in late
stage of disease. Most of these criteria are fundamental also for treatments
in the laboratory. For a treatment in the field however the number 2) and
4) are essential and also challenging.
Hitherto, multiple attempts were undertaken to find a suitable method
to treat amphibians against Bd. This research has resulted in several reports
including treatment protocols with elevated temperature, treatments with
different antifungal agents, treatment using antifungal skin bacteria or pep-
tides of amphibians, treatment with natural predators or treatment with salt
(Woodhams et al., 2011). As it is often the case with antifungal treatments
(Denning and Hope, 2010), most of these treatment methods have profound
disadvantages because some are toxic for amphibians or not tolerated by
them, too labor-intensive for the treatment of large numbers of animals, or
some are simply not effective against Bd (Berger et al., 2009; Garner et al.,
2009a; Martel et al., 2011; Woodhams et al., 2012). To date, there is no
treatment known that fulfills the criteria mentioned above and that was
tested successfully in natural habitats. Many methods that could be used
for captive amphibians are unlikely to be useful as anti-Bd treatments for
amphibian populations in natural habitats as they do not meet the crite-
ria #2 (effective after a single application), #4 (to treat large numbers of
amphibians rapidly) and #5 (safe for the environment). Hence, we need to
explore new treatments that seem promising for use in natural populations.
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Additionally, many treatments were developed to treat adult amphibians.
However, in many species, substantial mortality occurs shortly after meta-
morphosis (Garner et al., 2009b). If one could clear infection in tadpoles or
if one could at least reduce pathogen load of tadpoles shortly before meta-
morphosis, then metamorphosing amphibians would likely survive (Briggs
et al., 2010; Vredenburg et al., 2010; Kinney et al., 2011). Hence, there is a
need for treatments which can be used for tadpoles.
In the present article, we tested two antifungal agents that could po-
tentially be used for the mitigation of Bd in natural habitats. Virkon
Aquatic® (Du Pont, Sudbury, Suffolk, UK) and General Tonic® (Tetra
GmbH, Melle, Germany). Both agents were developed to treat large num-
bers of captive fish against pathogens (including viruses, bacteria and fungi).
We chose these agents because the application is very simple even for large
numbers of animals and because they are comparatively cheap and widely
available. Virkon Aquatic® has the same active substances as Virkon S,
a disinfectant that is recommended for the disinfection of field equipment
at sites with Bd (Webb et al., 2007) and is not harmful to tadpoles and
zooplankton (Schmidt et al., 2009b).
Our study species was the common midwife toad Alytes obstetricans
which is known to be highly susceptible to chytridiomycosis (Bosch, 2001;
Pasmans et al., 2010; Tobler and Schmidt, 2010; Bo¨ll et al., 2012). In Alytes
obstetricans mortality occurs usually shortly after metamorphosis (Tobler
and Schmidt 2010). Hence we focused our treatment on the aquatic life stage
of the species to make sure that the animals enter metamorphosis with no
infection or low infection burden. We treated naturally infected tadpoles of
the midwife toad Alytes obstetricans with different concentrations of General
Tonic® and Virkon Aquatic® .
2.2 Material and Methods
Study site In early March 2011 we collected 176 tadpoles of Alytes ob-
stetricans after hibernation from Chalchofen, a site in Switzerland in the
canton Baselland (7.76647◦E, 47.4775◦N, 395 masl). The site is located on
a south exposed hillside with sparsely growing trees and bushes around the
water bodies. The site consists of four small water bodies of about 3 - 16 m2
in size and about 0.5 - 0.8 m in depth. Three of the four ponds are located
close together while the fourth is at a distance of about 50 m. Two of the
four water bodies are densely vegetated while two have no aquatic vegeta-
tion. We found tadpoles in one of the two vegetated water bodies as well as
in the vegetation-free pond located 50 m away. We chose this site because
we knew that i) Alytes obstetricans is abundant at that site, ii) tadpoles do
hibernate there and iii) amphibians at the site are positive for Bd (in March
2011: n= 176, Bd prevalence = 77%, mean Bd zoospore count ± SE = 96
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± 10.43).
Procedure in the laboratory We transported the tadpoles to the lab-
oratory and placed them individually in clear plastic 1.5 L-containers with
clear plastic covers filled with 1 L of tap water. Holes in the covers enabled
circulation of air. Containers were placed on one shelf and randomly al-
located to a treatment. Tadpoles were fed ad libitum with fish food (Sera
Spirulina Tabs, Sera GmbH, Heinsberg, Germany) three times per week
throughout the course of the experiment. The water was changed before
starting the experiment and thereafter two times per week. The room was
equipped with full spectrum sunlight lamps set for a 12 h day length. Room
temperature was kept at 19 - 21◦C. Six days after capture the tadpoles were
staged (Gosner, 1960), weighed to the nearest 0.01 g (Scaletec Instruments,
Heiligenstadt, Germany), measured from the snout to the beginning of the
tail muscle to the nearest 0.1 mm and swabbed over the mouthparts with
a sterile rayon tipped plain swab with a plastic applicator (Copan, Brescia,
Italy). Further data on infection, size, and Gosner developmental stage were
recorded one week after the experiment was terminated. To avoid cross con-
tamination, gloves were changed between handling different animals, and
fresh containers were used for the weighing of each individual. Swabs were
analyzed for the presence of Bd with rt-qPCR (see below). Among those
tadpoles that tested positive for Bd (136 out of 176), 64 were chosen ran-
domly for use in the experiment. Hence, before starting the experiment Bd
prevalence was 100% in all treatment groups.
Antifungal agents We selected Virkon Aquatic® and General Tonic® as
possible agents to treat amphibians against Bd. According to the manufac-
turer, Virkon Aquatic® is an oxygen based disinfectant used for cleaning
and disinfection of surfaces associated with aquaculture and has been tested
on efficacy against a wide range of fish pathogens including viruses, bac-
teria and fungi (Antec International and DuPont Animal Health Solutions
http://www.antecint.co.uk/MAIN/virkaqua.htm). The active substance in
Virkon Aquatic® is potassium peroxomonosulphate triple salt. In the en-
vironment it degrades to potassium and sulfate ions. General Tonic® was
developed to treat captive fish against bacterial infections, ectoparasites and
for treating lesions. According to the manufacturer, the active substances
are Ethacridinlactat, Acriflavin, 9-Aminoacridin ∗HCl∗H2O and methylene
blue (Tetra GmbH D 49304 Melle, Germany, http://www.tetra.net).
Experimental treatments Each antifungal agent was tested in 6 differ-
ent concentrations (including a control). There were 5 replicates for each
concentration and 7 replicates for the control. Concentrations were chosen
according to recommendations of the manufacturer. Because concentrations
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depended on the antifungal agent, we did not treat the experiment as a fac-
torial experiment with the factors “antifungal agent” and “concentration”
but treated the tests of the two antifungal agent as separate experiments.
For Virkon Aquatic® the concentrations were 1, 2, 3, 4, and 10 mg L−1 . For
General Tonic® the concentrations were 0.625, 1.25, 2.5, 3.75 and 5 ml L−1 .
For Virkon Aquatic® the recommended normal concentration for the treat-
ment against different bacteria and viruses is 2 mg L−1 while for General
Tonic® the recommended normal concentration is 1.25 ml L−1 . The dif-
ferent concentrations were achieved by pipetting the corresponding amount
of the agent into 1 L of water and stirring it well. Tadpoles were kept in-
dividually for 7 days in the corresponding dilution and were observed daily.
Animals showing any abnormality in behavior, pigmentation or body shape
during the experiment were put into fresh tap water and were removed from
the experiment. Dead animals were stored in 98% ethanol. After seven days
the water was changed and tadpoles were kept an additional week before
swabbing. During this week Bd infection could regenerate after exposure to
the agent such that the risk of false negatives could be minimized.
DNA extractions and rt-PCR Upon completion of the experiment,
the tips of the swabs were cut off, put in 60 µl of PrepMan Ultra (Applied
Biosystems) and extracted applying the bead-beating protocol of Boyle et
al. (2004). These extractions were diluted 1/10 and amplified following
the rt-PCR protocol of Boyle et al. (2004). Samples were run in duplicate
with negative controls and 4 dilutions of standards (100, 10, 1, 0.1 zoospore
genomic equivalents, hereafter GE). If the results of the two PCR-wells were
inconsistent the analysis was repeated. Values of GE are corrected for the
1/10 dilution.
Response variables and statistical analyses We tested two main fea-
tures of the antifungal agent: 1) efficiency of the antifungal agent against Bd
(taking Bd prevalence and Bd zoospore counts as response variables) and 2)
side effects of the antifungal agent on the tadpoles (taking survival and size
of the tadpoles as response variables). We measured side effects because
we knew from other studies that a treatment can eliminate Bd efficiently
but could have unwelcome side effects on amphibians (Garner et al., 2009a;
Woodhams et al., 2012).
1) Analysis of efficiency: To analyze differences in prevalence after the
treatment among concentrations of the antifungal agent, we used a logistic
regression with binomial errors, including prevalence as dependent variable
and concentration of the antifungal agent as categorical explanatory variable
(recall that prevalence before the treatment was 100%). We also tested for
differences in GE after the treatment among concentrations of the antifungal
agent using linear regression. In this analysis, the log-transformed GE after
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the treatment were dependent variable and the concentration of the anti-
fungal agent was the continuous explanatory variable. Before starting the
experiment, GE varied by chance among concentrations of General Tonic® ,
having higher GE among high concentrations (linear regression with GE as
dependent variable and concentration as continuous explanatory variable, p
= 0.024). To account for variation in GE at the beginning of the experi-
ment, we included GE before the experiment as covarite in the statistical
analysis. We did the analyses separately for General Tonic® and for Virkon
Aquatic® .
2) Analysis of side effects on tadpoles: To analyze whether mortality
varied among treatments, we used a logistic regression with binomial errors.
Survival was the dependent variable and concentration of the antifungal
agent the categorical explanatory variable. We tested for an effect of both
agents on the size of tadpoles. We used principal component analysis to
combine mass and length of the tadpoles after the experiment into a single
variable (Schmidt et al. 2012). We used the first principal component axis
for further analyses. The first principal component axis (PC1) explained
83% (in the experiment where we used General Tonic® as the antifungal
agent) and 96% (in the experiment where we used Virkon Aquatic® as the
antifungal agent) of the variance. Both mass and length were positively
correlated with PC1 in General Tonic® (r= 0.70 and r= 0.70, respectively)
and in Virkon Aquatic® (r= 0.70 and r= 0.70, respectively). We tested for
an effect of the antifungal agents on PC1 using a linear regression where
PC1 was the dependent variable and the concentration of the agent the cat-
egorical explanatory variable. We did both analyses separately for General
Tonic® and for Virkon Aquatic® .
All statistical analyses were done in R version 2.15.0 (R Development
Core Team 2012).
2.3 Results
Results for treatment with General Tonic® General Tonic® sig-
nificantly reduced prevalence of Bd (logistic regression, p = 0.018) but
did not reduce prevalence to zero (Fig.2.1, Tab.2.1). Prevalence was re-
duced to 60% at the lowest concentration (Fig. 2.1). Among those that
remained infected, tadpoles treated with General Tonic® had significantly
lower zoospore counts at all concentrations compared to the control group
(linear regression, p = 0.011) (Fig. 2.1, Tab. 2.1).
There was a significant effect of the treatment with General Tonic® on
tadpole survival (logistic regression, p = 0.004) (Tab. 2.2, Fig. 2.2). Sur-
vival was 100% up to a concentration of 1.25 ml L−1 while it was reduced to
60% at 2.5 ml L−1 and 0% among 3.75 and 5 ml L−1 . Tadpoles started to
be lethargic in the General Tonic® treatment at a concentration of 2.5 ml
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Table 2.1: Effects of the antifungal agent General Tonic® or Virkon
Aquatic® on zoospore counts and on prevalences. At the beginning of
the experiment prevalence was 100% in all treatment groups. Prevalence
remained 100% among all treatment groups of Virkon Aquatic® . NA indi-
cates that animals were removed from the experiments because of mortality
or side effects. There are no p-values for prevalence among those concen-
trations where prevalence remained 100% (again NA in the table). P-values
are for the contrast between control and the respective concentration of the
antifungal agent. Significant p-values at α = 0.05 are marked with ∗.
compound concentration
effects on prevalence
p-value
effects on zoospore counts
p-value
GeneraltTonic® 0mltL-1 - -
GeneraltTonic® 0.625mltL-1 0.122 <0.001*
GeneraltTonic® 1.25mltL-1 0.026* 0.013*
GeneraltTonic® 2.5mltL-1 0.005* 0.006*
GeneraltTonic® 3.75mltL-1 NA NA
GeneraltTonic® 5mltL-1 NA NA
VirkontAquatic® 0mgtL-1 - -
VirkontAquatic® 10mgtL-1 NA 0.872
VirkontAquatic® 20mgtL-1 NA 0.164
VirkontAquatic® 30mgtL-1 NA 0.983
VirkontAquatic® 40mgtL-1 NA 0.598
VirkontAquatic® 100mgtL-1 NA 0.288
L−1 or above. Tadpoles did not exhibit any abnormal behavior at lower con-
centrations. We did not detect changes of pigmentation. Mass and length of
tadpoles, as summarized by PC1, did not differ among treatments at the be-
ginning of the experiment (linear regression, p <0.900). Tadpole size (PC1),
was significantly affected by the experimental treatment (linear regression,
p = 0.045). An ANOVA, where General Tonic® concentration was treated
as categorical explanatory variable, showed that PC1 was significantly lower
at all concentrations than in the control (Tab. 2.2).
Results for treatment with Virkon Aquatic® Prevalence of tadpoles
treated with Virkon Aquatic® remained 100% at all concentrations. Virkon
Aquatic® had no significant effect on zoospore counts (linear regression, p
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= 0.577) (Fig. 2.1; Tab. 2.1). Virkon Aquatic® had neither an effect on
mortality nor on PC1 (Fig. 2.2; p = 1.0 and p = 0.581, respectively). Sur-
vival was 100% for all concentrations. We did neither register any abnormal
behavior nor did we find changes in pigmentation.
2.4 Discussion
Outbreaks of chytridiomycosis have led to the extinction of amphibian species
and populations (Berger et al. 1998, Bosch et al. 2001, Vredenburg et al.
2010). Therefore, chytridiomycosis is considered to be a major threat to the
survival of amphibians (Daszak et al. 2000, Fisher et al. 2012). There are
methods to treat amphibians in captivity but most of the published meth-
ods cannot be used to treat amphibian populations in natural habitats. For
example, Garner et al. (2009a) showed that Itraconazole cleared Bd infec-
tion but led to depigmentation of tadpoles. Thus, there is an urgent need
to develop a method to treat amphibians in natural habitats against Bd
(Woodhams et al., 2011). As a first step towards that goal, we here tested
the efficiency of antifungal agents that seemed promising for use in natural
habitats. In our experiment we tested whether the antifungal agent General
Tonic® and Virkon Aquatic® were effective at clearing infection or reduc-
ing infection load and whether they had side effects on tadpoles of Alytes
obstetricans, a species known to be susceptible to Bd (Bosch et al. 2001,
Tobler and Schmidt 2010).
Virkon Aquatic® whose formulation is based on the same active sub-
stance as Virkon S which is often used and recommended for the disinfection
of field equipment (Webb et al. 2007) did not reduce Bd prevalence or load
in individually kept tadpoles in the lab. We exclude it therefore from further
discussion and focus on the antifungal agent General Tonic® .
General Tonic® reduced Bd loads efficiently but did not clear all tad-
poles totally from Bd (Fig. 2.1). General Tonic® may therefore be used to
treat amphibian larvae against Bd infection. It is very easy to apply also
for large numbers of animals and at a concentration of 0.625 ml L−1 Gen-
eral Tonic® reduced prevalence to 60% and infected animals had greatly
reduced pathogen burdens. Survival was not affected at 0.625 ml L−1 or
1.25 ml L−1 but was reduced to 60% at 2.5 ml L−1 . However, General
Tonic® should be used carefully because it had an effect on size (PC1) of
tadpoles. The long-term consequences of reduced body size on individual
fitness (e.g., breeding success) are unknown but should be the focus of fur-
ther study. Interestingly, the negative effect on PC1 was not detected in an
experiment where animals were kept in groups in mesocosms (C. C. Geiger,
B. R. Schmidt and F. C. Origgi, unpublished data).
General Tonic® reduced loads but not prevalence. In our opinion, this
is an important result because loads determine whether infection leads to
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chytridiomycosis and death of individuals. Vredenburg et al. (2010) showed
that amphibian mortality begins once infection loads reach a critical thresh-
old of 10,000 zoospores (the threshold may vary among amphibian species).
The models of Briggs et al. (2010) and Mitchell et al. (2008) show that re-
ducing Bd infection loads might help populations to persist with endemic Bd
infection. Thus, reducing Bd infection loads with General Tonic® could help
amphibians to survive despite the presence of Bd. To be helpful in preventing
deaths at metamorphosis it would seem that General Tonic® would have to
be applied when tadpoles are approaching metamorphosis. We do not claim
that General Tonic® is a better treatment than other established and suc-
cessful agents like for instance itraconazole (Garner et al., 2009a; Woodhams
et al., 2011; Brannelly et al., 2012). We selected General Tonic® simply be-
cause it might be an agent that could be used as a treatment in the field.
In summary, our experiment demonstrates that General Tonic® may be
used to treat amphibian larvae against Bd infection. Future research will
include experimental tests of efficiency of General Tonic® as a treatment
against Bd infection in mesocosms and natural ponds where side effects
of this agent on the amphibians and the pond ecosystem will be tested.
These experiments will show whether General Tonic® might be used to treat
amphibian populations in natural ponds against the emerging pathogen Bd
or whether side effects of this agent are too strong to make it recommendable
for application in the environment.
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Figure 2.1: a) and b): Effect of different concentrations of General
Tonic® and Virkon Aquatic® on prevalence of Bd in tadpoles of Alytes
obstetricans. In the General Tonic® treatment prevalence was reduced be-
ginning at the lowest concentration tested (0.625 ml L−1 ) while Virkon
Aquatic® showed no effect on prevalence. Symbols are for individual tad-
poles and show whether they cleared infection or whether they remained in-
fected. Symbols were slightly offset horizontally and vertically such that all
data points are visible. The line shows prevalence as predicted by the logistic
regression. c) and d): Boxplots showing infection loads of tadpoles after a
7-day treatment with different concentrations of General Tonic® or Virkon
Aquatic® . Concentration ”0” are the control groups. General Tonic® re-
duced zoospore counts beginning at a concentration of 0.625 ml L−1 . The
black line represents the median, the box represents the interquartile range
containing 50% of the values and whiskers mark the 1.5 fold interquartile
range. Outliers are marked with circles.
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Table 2.2: Side effects of the antifungal agent on tadpoles. We found a
mortality effect among tadpoles that were treated with high concentrations
of General Tonic® . There was also a significant effect of General Tonic® on
PC1 scores. We could not find any side effects among treatment groups with
Virkon Aquatic® . NA in the General Tonic® treatment means that animals
were removed from the experiments because of mortality or side effects. In
the Virkon Aquatic® treatment NA means that all animals survived. P-
values are for the contrast between control and the respective concentration
of the antifungal agent. Significant p-values at α = 0.05 are marked with ∗.
compound concentration
effects on mortality
p-value
effects on fitness (PC1)
p-value
GeneralkTonic® 0mlkL-1 NA NA
GeneralkTonic® 0.625mlkL-1 1 0.008*
GeneralkTonic® 1.25mlkL-1 1 0.009*
GeneralkTonic® 2.5mlkL-1 0.033* 0.04*
GeneralkTonic® 3.75mlkL-1 0.002* NA
GeneralkTonic® 5mlkL-1 <0.001* NA
VirkonkAquatic® 0mgkL-1 - -
VirkonkAquatic® 10mgkL-1 NA 0.691
VirkonkAquatic® 20mgkL-1 NA 0.196
VirkonkAquatic® 30mgkL-1 NA 0.265
VirkonkAquatic® 40mgkL-1 NA 0.182
VirkonkAquatic® 100mgkL-1 NA 0.969
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Figure 2.2: a) and b): Effect of General Tonic® on survival of tadpoles.
Based on the results of the logistic regression, predicted survival was 100%
up to a concentration of 1.25 ml L−1 while in Virkon Aquatic® survival
was 100% among all concentrations. Symbols are for individual tadpoles
and show whether they survived or died. Symbols were slightly offset hori-
zontally and vertically such that all data points are visible. The line shows
prevalence as predicted by the logistic regression. c) and d): effect of General
Tonic® and Virkon Aquatic® on fitness of tadpoles of Alytes obstetricans.
Fitness is represented by PC1 scores which are calculated by combining
mass and length in a principal component analysis. General Tonic® had a
significant negative effect on the PC1 scores while Virkon Aquatic® had no
effect on PC1 scores.
Chapter 3
Treating amphibians against
chytridiomycosis using
antifungal agents: an
experimental test of in
mesocosms
Corina C. Geiger, Francesco C. Origgi and Benedikt R. Schmidt
Abstract Emerging infectious diseases have been increasing at an alarm-
ing rate over the last decades and they might be the key threat to future
health of humans and wildlife. Chytridiomycosis, an emerging disease caused
by the fungus Batrachochytrium dendrobatidis (hereafter Bd) is causing pop-
ulation declines and substantial loss in amphibian biodiversity. There is no
method yet to treat amphibian populations against Bd in natural habitats
(ponds). Treating amphibians in their natural habitat means that not only
individuals, but whole pond ecosystem may be affected by the antifungal
drug. Here, we report on an experiment where we tested whether it is pos-
sible to treat larval amphibians against Bd in mesocosms and whether the
treatment has side effects on the amphibians and the pond ecosystem. We
set up mesocosms and introduced tadpoles of the midwife toad Alytes ob-
stetricans, Bufo bufo, Rana temporaria and other aquatic organisms and
we tested three antifungal agents (General Tonic® , Virkon Aquatic® and
PIP Pond Plus® ). We tested the efficiency of these compounds in reducing
Bd infection and transmission. Furthermore, we also tested for side effects
of the antifungal treatment on amphibians, snails and on structural and
functional metrics of the ecosystem. We found that PIP Pond Plus® had
no effect on Bd prevalence or loads, and we also found no noteworthy side
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effects. General Tonic® reduced Bd loads, had no effect on prevalence and
may reduce Bd transmission. General Tonic® had some negative short-term
effects on mollusks and the ecosystem but functional metrics of the ecosys-
tem were unaffected. Virkon Aquatic® had no effect on Bd loads and Bd
prevalence of infected individuals, but it blocked Bd transmission. Virkon
Aquatic® caused no short-term side effects on the ecosystem. In the long
run however, structural attributes of the ecosystem were affected by Virkon
Aquatic® , mainly in snail reproduction and in plankton numbers. These
results suggest that antifungal agents cannot eradicate Bd from natural en-
vironments and have effects on the pond ecosystem. However, the antifungal
treatments may be useful as a treatment in the case of a Bd-induced mass
die-off. Our results suggest that it may be possible to develop methods to
treat amphibians against Bd in their natural environment.
Keywords Alytes obstetricans, amphibian, antifungal agent, Batracho-
chytrium dendrobatidis, mesocosm, mitigation, ecosystem structure
3.1 Introduction
Outbreaks of infectious diseases caused by emerging pathogens have in-
creased globally over the past decades. These can pose serious threats to
humans, wildlife and biodiversity (Daszak et al., 2000; Jones et al., 2008;
Fisher et al., 2012).
Chytridiomycosis is an emerging disease of amphibians caused by the
fungus Batrachochytrium dendrobatidis (hereafter Bd) (Berger et al., 1998).
Chytridiomycosis caused the greatest disease-driven loss in biodiversity ever
documented (Fisher et al., 2012) because Bd infects over 500 amphibian
species (about 8% of all amphibian species known) in at least 54 countries
(27% of all countries globally; (Fisher et al., 2009)). Chytridiomycosis was
suggested to be one of the major drivers of the global decline of amphibians
(Houlahan et al., 2000; Stuart et al., 2004; Skerratt et al., 2007).
Because chytridiomycosis can drive species to extinction (Berger et al.,
1998; Lips et al., 2006; Skerratt et al., 2007), there is an urgent need to
learn how to mitigate the negative effects of chytridiomycosis on amphibian
populations (Woodhams et al., 2011). While it is possible to treat captive
amphibians against infection with Bd, treating amphibian populations in
their natural environments remains a challenge (Woodhams et al., 2011).
One mitigation strategy is to establish captive breeding programs to preserve
the most susceptible species from extinction (Zippel et al., 2011). A second
strategy is to find natural enemies of Bd or ecological conditions that are
unfavorable for the pathogen (Woodhams et al., 2003). The idea of a third
strategy is borrowed from agriculture where fungal diseases of crops are
treated using chemical antifungal agents (Woodhams et al., 2011).
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A strategy to treat amphibians and to mitigate the effects of chytrid-
iomycosis in the field should fulfill multiple objectives. First and foremost,
the treatment strategy should reduce Bd infection loads and prevalence.
Furthermore, a treatment should possibly also reduce transmission of infec-
tion from infected to non-infected individuals. A further objective is that
the treatments should be safe for individual amphibians, i.e. they should
have no negative side effects as it was documented for some antifungal agents
(Garner et al., 2009a) and is often observed when treating mycoses (Den-
ning and Hope, 2010). Last but not least, a treatment should also be safe
for the environment. That is, there should be no side effects on non-target
organisms in the aquatic community and ecosystem functions should not be
affected. This implies that the effect of antifungal treatment on some mea-
sure of “health” of an ecosystem should be assessed. According to Palmer
and Febria (2012), the best assessment of ecosystem health is achieved by
measuring structural metrics (like diversity of species or turbidity of water)
and also functional metrics like reproduction or decomposition rate (Wood-
ward et al., 2012). We designed an experiment with the aim to test the
efficiency of anti-Bd treatments using antifungal agents and possible side ef-
fects on amphibians and on structural and functional metrics of the aquatic
ecosystem.
Here, we report the results of an experiment where we used three an-
tifungal agents to treat larval amphibians against infection with Bd in ex-
perimental aquatic ecosystems in outdoor mesocosms (Wilbur, 1997). The
three antifungal agents that we used were developed to commercially treat
large numbers of captive fish against pathogens (including viruses, bacte-
ria and fungi) and their efficacy in treating Bd has been tested in previous
laboratory experiments (Woodhams et al., 2012; Geiger and Schmidt, 2013).
3.2 Material and Methods
Overview
We selected three different amphibian species for our experiment: The com-
mon midwife toad Alytes obstetricans is known to be susceptible to chytrid-
iomycosis (Bosch, 2001; Tobler and Schmidt, 2010; Bo¨ll et al., 2012) and
its overwintering tadpoles usually have the highest infection rates in our
natural study sites (Tobler and Schmidt, 2010; Bo¨ll et al., 2012). Overwin-
tered tadpoles served as infected animals in the experiment (we captured
infected individuals). As sentinel species that served to assess transmission
of Bd from infected to non-infected individuals, we used tadpoles of Bufo
bufo (which is susceptible to Bd;(Garner et al., 2009b)), Rana temporaria
(which is usually not infected; Eliane Ku¨pfer, personal communication) and
young of the year Alytes obstetricans.
To monitor side effects on other aquatic organisms we added crustaceans
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(Asellus aquaticus), beetles (Copelatus sp.), damselfly larvae (Coenagrion
puella), snails (Lymnea sp.), plants (Egeria densa) and different plankton
species. We also added leaf litter to the mesocosms to monitor litter break-
down. Leaf litter consisted of beech (Quercus robur), oak (Fagus sylvatica)
and maple (Acer pseudoplatanus). Fig. 3.1 gives an overview over the exe-
cution of the experiment and the measurements.
species in mesocosm period
A B C D E F G
start up intro pretreat treating
after
treat
metamorphosis aftermath
4 or 10 infection Alytes
(Alytes obstetricans)
3 sentinel Alytes
(Alytes obstetricans)
10 sentinel Rana
(Rana temporaria)
10 sentinel Bufo
(Bufo bufo)
2 snails
(Lymnea sp.)
4 beetles
(Copelatus sp.)
2 damselflies
(Coenagrion puella)
3 water assels
(Asellus aquaticus)
1 plant
(Egeria densa)
plankton
3 dried leafs
(Acer,Quercus, Fagus)
650 L water
day 1 25 55 86 116 147) 177
month March April May June July August
measures Gmass, length, stage
and/or chlorophyllV
swab
monitoring G4 visitsV
counts of individuals
Gadults, offspring or eggsV
time spent in)mesocosm
Treatments:
Pip Pond)Plus
General)Tonic
Virkon Aquatic
Figure 3.1: Time course of the experiment. The boxes extend from intro-
ducing an organism into the mesocosm (left edge) to taking it out (right
edge).
Antifungal agents
We chose commercially available antifungal agents that are used in aqua-
culture. We chose antifungal agents that were easy to apply by simply
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adding them to the pond water. We selected three agents for the treatment
against Bd: Virkon Aquatic® (Du Pont, Sudbury, Suffolk, UK), General
Tonic® (Tetra GmbH D 49304 Melle, Germany) and PIP Pond Plus® (Chrisal,
Winters-Van Asten, 3910 Neerpelt, Belgium).
Virkon Aquatic® is an oxygen-based disinfectant used for cleaning and
disinfection of surfaces associated with aquaculture and has been tested
for efficacy against a wide range of fish pathogens including viruses, bac-
teria and fungi (Antec International and DuPont Animal Health Solutions;
www.antecint.co.uk/MAIN/virkaqua.htm). The active substance in Virkon
Aquatic® is potassium peroxomonosulphate triple salt. In the environment
it degrades to potassium and sulfate ions. From Webb et al. (2007) we
know that Virkon S, whose formulation is based on the same active sub-
stance as Virkon Aquatic® , is recommended for the disinfection of field
equipment. However in a laboratory experiment, Virkon Aquatic® neither
reduced loads nor prevalence of Bd (Geiger and Schmidt, 2013), but ef-
fects of Virkon Aquatic® on Bd transmission from infected to non-infected
individuals has not yet been tested.
General Tonic® was developed to treat captive fish against bacterial
infections, ectoparasites and for treating lesions. The active substances are
Ethacridinlactat, Acriflavin, 9-Aminoacridin * HCI * H2O and methylene
blue (Tetra GmbH D 49304 Melle, Germany, http://www.tetra.net). In a
laboratory experiment, General Tonic® reduced loads and prevalence of Bd
(Geiger and Schmidt, 2013). Effects of General Tonic® on Bd transmission
from infected to non-infected individuals has not yet been tested. PIP Pond
Plus® is a probiotic additive for ponds and fish farms (Chrisal, Winters-Van
Asten, 3910 Neerpelt, Belgium; http://www.pippondplus.be/chrisal-de). It
was developed to establish a stable microbial community by competitive
exclusion of potential pathogenic microorganisms and boosting of the non-
pathogenic microbiota. Fish farmers reported less fungal diseases among
their fish when PIP Pond Plus® was applied. The exact composition of PIP
Pond Plus® is considered a corporate secret by the company but supposed
to contain a variety of bacteria and enzymes. In a laboratory experiment,
PIP Pond Plus® did neither reduce loads nor prevalence of Bd (Woodhams
et al., 2011). Effects of PIP Pond Plus® on Bd transmission from infected
to non-infected individuals have not yet been tested.
Mesocosm setup
We set up mesocosms in early March 2010 (on day 1, Fig. 3.1), several
weeks prior to the start of the experiment. The experimental units were
rectangular fiberglass containers (1.34 m2, 1000 L volume). We placed these
containers outdoors in an open field at the University of Zurich (8.55094◦E,
47.39592◦N, 507 masl). The mesocosms were started with 650 L of tap
water and 400g leaf litter (Quercus robur, Fagus sylvatica and Acer pseu-
24 CHAPTER 3. ANTIFUNGAL AGENTS IN MESOCOSMS
doplatanus) as substrate. Mesocosms were covered with green shade cloth
to prevent colonization by invertebrates.
We inoculated the mesocosms with several aliquots of pond water with
concentrated plankton from a nearby wetland (Bachenbu¨ler Allmend, 8.54295◦E,
47.48309◦N, 423 masl). In early April 2010 we added a selection of aquatic
organisms into each mesocosm. 3 Asellus aquaticus (Crustacea; 1 female,
2 males); 4 water beetles (Insecta; Copelatus sp.), 2 larvae of damselflies
(Insecta; Coenagrion puella), 2 water snails (Mollusca; Lymnea sp.). All
macroinvertebrates were collected in nearby wetlands. All these organisms
were freely moving and feeding in the mesocosms except for Coenagrion
puella which was confined to a floating screen cage of approximately 1 L
volume. Coenagrion puella fed on plankton that was small enough to enter
the cage through the mesh. In addition to these organisms, we introduced
one submersed plant of the species Egeria densa that we had bought from
a store. Furthermore, we placed mesh bags with a mesh width of 1 mm
containing dried leaves in each mesocosm. Each mesh bag contained three
dried leafs: one of Quercus robur, one of Fagus sylvatica and one of Acer
pseudoplatanus. The purpose of these enclosed leaves was to detect side
effects of the antifungal agents on the breakdown of organic material by mi-
croorganisms. The leaves were weighed at the start of the experiment and
at the end.
Experimental design
The experiment had a four-by-two factorial design. The four levels of treat-
ment (the antifungal agents General Tonic® and Virkon Aquatic® , the
probiotic agent PIP Pond Plus® and the control) were crossed with two
levels of density of infected tadpoles (10 or 4 infected tadpoles of Alytes
obstetricans). Each treatment x density combination was replicated 3 times
while the two control x density combinations were replicated 5 times. Treat-
ments were assigned randomly to mesocosms.
Stocking with amphibians
All amphibians used in the experiment were caught in a pond near Zunz-
gen, Switzerland (Tobler and Schmidt, 2010). We chose this site because
we knew that i) Alytes obstetricans is abundant at that site, ii) tadpoles do
hibernate there, iii) the site is positive for Bd and iv) the other amphibian
species we needed for this experiment occur there too. In early March 2010,
we collected 216 tadpoles of Alytes obstetricans that had hibernated in the
pond. We brought the tadpoles to the university and placed them individu-
ally in clear plastic containers. After four days we swabbed every individual
over the mouthparts with a sterile rayon tipped plain swab with a plastic
applicator (Copan, Brescia, Italy). Swabs were analyzed for the presence
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of Bd with rt-PCR (see below). Among those tadpoles that tested positive
for Bd, 196 were chosen for the experiment and introduced randomly into
the mesocosms in groups of 4 or 10 tadpoles, respectively. We call these
tadpoles “infected Alytes”. When tadpoles entered metamorphosis, infected
Alytes were caught out of the mesocosms and brought to the laboratory,
where they were placed in individual one-liter plastic containers with little
tab water and with three dried beech tree (Fagus sylvatica) leafs. Contain-
ers were tilted so that both land and water were available to the toadlets.
The laboratory was equipped with full spectrum sunlight lamps set for a 12
h day length. Room temperature was kept at 19 - 21◦C. We fed the toadlets
crickets of adequate size ad libitum three times a week. For each individ-
ual, the experiment ended when it reached stage 46 or upon death. After
the experiment the survivors were treated with Itraconazole and released at
their original pond.
We also wanted to test whether intra- and interspecific transmission of
Bd from infected to uninfected amphibians is influenced by the treatment
with antifungal agents. To test for interspecific transmission of Bd, we in-
troduced 10 laboratory hatched larvae of Bufo bufo and 10 larvae of Rana
temporaria as sentinel tadpoles for interspecific transmission into each meso-
cosm. Infection with Bd was reported in tadpoles of Bufo bufo but not (yet)
in Rana temporaria tadpoles. To avoid infection of sentinel tadpoles prior
to the experiment, we collected eggs in the field and hatched tadpoles in
the laboratory. Hatchlings were added to the mesocosms at 3 days of age
(Bufo bufo) or 8 days of age (Rana temporaria). We call these tadpoles
“sentinel Bufo” and “sentinel Rana”. After the treatment period 5 tadpoles
of sentinel Bufo and 5 of sentinel Rana were euthanized with MS222 and the
remaining 5 of each of them were euthanized upon metamorphosis. To test
for intraspecific Bd transmission, we introduced 4 young of the year tadpoles
of Alytes obstetricans as sentinels two weeks after the last addition of anti-
fungal agents to the mesocosms. We call these tadpoles “sentinel Alytes”.
These sentinel Alytes tadpoles stemmed from 10 adult egg string-carrying
males of Alytes obstetricans that we had collected in Zunzgen. We trans-
ported the males in individual boxes to the university, swabbed them over
the whole body and analyzed the swabs for the presence of Bd with rt-PCR
(see below). As all males turned out Bd-negative, we kept them together
in a terrarium of about 0.25m3 containing a land and a water part. When-
ever enough tadpoles had hatched to provide each mesocosm with at least
one individual, we introduced the tadpoles to the mesocosms (1 tadpole per
mesocosm at beginning of June, 1 tadpole at the end of June and 2 tadpoles
at the end of July; Fig. 3.1, Tab. 3.1). At the end of the experiment end of
August, all sentinel Alytes were caught out of the mesocosms, treated with
Itraconazole and brought back to their original ponds.
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Table 3.1: Measurements taken to evaluate effects of the
agents on Bd infection and transmission and to assess side
effects of the agents on amphibians, on snails and on struc-
ture and function of the ecosystem. See also Fig. 3.1.
species response time of
measure
measuring method symbol
in Fig.1
Bd infection
“infectedGAlytes” BdGloads,
BdGprevalence
A,GF swab (belly,Gfeet)
Bd transmission
“sentinel Bufo” BdGloads,
BdGprevalence
E individualGbuccalGswabGfromGthe
mouthpartsGofG5GtadpolesGper
mesocosm
“sentinel Rana” BdGloads,
BdGprevalence
E swabG(mouthpartGofG5Gtadpoles
perGmesocosm)
“sentinel Alytes” BdGloads,
BdGprevalence
G swabG(mouthpartGofG5Gtadpoles
perGmesocosm)
side effects on amphibian size
“infection Alytes” PC1GscoresGof
mass and
length
A,GF mass:GtoGtheGnearestG0.01Gg
length:GfromGtheGsnoutGtoGthe
beginningGofGthe tailGmuscleGto
theGnearestG0.1Gmm
“sentinel Bufo” PC1GscoresGof
mass and
length
C,GE asGabove,GbutGnoGindividual
measurementGforGmassG(mean
amongGanimalsGinmesocosm)
“sentinel Rana” PC1GscoresGof
mass and
length
C,GE asGabove
“sentinel Alytes” PC1GscoresGof
mass and
length
G asGabove
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side effects on amphibian histology
“infection Alytes” damages)in
several)organs
F see)“Material)and)Methods”
side effects on amphibian behavior
“infection Alytes” behavior D-)weekly counts)of)tadpoles)resting-
feeding)or)swimming)during)one
minute of)observation
“sentinel Bufo” behavior D-)weekly as)above
“sentinel Rana” behavior D-)weekly as)above
side effect on snails
snails)2Lymnea sp.3 no.)clutches-
protruding-
survival adults
D-)weekly counts)of clutches-)counts)of
adults)protruding)out)of)the)shell-
number)of surviving)adults)per
mesocosm
snails)2Lymnea sp.3 no.)clutches-
no.)offspring-
PC1)scores)of
mass and
length-
survival)adults
G counts of)egg)clutches)and
offspring)on)0.75)m2 of)the
mesocosm wall-)mass)and)length
of)2)offspring snails)per
mesocosm and)of)the)2)adult
snails- number)of surviving)adults
permesocosm
short-term effects on ecosystem structure
beetles
2Copelatus sp.)
activity D-)weekly number)of)swimming)beetles
monitored)within)1)minute)of
observation
damselflies
2Coenagrion puella3
survival-
molting)rate
D-)weekly counts)of survivors)and)molts
plankton abundance D-)weekly 13)no-)23)few-)33)normal)or)43
clouds)of)plankton
water)inmesocosms turbidity D-)weekly categories:)13)clear)to)the
bottom-)23)see-through)to)40cm
depth-)33 to)30)cm- 4)3 to)10)cm
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long-term effects on ecosystem structure
plankton counts per
genus
E water9column9of9Ø9209cm9and920
cm9depth,9filtered9with9a9plankton
net9:mesh9size9of91009μm3.9The
catch9was9stored9in998G9ethanol
and individuals9per9genus9were
counted9under9the9binocular.
water9assels
:Asellus aquaticus3
counts G counts9of9individuals9per
mesocosm
beetles
(Copelatus sp.)
mass C,9E body9mass:9to9the9nearest90.0001
g counts of9adults
damselflies
:Coenagrion puella3
molting9rate E molting9rate9estimated9from
counts9of9skins9found9within
enclosures,
plants9:Egeria densa3 chlorophyll
content
C,9E mean9chlorophyll9content9of93
leafs9per9plant
ecosystem function
littre
(Quercus robur),
(Fagus sylvatica) ,
(Acer pseudoplatanus)
littre
breakdown
A,9G dry9mass9before9and9after9the
experiment9to9the9nearest
0.00019g
Antifungal treatments
Apart from the control group, we added one of the three different anti-
fungal agents General Tonic® , Virkon Aquatic® or PIP Pond Plus® to
each of the mesocosms. The antifungal agents General Tonic® and Virkon
Aquatic® were added once a week starting end of April and ending end
of May (Fig. 3.1). We added 0.25 mlL−1 of General Tonic® per week
and 2 mgL−1 of Virkon Aquatic® per week. The concentration of Virkon
Aquatic® was in accordance with the standard concentration recommended
by the manufacturer. In the case of General Tonic® we applied a lower con-
centration than recommended because in a previous experiment we found
negative effects of the recommended concentration on tadpole size (Geiger
and Schmidt 2013). The probiotic agent PIP Pond Plus® was applied daily
during the first week and weekly during the three following weeks (Fig. 3.1).
During the first week, daily concentrations were 0.05 mlL−1 water volume,
and during the weeks 2, 3 and 4 0.01 mlL−1 volume were added weekly.
This treatment protocol followed the suggestion of the manufacturer. For
all three antifungal agents, the agent was added directly into the mesocosm
and mixed by stirring the water for one minute with a plastic stick drawing
8-shaped lines into the water. The stick was dried between uses in different
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mesocosms to avoid cross-contamination.
Measurements: We measured five categories of responses: 1) effectiveness
of the agents in reducing infection with Bd, 2) transmission of Bd, 3) side
effects of the agents on amphibians, 4) side effects on snails and 5) side
effects on structure and function of the ecosystem.
Data on the effectiveness of the experimental treatments in reducing
Bd infection were measured at metamorphosis (Gosner stage 45) among
infected Alytes, as tadpoles at the end of the experiment among sentinel
Alytes and 4 (sentinel Rana) or 10 (sentinel Bufo) days after the last addition
of antifungal agents to mesocosms (Fig. 3.1, Tab. 3.1). All infected Alytes
were swabbed with a sterile rayon swab over the belly and the feet, as they
were already undergoing metamorphosis at that time. Swabs of the sentinel
tadpoles were collected from 3 tadpoles (sentinel Alytes) or from 5 tadpoles
(sentinel Rana and sentinel Bufo) per mesocosm by collecting individual
swabs from the mouthparts with sterile rayon swabs. We analyzed the swabs
for the presence of Bd with rt-PCR (see below).
To assess the side effects on amphibians, we recorded the body mass,
body length and developmental stage of tadpoles. Infected Alytes were mea-
sured before they were added to the mesocosms and again at metamorphosis
(Gosner stage 45). Sentinel Alytes were measured and the development stage
was recorded when the experiment was halted on day 177. On day 86 We
took the length and defined the stage of 5 tadpoles of sentinel Rana and 5
sentinel Bufo per mesocosm and measured mass in these groups of 5. Mass
was measured to the nearest 0.01g on a Scaletec Scale (Scaletec Instruments,
Heiligenstadt, Germany) after blotting tadpoles dry on a paper tissue. Body
length was measured to the nearest 0.1 mm from the tip of the snout to the
beginning of the tail muscle using a sliding caliper. Developmental stage
was based on the Gosner (1960) staging table.
Tadpole behavior was recorded weekly during the month (= 4 visits)
when antifungal agents were added to mesocosms by counting in each meso-
cosm the number of tadpoles (each species separately) resting, feeding or
swimming (Van Buskirk 2001). Behavior data was not recorded for sentinel
Alytes.
To detect effects on internal organs, a subsample of 11 infected Alytes per
treatment was sacrificed at metamorphosis and then prepared for histological
inspection (see below). In order to assess side effects on snails we monitored
survival and behavior (retreating into the shell or not) of adult snails and we
counted egg clutches weekly during the month (= 4 visits) when antifungal
agents were added to mesocosms. On day 129 we registered survival of adult
snails. On day 129 and at the end of the experiment we counted the number
of egg clutches and the number of offspring on 0.75m2 of the mesocosm wall.
Before introduction (adult snails) and on day 129 (adults and offspring) we
also measured mass to the nearest 0.01g and shell length to the nearest 0.1
mm of the two adult and of two haphazardly chosen offspring snails in the
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mesocosms.
To detect effects on structure of the ecosystem we counted the number of
water beetles in each mesocosm weekly during treatment period by recording
the swimming beetles detected within one minute of observation. Addition-
ally, before introduction and at the end of the experiment we measured
the total mass of beetles per mesocosm with a scale (Mettler Instrumente,
Na¨nikon-Uster, Switzerland) to the nearest 0.0001g, and scored whether re-
production had taken place. For larval damselflies, we counted the number of
molted skins per mesocosm (within the enclosure) weekly during the month
when antifungal agents were added. We also recorded survival and the num-
ber of damselflies that underwent metamorphosis. Effects on crustaceans
were recorded by counting the number of crustaceans in every mesocosm
at the end of the experiment. The plankton density was monitored weekly
during the month when antifungal agents were added to mesocosms as one
of the following categories: 1 (no), 2 (few), 3 (intermediate) or 4 (highly
abundant). On day 92, we used a plankton net (mesh size 65µm of 19.5
cm diameter) to filter a water column of 20 cm height. From this, we de-
termined the genus of zooplankton present and their respective counts and
we counted the number of algae. On day 92, we measured the chlorophyll
content of Egeria leaves with a chlorophyll meter (Minolta SPAD 502 DL
meter, Konica Minolta Photo Imaging, USA). The turbidity of the water
in the mesocosms was also assessed on a weekly basis during the treatment
as being clear (see-through to the bottom at 50cm depth), see-through to a
depth of 40 cm, 30 cm or 10 cm.
Side effects on ecosystem function were assessed by measuring the mass
of the beech, oak and maple leaves introduced into the mesocosms with
bags before the experiment and at the end on day 177 (Woodward et al.
2012). Dry mass was measured to the nearest 0.0001 g (Mettler Instrumente,
Na¨nikon-Uster, Switzerland).
Histological analysis
A sample of 44 specimens of the infected Alytes (11 of each treatment level)
was delivered to the Zentrum fu¨r Fisch- und Wildtiermedizin (FIWI) in
Bern, Switzerland for pathological investigation. There, the tadpoles were
fixed in 10% buffered formalin and sectioned cranio-caudally along the mid-
line. The two symmetrical portion of the body were then layered flat in the
histocassette, processed as such and embedded in paraffin. Five micron-thick
sections were obtained from each specimen and stained routinely with hema-
toxylin and eosion (H&E). All the sections obtained were screened before
full histological examination and additional deep cuts were performed until
the major organs were visible in the examined sections, if necessary. Ad-
ditionally, special stains including Grocott, Gram, PAS, and Zihel-Neelsen
were applied as appropriately. Slides were observed under light microscopy
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by a single veterinary pathologist and the detected integument changes were
recorded for each specimen. Tissue changes affecting any of the observed
organs and tissues suggestive of a potential toxic effect were recorded for
each individual. Tissue changes were scored as present or absent and sub-
jectively ranked from minimal (+) to severe (+ + ++) by the pathologist.
Additionally, changes associated with the presence of fungal organisms and
other etiologic agents were also recorded.
DNA extractions and rt-PCR
The tips of Bd swabs were cut off, put in 60 µl of PrepMan Ultra (Applied
Biosystems) and extracted applying the bead-beating protocol of Boyle et al.
(2004). These extractions were diluted 1/10 and amplified following the rt-
PCR protocol by (Boyle et al. 2004). Wells containing 0.01 GE or more
were scored positive. Samples were run in duplicate with negative controls
and 4 dilutions of standards (100, 10, 1, 0.1 zoospore genomic equivalents,
hereafter GE). If the results of the two PCR-wells were inconsistent the
analysis was repeated. Values of GE are corrected for the 1/10 dilution.
Response variables and statistical analyses
We tested whether experimental treatments had an effect on Bd infection
and prevalence, whether transmission of Bd to uninfected individuals oc-
curred and whether there were side effects on tadpoles and the aquatic
ecosystem.
Analyzing effects of antifungal agents on Bd infection loads and
prevalence We tested for treatment effects on log-transformed loads of
infected Alytes individuals using a linear mixed effects model (lme) with
antifungal agent and number of infected Alytes as explanatory variables.
Mesocosm was used as a random variable because individuals within meso-
cosms were not independent. We deleted one outlier from an infected Alytes
with extraordinarily high loads that was kept at low tadpole density in
the General Tonic® treatment. To analyze differences in prevalence among
treatments, we used a generalized linear mixed model (glmer) with a bino-
mial error distribution with infection status of individuals (Bd detected or
Bd not detected) as dependent variable and type of antifungal agent and
number of infected Alytes as explanatory variables. Mesocosm was used as
a random variable. Recall that prevalence before the treatment was 100%
among the infection Alytes. Because we tested two hypotheses on how the
agents affect Bd infection, we lowered the usual type I error probability of
0.05 with Bonferroni correction to 0.025.
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Analyzing effects of antifungal agents on Bd transmission We
tested for differences in log-transformed loads of sentinel Alytes, sentinel
Rana and sentinel Bufo among treatments using a linear mixed effects model
(lme) with antifungal agent and tadpole density as explanatory variables and
mesocosm as grouping (random) variable. To analyze differences in preva-
lence among treatments, we used a generalized linear mixed model (glmer)
with a binomial error distribution with infection status (Bd detected or
Bd not detected) as dependent variable and type of antifungal agent, num-
ber of infected tadpoles (= tadpole density) and mesocosm as explanatory
variables, including mesocosm as grouping (random) variable. We ran this
model separately for sentinel Alytes, sentinel Rana and sentinel Bufo. Recall
that prevalence before the treatment was 0% among all sentinel tadpoles.
In total we tested six hypotheses on how the agents act on Bd transmis-
sion. We therefore lowered the usual type I error probability of 0.05 with
Bonferroni correction to 0.05/6 = 0.0083.
Analyzing side effects of antifungal agents on amphibians We
tested for an effect of antifungal agents on the size of individual tadpoles.
We used principal component analysis to combine mass and length of the
metamorphosing animals (infected Alytes) or of the sentinel tadpoles (sen-
tinel Alytes, sentinel Rana and sentinel Bufo) after the treatment into a
single variable (Schmidt et al. 2012). We took individual measures of in-
fected Alytes and of sentinel Alytes and the mean of all individuals per
mesocosm of sentinel Rana and sentinel Bufo. The first principal compo-
nent axis (PC1) explained 90% (infection Alytes), 94% (sentinel Alytes),
92% (sentinel Bufo) and 79% (sentinel Rana) of the variance. We used the
first principal component for further analyses. We tested for an effect of
the antifungal agent on PC1 of infection Alytes and sentinel Alytes using
a linear mixed effects model (lme) where PC1 of either of the two amphib-
ian groups was the dependent variable and antifungal agent and number of
infection Alytes were the explanatory variables and we included mesocosm
as grouping (random) variable. To analyze effect of agent on PC1 (mean
values per mesocosm) of sentinel Rana and sentinel Bufo we used a linear
model (lm) where we included PC1 as dependent variable and agent and
number of infection Alytes as explanatory variables. For detection of effects
of agents on histological traits we used a logistic regression with binomial
errors, including detected “damages” on the different organs as dependent
binomial variable and antifungal agent as categorical explanatory variable.
We tested for differences in behavior of tadpoles among antifungal agents
and among tadpole density and among visits using a linear mixed effects
model (lme) including the percentage of active tadpoles per mesocosm dur-
ing one visit as dependent variable and agent, number of infected Alytes and
visit as explanatory variable and we included mesocosm, as grouping (ran-
3.2. MATERIAL AND METHODS 33
dom) variable. We ran the analysis separately for infected Alytes, sentinel
Bufo and for sentinel Rana (Tab. 3.3).
Analyzing side effects of antifungal agents on snails Short-term re-
sponses of snails measured repeatedly during the month when antifungal
agents were added to the mesocosms, were analyzed using MANOVA in-
cluding the short-term responses of the snails as dependent variable and
agent, tadpole density of infected Alytes and visit as explanatory variable.
We analyzed short-term effects of agent and tadpole density of infected
Alytes on each response using a linear mixed effects model (lme) including
the response of the snails as dependent variable and agent, tadpole density
and visit as explanatory variables and we included mesocosm as grouping
(random) variable (Tab. 3.4).
Long-term effects of antifungal agents on different features of snails were
analyzed using MANOVA where we included the responses of snails mea-
sured on day 129 as dependent variables and agent and tadpole density of
infected Alytes as explanatory variables. To analyze effects of agents and
tadpole density on each of these measured responses we fitted linear models
(lm) where we included the response of the snail as dependent variable and
agent and tadpole density as explanatory variables (Tab. 3.4).
Analyzing side effects of antifungal agents on the aquatic ecosys-
tem We ran three sets of analysis: 1) for detection of short-term effects on
structural metrics of the ecosystem including the data we sampled during
the 4 visits when antifungal agents were added to mesocosms. 2) Long-term
effects on structural metrics of the ecosystem including data of time-point-
measurements of different traits measured some weeks or month after the
last treatment or at the end of the experiment on day 177. 3) Effects on func-
tional metrics, like litter breakdown and reproduction of snails, measured at
the end of the experiment on day 177.
1) Short-term effects on ecosystem structure: We analyzed overall effects
of agents and tadpole density on short-term effects using MANOVA where
we included responses of ecosystem structure, measured repeatedly during
the month when antifungal agents were added to the mesocosms, as depen-
dent variables and agent, tadpole density and visit as explanatory variable.
The responses measured repeatedly as continuous variables were analyzed
using a linear mixed effects model (lme) including the response of the trait
as dependent variable and agent and tadpole density as explanatory vari-
ables and we included mesocosm as grouping (random) variable. Responses
measured as categorical variables (plankton density and turbidity of water)
were transformed into binomial data and analyzed using a generalized linear
mixed model (glmer) with a binomial error distribution including the bino-
mial response as dependent variable, antifungal agent, tadpole density and
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visit as explanatory variable and we included mesocosm as grouping (ran-
dom) variable. We ran the analysis separately for each measured response
(Tab. 3.5).
2) Long-term effects on ecosystem structure: Responses on structural
metrics of the ecosystem were grouped into “plankton” (consisting of 6 dif-
ferent variables) and “invertebrates and plants” (consisting of 4 variables).
We analyzed effects of the antifungal agents and tadpole density on each
category separately using MANOVA including the category as dependent
variable and agent and tadpole density as explanatory variables. To analyze
effects of agents and tadpole density on responses of each measured trait we
fitted a linear model (lm) where we included the measured response of each
trait as dependent variable and agent and tadpole density as explanatory
variable (Tab. 3.6).
3) Effects on ecosystem function: Responses on functional metrics of the
ecosystem were grouped into “litter breakdown” (3 variables). We analyzed
effects of agent and tadpole density on litter breakdown using MANOVA
including the responses in the group as dependent variable and agent and
tadpole density as explanatory variables. We analyzed effects of agents and
tadpole density on each single response of litter breakdown and reproduc-
tion using a linear model (lm) where we included the response as dependent
variable and agent and tadpole density as explanatory variable (Tab. 3.7).
In total we tested two hypotheses on how the agents act on Bd infection,
six hypotheses on how the agents act on Bd transmission and 39 hypothe-
ses concerning side effects. We lowered the usual alpha level of 0.05 with
Bonferroni correction only for the results concerning effects of antifungal
agents on Bd infection and Bd transmission. We did so because we wanted
to avoid a false conclusion that a treatment might successfully treat am-
phibians against infection with Bd when in reality it did not. In contrast,
when we tested for side effects, we wanted to be conservative and therefore
kept alpha at 0.05. There, we were willing to accept some “false alarms”.
We used R version 2.15.0 for all statistical analyses (RDevelopment-
CoreTeam, 2012).
3.3 Results
Effects of the antifungal agents on Bd infection
Prevalence of infected Alytes was neither affected significantly by the anti-
fungal agent (p = 0.672) nor by tadpole density (p = 0.466) (Fig. 3.2). After
Bonferroni correction (α = 0.025) we found a significant effect of antifungal
agent on Bd loads among those infected Alytes that remained infected (lme,
p = 0.004). Compared to the control group, General Tonic® reduced Bd
loads of infected Alytes significantly (lme, estimate ± SE = -1.687 ± 0.546,
p = 0.005), while the other agents had no significant effect on Bd loads of
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infected Alytes (lme, p
PIP Pond Plus®
= 0.407, p
Virkon Aquatic®
= 0.318) (Fig.
3.2). Tadpole density had no significant effect on Bd loads.
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Figure 3.2: Effect of agent on the logarithm of Bd loads and on Bd prevalence
of infected Alytes. The boxplots show infection loads of metamorphosing
infected Alytes after four weeks of treatment with General Tonic® (GT),
Virkon Aquatic® (VA), PIP Pond Plus® (PIP) or in the control group. The
black line represents the median, the box represents the interquartile range
containing 50% of the values and whiskers mark the 1.5 fold interquartile
range.
Effects of the antifungal agents on Bd transmission
Among sentinel Rana only five tadpoles became infected (2 control, 1 Gen-
eral Tonic® , 1 Virkon Aquatic® , 1 PIP Pond Plus® ); we therefore did
not fit a statistical model to the sentinel Rana data. After Bonferroni
correction (α = 0.0083) we found a significant effect of antifungal agent
on Bd prevalence in sentinel Alytes (p = 0.008). Compared to the con-
trol group prevalence of sentinel Alytes was neither affected significantly
by General Tonic® (estimate ± SE = -0.862 ± 0.668, p = 0.197) nor by
PIP Pond Plus® (estimate ± SE = -0.16 ± 0.607, p = 0.792) but Virkon
Aquatic® tended to reduce prevalence in sentinel Alytes (estimate ± SE =
-1.372 ± 0.578, p = 0.029). Antifungal agent showed no significant effect
on prevalence in sentinel Bufo (p = 0.651) (Fig. 3.3). Tadpole density had
no effect on prevalence of sentinel Alytes (p = 0.103), but we found a weak
positive effect of tadpole density on prevalence of sentinel Bufo (estimate ±
SE = 1.844 ± 0.791, p = 0.010) (Fig. 3.3). We found no significant effect of
antifungal agent or tadpole density on Bd loads of infected sentinel Alytes
(pagent = 0.288, ptadpole density = 0.636) or on Bd loads of sentinel Bufo (pagent
= 0.142, ptadpole density = 0.089) (Fig. 3.3).
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Figure 3.3: Effect of agent on transmission of Bd to sentinel tadpoles. The
boxplots show infection loads of tadpoles of sentinel Alytes, sentinel Rana
and sentinel Bufo after four weeks of treatment with different antifungal
agents or in the control group. The black line represents the median, the
box represents the interquartile range containing 50% of the values and
whiskers mark the 1.5 fold interquartile range. Outliers are marked with
circles.
Side effects of the antifungal agents on amphibians
Mass and length of infected Alytes, sentinel Alytes and sentinel Rana, as
summarized by PC1, was neither affected by agent (lme, pinfected Alytes =
0.133, pseintinel Alytes = 0.846; lm, psentinel Rana = 0.523) nor by tadpole density
(lme, pinfected Alytes = 0.946, psentinel Alytes = 0.613; lm, psentinel Rana = 0.923)
(Fig. 3.4). Among tadpoles of sentinel Bufo we found a significant negative
effect of agent on PC1 (lm, p = 0.001) (Fig. 3.4). Compared to the control
there was a significant negative effect of General Tonic® (lm, estimate ±
SE = -1.854 ± 0.544, p = 0.002) and Virkon Aquatic® (estimate ± SE =
-1.824 ± 0.544, p = 0.003) on PC1 scores of sentinel Bufo. Tadpole density
showed no effect on PC1 of sentinel Bufo (lm, p = 0.394) (Fig. 3.4).
We did not detect severe histological changes in infected Alytes. Among
the following organs we even found too few damages among all treatment
groups to fit a statistical model: skin, lung, gonads, thyroid, oral mucosa
and esophagus, stomach, pancreas, spleen and skeleton. Among those or-
gans where we fit a model none of them returned significant results (lo-
gistic regression, pliver= 0.092, pheart = 0.065, pcentral nervous system = 0.182,
pintestine proteasis = 0.145, pskeletal muscle = 0.555). General Autolysis caused no
difference among different antifungal agents (logistic regression, p = 0.100)
however compared to the control, General Tonic® reduced general autolysis
significantly (logistic regression, estimate ± SE = -2.485±1.211, p = 0.040),
while the other agents returned no effect (p
PIP Pond Plus®
= 0.395, pVirkon aquatic
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= 0.670). The tissue changes observed in the examined tissues, besides those
directly related to the fungal infection, included a series of minimal to mild,
more rarely moderate non-specific changes. These included hydropic degen-
eration and cell vacuolization in the liver, while in the kidney the collection
of tubular material (amorphous material, cell debris and sloughed epithelial
cells) along with occasional mineralization and cell necrosis on a single occa-
sion were recorded. Variable amounts of eosinophilic hyaline droplets were
seen in the tubules of the kidneys of the control and treatment groups except
for those treated with General Tonic® , where no such structures could be
seen in the examined sections. In the skeletal muscle there was multifocal
minimal to mild myofiber degeneration. These changes were observed both
in the controls and treatment groups. A detailed summary of the described
lesions is reported in Tab. 3.2. Sporadical observations of endoparasitism
were also recorded.
Table 3.2: Tissue changes observed in metamorphosing individuals of in-
fected Alytes. HD= Hydropic degeneration; Vac.= Vacuolization; Cell R.=
Cell rounding; Tub. Mat.= Tubular material including amorphous mate-
rial, cell debries and sloughed tubular epithelial cells; PM= Pigmented ma-
terial/macrophages; Min.= Mineralization; Nec.= Necrosis; HyD= Hyaline
droplets; My.D.= Myofiber degeneration; PIP = PIP Pond Plus® ; VA=
Virkon Aquatic® ; GT= General Tonic® . Full size numbers refer to the
number of individuals with the specific lesions. The subscript numbers refers
to the actual number of individuals examined among those available (Those
excluded comprised individuals with globally or specific autolytic tissues,
which could not be read or those individual for whom the specific tissue
considered was not available). Superscript numbers refer to the numbers
of individuals whose tissue were characterized by low-grade autolysis, which
did not compromise significantly the reading and interpretation of the tissue
changes.
tissue4lesions
antifungal
agent
autolysis liver kidney skeletal
muscle
HD Vac. Cell4R. Tub.Mat. PM Min. Nec. Vac HyD My.D.
control 6 410 2110 010 4310 010 010 010 010 729 6110
PIP 4 610 110 110 4210 010 010 1110 010 519 10310
VA 5 59 529 09 328 08 08 08 18 3110 8310
GT 1 211 4111 011 211 211 011 011 111 011 511
We found no significant effects of the factors agent and tadpole density
on the activity of infected Alytes and sentinel Rana (Tab. 3.3). Activity of
sentinel Bufo tended to be affected by the factor agent. Compared to the
control group General Tonic® (lme, estimate ± SE = -10.333 ± 4.665, p
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= 0.037) and Virkon Aquatic® (lme, estimate ± SE = -11.583 ± 4.665, p
= 0.021) reduced the activity of sentinel Bufo significantly (Tab. 3.3, Fig.
3.5).
Table 3.3: Effects of antifungal agents on amphibian behavior. Analysis
of deviance table of linear mixed effects model (lme) showing differences in
tadpole activity among visits, among tadpole densities and among agents.
Values of parameter estimates show the strength of an effect under the
regime of a certain antifungal agent. Significant values are marked with
* (α = 0.05), trends with (∗).
Species factor or level estimate ± SE p-value
infected Alytes visit
tadpole9density
agent
General9Tonic®
PIP9pond9plus®
Virkon9Aquatic®
-0.589 ±90.788
0.1049±90.321
-0.6259±92.635
-3.5429±92.635
-5.2089±92.635
0.457
0.748
0.209
0.815
0.192
0.060()*
sentinel Rana visit
tadpole9density
agent
General9Tonic®
PIP9pond9plus®
Virkon9Aquatic®
-0.607 ±90.940
-0.5069±90.425
-2.8339±93.483
-4.5009±93.483
-2.4179±93.483
0.520
0.245
0.618
0.424
0.209
0.495
sentinel Bufo visit
tadpole9density
agent
General9Tonic®
PIP9pond9plus®
Virkon9Aquatic®
-2.071 ±91.428
0.178 ±90.569
-10.333 ±94.665
-4.917 ±94.665
-11.583 ±94.665
0.150
0.756
0.068()*
0.037)
0.303
0.021)
Side effects of antifungal agents on snails
In the short run results of MANOVA revealed that snails were significantly
affected by antifungal agents and by visit but not by tadpole density (Tab.
3.4). Clutch numbers did differ among visits but not among antifungal
agents or tadpole density (Tab. 3.4). We found a significant effect of anti-
fungal agent on snail protruding from shells and on snail survival (Tab. 3.4,
Fig. 3.6). General Tonic® caused the snails to protrude significantly less
than in the control group while the other antifungal agents had no effect
on this snail behavior (Tab. 3.4). General Tonic® also reduced survival of
adult snails significantly while none of the other agents showed an effect on
this response (Tab. 3.4).
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Table 3.4: Short- and long-term effects of agents on snails.
Multivariate and univariate analyses of responses to visit,
tadpole density and agent by snails. P-values for multivariate
effects are indicated in bold type. Results of the univariate
analysis show differences of each response among visit, tad-
pole density and agent and they also show contrasts between
each agent and the control group. Values of parameter es-
timates show the strength and direction of an effect of the
respective antifungal agent. Significant values (α = 0.05) are
marked with ∗.
response*variable factor*or*level estimate*±*SE p-value
MANOVA*of*short*term*responses
visit
tadpole3density
agent
<0.001*
0.270
0.005*
Univariate*LME
number3snail3clutches visit
tadpole3density
agent
General3Tonic®
PIP3pond3plus®
Virkon3Aquatic®
1.3463±30.152
0.032 ±30.096
-0.675 ±30.786
-0.008 ±30.786
-0.675 ±30.786
<0.0018
0.736
0.723
0.400
0.992
0.400
snail3protruding visit
tadpole3density
agent
General3Tonic®
PIP pond3plus®
Virkon3Aquatic®
-0.1463±30.047
-0.0083± 0.022
-0.483 ±30.188
0.100 ±30.188
0.225 ±30.188
0.0038
0.701
0.0158
0.0178
0.600
0.244
survival3adult3snails visit
tadpole3density
agent
General3Tonic®
PIP3pond3plus®
Virkon3Aquatic®
-0.1253±30.046
-0.0213±30.021
-0.475 ±30.177
-0.016 ±30.177
0.150 ±30.177
0.0098
0.346
0.0248
0.0148
0.926
0.407
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MANOVA of long term responses
tadpole1density
agent
0.118
0.379
Univariate LME
number1snail1clutches tadpole1density
agent
General1Tonic®
PIP pond1plus®
Virkon1Aquatic®
v0(1551±10(158
v0(033 ± 1(292
0(9671± 1(292
1(633 ± 1(292
0(336
0(561
0(980
0(462
0(219
number1snail1offspring tadpole1density
agent
General1Tonic®
PIP1pond1plus®
Virkon1Aquatic®
0(119 ± 1(033
v5(067 ± 8(467
v2(067 ± 8(467
27(267 ± 8(467
0(909
0(007f
0(555
0(809
0(004f
PC11offspring1snails tadpole1density
agent
General1Tonic®
PIP1pond1plus®
Virkon1Aquatic®
0(312 ±10(822
0(809 ± 0(885
v0(092 ±10(822
0(330
0(810
0(708
0(372
0(911
PC11adult1snails tadpole1density
agent
General1Tonic®
PIP1pond1plus®
Virkon1Aquatic®
v0(209 ± 0(078
v0(187 ± 0(688
v0(314 ± 0(604
1(571 ± 0(639
0(015f
0(076
0(788
0(608
0(024f
survival1adult1snails tadpole1density
agent
General1Tonic®
PIP1pond1plus®
Virkon1Aquatic®
0(023 ± 0(018
v0(216 ±10(151
0(033 ±10(151
0(283 ±10(151
0(207
0(053
0(164
0(827
0(0727f4
Results of MANOVA showed that, in the long run, snails were neither
affected by antifungal agents nor by tadpole density. The number of snail
clutches in the long run neither differed among agents nor among tadpole
density. The number of snail offspring was affected by agent, returning
significantly more offspring under the regime of Virkon Aquatic® (Tab. 3.4,
Fig. 3.6). Tadpole density did not affect the number of snail offspring. Mass
and length of snail offspring, summarized by PC1, did neither differ among
agents nor among tadpole density (Tab. 3.4). PC1 scores of adult snails
were significantly reduced at high tadpole density (Tab. 3.4). Antifungal
agent tended to affect PC1 scores of adult snails. Compared to the control
group Virkon Aquatic® increased PC1 scores of adult snails significantly
(Tab. 3.4, Fig. 3.6). Survival of adult snails was not affected by tadpole
density but tended to differ among antifungal agents. Compared to the
control group Virkon Aquatic® tended to increase survival of adult snails
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while the other agents showed no effect on survival (Tab. 3.4).
Side effects of the antifungal agents on structure and function
of the ecosystem
Short term effects on ecosystem structure Results of MANOVA re-
vealed significant differences in responses among visits and among agents
(Tab. 3.5). All measured responses were significantly different among visits
except for plankton density (Tab. 3.5). We did not find an effect of the
factor tadpole density on any of the measured variables (Tab. 3.5). Agent
had no effect on any of the continuous variables (Tab. 3.5). Antifungal
agent had a significant effect on “plankton density” and “water turbidity”.
General Tonic® reduced density of plankton significantly and it caused the
water to be turbid (Tab. 3.5).
Long-term effects on ecosystem structure Results of MANOVA showed
that the category “plankton” tended to be affected by antifungal agent
(MANOVA, p = 0.075) but not by tadpole density (Tab. 3.6). Within
the category “plankton” we found that, Daphnia sp. and Alona sp. dif-
fered significantly in number among agents but not among different tadpole
densities (Tab. 3.6, Fig. 3.7). Number of Alona sp. increased significantly
under the regime of Virkon Aquatic® compared to the control group (Tab.
3.6, Fig. 3.7). Numbers of Daphnia sp. differed significantly among agents
(lme, p = 0.017). Compared to the control group numbers of Daphnia sp.
were significantly higher in the Virkon Aquatic® treatment (Tab. 3.6). We
found no effect of agent or tadpole density on numbers of Volvox sp., Cypris
sp., Cyclops sp. and numbers of nauplius larvae (these are larvae of crus-
taceans e.g. of Cypris sp. and Cyclops .sp). Compared to the control group
numbers of Volvox sp. tended to be higher and numbers of Cypris sp. were
significantly higher in the Virkon Aquatic® treatment (Tab. 3.6). Results
of MANOVA revealed no effect of agent or tadpole density on the category
“invertebrates and plants” (Tab. 3.6). Responses of numbers of assels, mass
of beetles, molting rate of damselflies and chlorophyll content of plants did
not differ significantly among agents or among tadpole density (Tab. 3.6).
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Table 3.6: Long-term effects of antifungal agents on ecosys-
tem structure. Multivariate and univariate analysis of re-
sponses by “plankton” and by “invertebrates and plants” to
agent and tadpole density. P-values for multivariate effects
are indicated in bold type. Results of the univariate analy-
sis show differences of each response among tadpole density
and among agent and they also show contrasts between each
agent and the control group. Values of parameter estimates
show the strength and direction of an effect of the respective
antifungal agent. Significant values (α = 0.05) are marked
with∗, trends with (∗).
response*variable factor*or*level estimate p-value
MANOVA
Plankton tadpole±density
agent
0.107
0.075(*)
Univariate*LME
Alona sp. tadpole±density
agent
General±Tonic®
PIP±pond±plus®
Virkon±Aquatic®
-0.435±±±0.370
-0.433±±±0.506
0.840±±±0.506
1.316±±±0.506
0.252
0.017*
0.401
0.110
0.016*
Daphnia sp. tadpole±density
agent
General±Tonic®
PIP±pond±plus®
Virkon±Aquatic®
14.071±±±12.527
-15.700±±±17.116
-3.533±±±17.116
46.800±±±17.116
0.273
0.017*
0.369
0.838
0.012*
Volvox sp. tadpole±density
agent
General±Tonic®
PIP±pond±plus®
Virkon±Aquatic®
-59.50±±±42.69
-35.67±±±58.32
-8.50±±±58.32
114.00±±±58.32
0.177
0.130
0.546
0.885
0.063(*)
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Cypris sp. tadpole±density
agent
General±Tonic®
PIP±pond±plus®
Virkon±Aquatic®
h1.785±±±1.537
0.033±±±2.100
2.700±±±2.100
4.366±±±2.100
0.257
0.161
0.987
0.211
0.049f
Cyclops sp. tadpole±density
agent
General±Tonic®
PIP±pond±plus®
Virkon±Aquatic®
3.643±±±3.921
h4.700±±±5.358
h6.033±±±5.358
h6.033±±±5.358
0.363
0.595
0.389
0.272
0.272
Nauplius±larvae tadpole±density
agent
General±Tonic®
PIP±pond±plus®
Virkon±Aquatic®
h0.571±±±3.652
h3.700±±±4.990
h3.700±±±4.990
1.866±±±4.990
0.848
0.877
0.466
0.466
0.712
Invertebrates and plants tadpole±density
agent
0.712
0.344
counts of assels tadpole±density
agent
h6.642±±±13.384 0.625
0.432
mass±of beetles tadpole±density
agent
0.0006±±±0.0005 0.279
0.510
counts±of damselfly±molts tadpole±density
agent
0.429±± 0.289 0.152
0.927
chlorophyll±of±plants tadpole±density
agent
1.166±±±1.133 0.314
0.237
Effects on ecosystem function Results of a MANOVA revealed no sig-
nificant effect of agent or tadpole density on the category “litter breakdown”
(Tab. 3.7). The percentage of litter breakdown of beech, oak and maple nei-
ther differed among agents nor among tadpole density (Tab. 3.7).
3.4 Discussion
The experiment mimicked a natural pond ecosystem and a possible treat-
ment of amphibians using antifungal agents against the pathogen Batracho-
chytrium dendrobatidis. The setup of the experiment was mostly oriented
at the system we find in natural ponds here. The spectrum of species we
introduced into the mesocosm is very common here and the timing of intro-
duction of the species as well is geared to the natural coming and going of
species in natural ponds here. Our experiment offers insight into 1) effects
of antifungal treatment on Bd infection of infected Alytes metamorphs; 2)
effects of antifungal treatment on transmission of Bd to uninfected amphib-
ians. Importantly, we also tested whether the antifungal treatment had side
effects on amphibians and on the aquatic community and ecosystem. The
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three antifungal agents differed in their effect on Bd infection. We found
no effects of PIP Pond Plus® and Virkon Aquatic® on Bd infection status
and infection loads of infected Alytes tadpoles (Woodhams et al. 2012, Fig.
3.2). In contrast, we showed that General Tonic® is effective in reducing
loads of infected animals but not in clearing infection. Under the semi-
natural mesocosm conditions , General Tonic® reduced loads of infected
metamorphs of Alytes obstetricans significantly to a low level (mean GE ±
SE = 174.21 ± 65.40). This result is promising because Tobler and Schmidt
(2010) found that surviving metamorphs of Alytes obstetricans had Bd loads
that exceeded the level of treated individuals in this study (mean GE ± SE
of surviving Alytes metamorphs in Tobler and Schmidt (2010): = 282 ±
1132). We thus suggest that General Tonic® can reduce Bd loads to a level
that is tolerated by Alytes obstetricans. Because we measured Bd loads after
metamorphosis, our results furthermore show that the treatment with Gen-
eral Tonic® during the tadpole stage is effective throughout metamorphosis
even if animals leave the treatment at stage 42 and finish metamorphosis in
a Bd-friendly temperature of 19-21◦C.
Transmission of Bd occurred when uninfected sentinel tadpoles became
infected with Bd. Transmission occurred in all treatments. We expected
that if antifungal treatments decrease loads, then transmission should be
reduced. Indeed, visual inspection of the results (Fig. 3.3) suggests that
infection of sentinel tadpoles was lowest when tadpoles where treated with
General Tonic® and Virkon Aquatic® . The statistical analysis, however,
showed that differences were mostly not significant either among density
of infected Alytes or among antifungal agent. Results suggest that Virkon
Aquatic® blocked transmission from infected to uninfected Alytes tadpoles
even though it did not affect Bd loads. It may be that Virkon Aquatic® af-
fects free swimming zoospores. We tentatively conclude that both General
Tonic® and Virkon Aquatic® appear to reduce transmission but admit that
a more powerful experiment (with more replicates and larger numbers of
sentinel tadpoles) would be necessary to confirm this conclusion.
Antifungal treatments did not only affect Bd infection and transmission
but also had effects of tadpoles and the aquatic ecosystem. Antifungal agents
affected tadpole size and behavior but had no severe pathological effects on
organs and tissue. Antifungal agents had sometimes negative effects on
tadpole size (Fig. 3.4). Those effects were both agent- and species-specific.
We found no negative effect of antifungal agents on size of infected and
sentinel Alytes. This result contrasts with a previous laboratory experiment
where General Tonic® had a negative effect on size of Alytes obstetricans
tadpoles (Geiger and Schmidt 2013). Taken together, these results imply
that side-effects of antifungal agents can be context-dependent and may
therefore be difficult to extrapolate to other systems such as natural ponds.
The tissue changes observed in the examined individuals which might
be interpreted as the expression of a presumptive toxic process were gener-
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ally minimal to mild, with more rare findings of moderate alterations and
were present across all treatment groups and controls. The frequent autol-
ysis that was present in several of the examined tadpoles compromised a
conclusive assessment of the actual effect, if any, of the antifungals used in
this study. For a more conclusive assessment concerning the actual poten-
tial toxic effects of the drugs investigated in this study a larger sample size
needs to be examined along with the ultrastructural analysis of the tissues
of the treated amphibians in order to determine also those changes which
cannot be obviously detected under light microscopy. Behavioral responses
of tadpoles were also species- and antifungal-agent specific. The ecological
consequences of reduced activity in response to General Tonic® and Virkon
Aquatic® are difficult to predict. Reduced activity may lead to reduced
food intake but it may also reduce predation mortality (Werner and Anholt,
1993). Reduced activity may also be a response to higher food availability
(Anholt and Werner, 1998).
Our results suggest that snails respond sensitively to antifungal agents.
Due to their ability to accumulate large amounts of pollutants, snails are
even suggested as bioindicator species (Basopo and Naik, 2012). In the
present experiment snails responded in many ways to the antifungal agents.
Like in the previous discussed results, General Tonic® caused effects in the
short-run while Virkon Aquatic® showed only long-term effects on snails.
General Tonic® provoked a survival effect and caused the snails to retreat
more into their shells. The survival effect of the adult snails disappeared in
the long run and a “normal” number of offspring emerged from the General
Tonic® treated mesocosms. Virkon Aquatic® had no effect in the short run.
In the long run however more offspring emerged which might be due to the
better survival and higher physical constitution of the adult snails. Below
the line, we do not recommend a treatment with General Tonic® at sites with
rare and delicate mollusks while a treatment with Virkon Aquatic® might
less be of a concern but requires a careful monitoring of mollusks. Our
findings on side effects on other aquatic organisms are consistent with the
findings on Bd infection and on snails: effects of General Tonic® disappear
after few weeks while effects of Virkon Aquatic® emerge several weeks or
months after the treatment. During the month when agents were added
to the mesocosms General Tonic® reduced plankton density drastically and
caused the water to be turbid. Insects (damselflies and beetles) were not af-
fected by General Tonic® . Virkon Aquatic® returned no short-term effects
on any of the measured aquatic organisms.
Measurements we did several weeks after the last application of the an-
tifungal agent inferred that short-term effects of General Tonic® disappear
relatively quickly and no long-term effects emerged. However, the water in
the treatment with General Tonic® remained darker and more turbid than in
the other treatments. In the Virkon Aquatic® treatment we found that side
effects appear only after several weeks when the number of different plank-
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ton species increased. These changes implicate that Virkon Aquatic® caused
changes not immediately, but may change a system over the course of some
weeks, while General Tonic® changes a system immediately but not sus-
tainably. Summarizing short- and long-term effects on structural metrics
we suggest that a treatment with antifungal agents affects plankton densi-
ties causing declines immediately or increase after several weeks but it may
not affect insects, crustaceans or plants heavily.
Counts of individuals, measures of water turbidity, chlorophyll content
and biological diversity are point-in-time measurements that reflect the ac-
tual status or condition of an ecosystem. Therefore, we also conducted
functional measurements that represent also dynamics and performance of
an ecosystem (Palmer and Febria, 2012). Woodward et al. (2012) suggest
litter breakdown and reproduction as a measurement of ecosystem function.
In our experiment, the breakdown of oak, maple, and beech leafs was not
affected by General Tonic® and neither by Virkon Aquatic® .
All side effects considered we tested 39 hypotheses of which 12 returned
significant results and 3 a trend. This is a high outcome of significances,
however we bring in mind that we did no Bonferroni correction and we may
reckon that we registered some false alarms. A trend however is obvious:
General Tonic® caused declines in a variety of responses in the short run
while Virkon Aquatic® boosted numbers of individuals in the long run.
Consequences of either of the two effects are difficult to predict and depend
much on the system where the antifungal agent is applied.
In summary, we showed that commercially available antifungal agents
can reduce Bd loads in experimental mesocosms and may also reduce Bd
transmission. Negative side effects on amphibians were, in our opinion,
context- and species-specific but overall relatively benign. Yet, antifungal
agents have a number of side effects on the ecosystem.
Our main motivation for the experiment was to test a method inspired by
use of antifungal agents in agriculture that may be used to treat amphibians
against Bd in natural systems. While it is possible to treat amphibians
against Bd in captivity, no treatments are available for natural systems
(Lubick, 2010; Woodhams et al., 2011; Garner et al., 2012). Given our
results, we believe that General Tonic® might be considered a candidate
antifungal agent worth additional studies to better explore its treatment
potential and side-effects to make recommendations about whether it may be
used in natural environments. General Tonic® does not clear infection but
it reduces Bd loads. Vredenburg et al. (2010) showed that amphibian mass
mortality begins when the infection intensity reaches a critical threshold of
10,000 zoospores (the threshold might be species-specific). The models of
Briggs et al. (2010) and Mitchell et al. (2008) suggest that reducing Bd
infection loads might help populations to persist with endemic Bd infection.
Hence, reducing Bd infection loads, rather than eradicating the pathogen,
may be a viable strategy to help amphibians to persist despite the presence
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of Bd. Clearly, experimental mitigation in natural systems is a necessary
next step. Such experiments will show whether Bd mitigation in the field is
possible.
The drawback is, of course, that Bd will persist and that repeated treat-
ments may be necessary. As it is the case with habitat management, amphib-
ian conservation of the future may include recurrent antifungal treatments
(Woodhams et al., 2011). At best, repeated treatments might eventually re-
duce Bd loads permanently and might lead to the eradication of the pathogen
(Lubick 2010). While this may be positive from an amphibian conservation-
ists point of view, recurrent treatment of natural systems with antifungal
agents is likely to have consequences for the ecosystem. Here, we reported
some negative effects on snails and the wider ecosystem. Recurrent treat-
ment may exacerbate such effects. The crucial question is: when shall we
treat a natural system? What are the costs and the benefits? While the ben-
efit for amphibians seems clear, we know that there are costs but the costs
are much harder to quantify (Fig. 3.8). In such a situation, we recommend
a precautionary approach. That is, one should only use antifungal agents in
natural habitats when the expected benefit is large and likely outweighs the
costs. A benefit may be large if one is witnessing a catastrophic Bd-induced
population decline. In stable situations, where Bd does not appear to have
an immediate catastrophic effect, e.g. Tobler et al. (2012), we would not rec-
ommend the use of antifungal agents. Costs of antifungal treatments may
also depend on habitat type. Antifungal treatments may be more admissible
in simple habitats (such as the gorges inhabited by the Mallorcan midwife
toad Alytes muletensis; Woodhams et al. 2011) or man-made habitats such
as gravel pits (where the common midwife toad Alytes obstetricans is com-
monly found). An assessment of costs and benefits of anti-Bd treatments
should also evaluate other strategies; e.g. in the long run it may be better to
block disease transmission rather than treating infected individuals (Garner
et al. 2012) and approaches (e.g. use of probiotic bacteria; Woodhams et
al. 2011).
While it is possible to treat natural populations against pathogens, e.g.
Hudson et al. (1998), there is no such treatment yet for emerging infectious
diseases such as Bd. Our mesocosm experiment is an important step towards
Bd mitigation but there is still much to learn before any treatment can be
recommended.
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Figure 3.4: Boxplots showing effects of the antifungal agents General
Tonic® (GT), PIP Pond Plus® (PIP) and Virkon Aquatic® (VA) on mass
and length of metamorphosing amphibians (infected Alytes) and tadpoles
(sentinel Alytes, sentinel Bufo and sentinel Rana). Mass and length is sum-
marized by PC1 score. The black line represents the median, the box rep-
resents the interquartile range containing 50% of the values and whiskers
mark the 1.5 fold interquartile range. Outliers are marked with circles.
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Figure 3.5: Short-term effects of agents on tadpole activity during the
treatment-period. Visit 1 was right after the first treatment and visit 4 right
after the last treatment. Here we calculated the percentage of tadpoles that
were active (swimming or feeding) in a mesocosm.
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Figure 3.6: Short- and long-term side effects of antifungal agents on re-
sponses of snails. Behavior and survival of adult snails represent short-term
effects measured between the first treatment (=visit 1) and the last treat-
ment (=visit 4). Boxplots showing offspring and size of adult snails represent
long-term effects measured on day 177 or 129 respectively.
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Table 3.5: Short-term effects on ecosystem structure. Multivariate and uni-
variate analysis of responses measured repeatedly during the treatment pe-
riod to visit, agent and tadpole density. The response vector of the mul-
tivariate analysis is defined by the six variables of structural metrics and
p-values to each factor are shown in bold type. Results of the univariate
model show differences of each response among visit, tadpole density and
agent and they also show contrasts between each agent and the control
group. Values of parameter estimates show the strength and direction of an
effect of the respective antifungal agent. Significant values (α = 0.05) are
marked with ∗.
response1variable factor1or1level estimate1±1SE p-value
MANOVA
Short-term1effects1on1ecosystem
structure
visit
tadpole3density
agent
<0.001
0.595
<0.001
Univariate1LME
beetle3activity visit
tadpole3density
agent
General3Tonic®
PIP3pond3plus®
Virkon3Aquatic®
w0(2393±30(066
0(0273±30(027
w0(2253±30(219
0(0253±30(219
w0(2253±30(219
<0(001m
0(326
0(559
0(314
0(910
0(314
damselfly3survival visit
tadpole3density
agent
General3Tonic®
PIP3pond3plus®
Virkon Aquatic®
w0(0793±30(037
0(0183±30(022
w0(1253±30(179
w0(1673±30(179
w0(1253±30(179
0(038m
0(421
0(779
0(491
0(360
0(491
counts3of damselfly3molts visit
tadpole3density
agent
General3Tonic®
PIP3pond3plus®
Virkon3Aquatic®
w0(1073±30(050
0(0003±30(018
w0(1253±30(152
0(0833±30(152
w0(1253±30(152
0(034m
1(000
0(536
0(419
0(589
0(419
plankton3density visit
tadpole3density
agent
General3Tonic®
PIP3pond3plus®
Virkon3Aquatic®
w0(0933±30(306
w0(0783±30(116
w4(3283±30(895
0(1923±31(255
w0(5483±31(037
0(760
0(498
<0(001m
<0(001m
0(879
0(597
water3turbidity visit
tadpole3density
agent
General3Tonic®
PIP3pond3plus®
Virkon3Aquatic®
0(5803±30(319
w0(1123±30(114
4(0953±31(137
0(5373±31(451
1(2963±31(268
0(069*m4
0(325
<0(001m
<0(001m
0(711
0(306
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Figure 3.7: Long-term effects of the agents on ecosystem structure. Boxplots
showing effects of the antifungal agents General Tonic® (GT), PIP Pond
Plus® (PIP) and Virkon Aquatic® (VA) on number of Daphnia sp. and
Alona sp. The black line represents the median, the box represents the
interquartile range containing 50% of the values and whiskers mark the 1.5
fold interquartile range. Outliers are marked with circles.
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Table 3.7: Effects of antifungal agents on ecosystem function. Multivariate
and univariate analysis of responses by litter breakdown to agent and tadpole
density. P-values for multivariate effects are indicated in bold type. Results
of the univariate analysis show differences of each response among tadpole
density and among agent and they also show contrasts between each agent
and the control group. Values of parameter estimates show the strength and
direction of an effect of the respective antifungal agent. Significant values
(α = 0.05) are marked with*, trends with (∗).
response5variable factor5or5level estimate p-value
MANOVA
Litter5breakdown tadpole1density
agent
0.395
0.725
Univariate5LME
41beech1decomposed tadpole1density
agent
General1Tonic®
PIP1pond1plus®
Virkon1Aquatic®
8.107 ±16.491
9.540 ±19.012
4.585 ±18.515
6.584 ±19.012
0.227
0.793
0.303
0.596
0.474
41oak1decomposed tadpole1density
agent
General1Tonic®
PIP1pond1plus®
Virkon1Aquatic®
4.825 ±15.941
-7.016 ±18.253
-12.761 ± 7.761
3.214 ±18.253
0.426
0.288
0.405
0.115
0.701
41maple1decomposed tadpole1density
agent
General1Tonic®
PIP1pond1plus®
Virkon1Aquatic®
-9.694 ±15.925
-13.354 ±18.095
-8.624 ±18.095
-3.623 ±18.095
0.115
0.402
0.113
0.298
0.659
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Figure 3.8: Percentaged difference of agent-induced changes in mesocosms.
The mean of the traits in the control group was taken as zero. The chart
shows at a glance which traits are affected by a treatment (i.e. are dislodged
from the zero-line) and which traits not. Significant differences are marked
with *, trends with (*).
Chapter 4
Experimental mitigation of
the amphibian chytrid
fungus (Batrachochytrium
dendrobatidis) in natural
ponds
Corina C. Geiger and Benedikt R. Schmidt
Abstract The disease chytridiomycosis, caused by the fungus Batracho-
chytrium dendrobatidis (hereafter Bd), is one of the most devastating emerg-
ing infectious diseases and is threatening amphibians worldwide. To halt
amphibian declines, there is a need for methods that can be used to mit-
igate the effects of chytridiomycosis in amphibian populations. Here we
report on three experiments, one in mesocosms and two in natural ponds,
where we tested whether a treatment with antifungal agents during the tad-
pole stage reduces Bd infection in the short and in the long term. We set
up experimental mesocosms and introduced infected tadpoles of Alytes ob-
stetricans. After a week we treated them with Itraconazole and returned
them to their original mesocosm. Upon metamorphosis we caught tadpoles
out and kept them individually in the laboratory and monitored infection,
survival and body size of each individual. For the second experiment we
chose seven ponds for experimental antifungal treatments where infected
tadpoles of Alytes obstetricans hibernate. In spring we caught tadpoles,
treated them with Itraconazole and returned them back into their original
ponds. We monitored Bd infection of treated as well as of untreated tadpoles
regularly over the course of a year. We did experiment three a year later at
the same sites. Experiment three was similar to the second experiment but
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we applied another antifungal agent (General Tonic® ) and we did treat-
ments not only once but monthly starting in spring and ending in fall. We
found that a treatment with Itraconazole in mesocosms in the tadpole stage
reduced Bd loads and Bd prevalence before and after metamorphosis and
reduced mortality of metamorphosed individuals. Itraconazole also reduced
Bd loads and prevalence in natural ponds in the short term but not in the
long term. Repeated treatments with General Tonic® reduced Bd loads in
the short term but this effect was not sustained in the long run when treat-
ments were no longer applied. Repeated treatments reduced prevalence of
untreated tadpoles. This effect might be caused by the temporary removal
of a subsample of infected animals during the treatment period. However we
observed this effect only among young of the year tadpoles that entered the
pond uninfected. Reducing tadpole density by removing individuals tem-
porarily from a pond might thus be an effective strategy to keep prevalence
on a low level, given that prevalence is low. Finally we found that a treat-
ment in fall is not effective. These results suggest that antifungal agents
can reduce infection but cannot eradicate Bd from natural environments.
However, treatments are effective for a short time and thus might serve as
an emergency measure in the case of a Bd-induced mass die-off.
Keywords amphibian, Alytes obstetricans, Batrachochytrium dendroba-
tidis, disease, mitigation, treatment, General Tonic® , Itraconazole, meso-
cosms, natural habitat.
4.1 Introduction
One of the most severe and increasing threats to biodiversity and wildlife are
emerging infectious diseases (EIDs) (Daszak et al., 2000, 2001; Greger, 2007;
Smith et al., 2009). EIDs are responsible for the decline of numerous plant
and animal species resulting in an impact on the structure and function of
ecological communities (Whiles et al., 2006). One of the most devastating
EID is the fungal disease chytridiomycosis. It is caused by the fungus Ba-
trachochytrium dendrobatidis (hereafter Bd), and threatens amphibian pop-
ulations around the globe (Skerratt et al., 2007). Bd is a generalist pathogen
and infects of over 500 species on all continents (Fisher et al., 2009). The
pathogen has apparently spread at an alarming rate over large distances
and amphibian populations collapsed after emergence of the pathogen (Lips
et al., 2006; Wake and Vredenburg, 2008).
Once the pathogen emerged at a place, it can persist and in some areas
it is even suggested to be enzootic (Longo et al., 2010; Tobler et al., 2012).
The fungus can survive up to three months in moist sterile river sand and
grows on sterile feathers, dead algae and arthropod exoskeletons (Johnson
and Speare, 2005). Good evidence exist that multiple asymptomatically
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infected amphibian species serve as reservoir hosts (Daszak et al., 2001;
Weldon et al., 2004; Picco and Collins, 2008). One important reservoir
is the tadpole stage. Tadpoles can act as a within-host reservoir for the
pathogen (Briggs et al., 2010) because infection in tadpoles is restricted to
the mouthparts (Berger et al., 2005). Tadpoles are asymptomatic but they
produce zoospores (Rollins-Smith, 1998).
In consideration of these reservoirs and diversity of hosts, a development
of a mitigation strategy is a challenging issue and the complete eradica-
tion of the pathogen from an environment may be impossible (Lubick, 2010;
Woodhams et al., 2011). In the present article we report on experiments
in mesocosms and in natural ponds where naturally infected tadpoles were
treated against Bd. We decided to focus on tadpoles because a success-
ful treatment of tadpoles may allow amphibian populations to persist with
Bd. Briggs et al. (2010) found that persistence of Bd is enhanced by the
long-lived tadpole stage. Clearing infection in tadpoles or at least reducing
pathogen loads shortly before metamorphosis might thus reduce mortality
among metamorphosing individuals (Briggs et al., 2010; Vredenburg et al.,
2010). Moreover tadpoles are often better accessible than adult individuals.
Furthermore, population models lead us to expect that enhancing juvenile
survival should increase population viability (Lampo and De Leo, 1998; Hels
and Nachman, 2002; Conroy and Brook, 2003).
We designed three experiments in each of which we captured tadpoles in
ponds and released them back into the ponds after anti-Bd treatment. We
first tested the method in a mesocosm experiment under natural but con-
trolled conditions and thereafter tested the method in natural ponds. The
aim of the mesocosm experiment was to test the efficiency of an Itracona-
zole treatment (Garner et al., 2009a) during the tadpole stage in reduction
of Bd infection, its effect on size of individuals, and also on survival of meta-
morphosed individuals. The aim of the two pond experiments was to test
the efficiency of the antifungal agents Itraconazole and General Tonic® in
reducing Bd infection (Geiger and Schmidt, 2013). The main goals of the
two experiments were (i) to test whether anti-fungal treatments reduce Bd
infection or infection intensity permanently and (ii) whether treatments had
any side effects on treated tadpoles.
4.2 Material and Methods
Overview
This study consists of three experiments: i) A mesocosm experiment in
which we tested whether Itraconazole can be used to treat tadpoles of Alytes
obstetricans under semi-natural conditions against Bd, ii) an field experi-
ment in which we used Itraconazole to treat tadpoles of Alytes obstetricans
against Bd in natural ponds and iii) a field experiment in which we used
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General Tonic® to treat tadpoles of Alytes obstetricans against Bd. We
selected Alytes obstetricans as our model species because it is known to be
susceptible to Bd (Bosch, 2001; Tobler and Schmidt, 2010; Walker et al.,
2010; Bo¨ll et al., 2012).
General procedures
Antifungal agents: Itraconazole (Sporanox Oral Solution, Janssen-Cilag AG,
Baar, Switzerland) was found to be an effective antifungal agent against
Bd infection of tadpoles of Alytes muletensis and A. obstetricans (Garner
et al., 2009a) Itraconazole cleared 100% of tadpoles of both species from
Bd when they were bathed for 5 min. daily in a 1 mgL−1 Itraconazole
solution over 7 days (Garner et al., 2009a). In Alytes obstetricans, no depig-
mentation was observed (Tobler and Schmidt, 2010). General Tonic® was
developed to treat captive fish against bacterial infections, ectoparasites and
for treating lesions. The active substances are ethacridinlactat, acriflavin,
9-aminoacridin * HCI * H2O and methylene blue (Tetra GmbH D 49304
Melle, Germany, www.tetra.net). In a previous laboratory and mesocosm
experiment we showed that General Tonic® reduced loads and prevalence of
Bd (Geiger and Schmidt 2013). DNA extractions and rt-PCR: The tips of
Bd swabs were cut off, put in 60 µl of PrepMan Ultra (Applied Biosystems)
and extracted applying the bead-beating protocol of Boyle et al. (2004). Ex-
tractions were afterwards diluted 1/10 and amplified following the rt-PCR
protocol by (Boyle et al. 2004). Wells containing 0.01 genomic equivalents
(GE) or more were scored positive. Samples were run in duplicate with
negative controls and 4 dilutions of standards (100, 10, 1, 0.1 zoospore ge-
nomic equivalents, hereafter loads). If the results of the two PCR-wells were
inconsistent the analysis was repeated. Values of Bd loads are corrected for
the 1/10 dilution.
Mesocosm experiment
This experiment in mesocosms served as a pilot study for experiment in
natural ponds.
Experimental design The experiment had a three-by-two factorial de-
sign. The first factor was population of origin. We used tadpoles from two
populations (see below). The two populations were crossed with a factor
“Itraconazole treatment”. We kept tadpoles at a density of n=4 per meso-
cosms. In the control, no tadpoles were treated against Bd. In the “all”
treatment, all tadpoles were treated against Bd. In the “half” treatment,
2 out of 4 tadpoles were treated against Bd. Each of the resulting 6 treat-
ment x population combinations was replicated three times. Treatments
were assigned randomly to mesocosms.
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Mesocosm setup We set up 18 mesocosms in early March 2009, several
weeks prior to the start of the experiment. The experimental units were
rectangular fiberglass containers (1.34 m2, 1000 L volume). We placed these
containers outdoors in an open field at the University of Zurich (8.55094◦E,
47.39592◦N, 507 masl). The mesocosms were started with 650 L of tap
water and 400 g leaf litter (Quercus robur, Fagus sylvatica and Acer pseudo-
platanus) as substrate. Mesocosms were covered with green shade cloth to
prevent colonization by invertebrates. We inoculated the mesocosms with
several aliquots of pond water with concentrated plankton from a nearby
wetland (Bachenbu¨ler Allmend, 8.54295◦E, 47.48309◦N, 423 masl).
Stocking with amphibians All amphibians used in the experiment were
from either a pond near Itingen or Zunzgen, Switzerland (Tobler and Schmidt
2010). We chose these two sites because we knew that i) Alytes obstetricans
is abundant there, ii) tadpoles do hibernate there, iii) the site is positive for
Bd and iv) the other amphibian species we needed for this experiment occur
there too.
In late March 2009, we collected 146 tadpoles (72 in Itingen, 74 in Zunz-
gen) of Alytes obstetricans that had hibernated in the pond. We brought the
tadpoles to the University and placed them individually in clear plastic con-
tainers. After two days we swabbed every individual over the mouthparts
with a sterile rayon tipped plain swab with a plastic applicator (Copan,
Brescia, Italy). Swabs were analyzed for the presence of Bd with rt-PCR.
Among those tadpoles that tested positive for Bd, 72 (36 from Itingen, 36
from Zunzgen) were chosen for the experiment. Individuals were randomly
assigned to one of the three treatment combinations (all, half, and control).
We marked each individual with a red or orange (untreated) or rather green
or pink (treated) Visible Implant Elastomer tag (VIE) (Northwest Marine
Technology, Ben Nevis Loop Rd Shaw Island, Washington, USA; (Anholt
et al., 1998)). To be able to recognize animals individually we put markings
either on the left or on the right side of the animal. To create a realis-
tic amphibian assemblage, we also added 20 laboratory hatched tadpoles
of Bufo bufo and 20 of Rana temporaria to each mesocosm. All of them
were collected in Zunzgen. Upon metamorphosis B. bufo and R. tempo-
raria were euthanized with MS222 and stored in 98% ethanol, while the
surviving A. obstetricans were caught out of the mesocosms and brought to
the laboratory. We placed them individually in one-litre plastic containers
with little tab water and with three dried beech tree (Fagus sylvatica) leafs
(Tobler and Schmidt 2010). Containers were tilted so that both land and
water were available to the toadlets. The laboratory was equipped with full
spectrum sunlight lamps set for a 12 h day length. Room temperature was
kept at 19 - 21◦C. We fed the toadlets crickets of adequate size ad libitum
three times a week. For each individual, the experiment ended 30 days after
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stage 42 or upon death. After the experiment the survivors were treated
with Itraconazole and released close to their original pond.
Antifungal treatments After having spent a week in the mesocosms, we
caught the 72 marked and infected Alytes obstetricans tadpoles out of the
mesocosms and brought them to the laboratory. We started the 7-day treat-
ment by giving the “treated” tadpoles a daily bath for 5 min. in a solution of
1 mg L−1 Itraconazole (Garner et al. 2009, Tobler and Schmidt 2010). “un-
treated” tadpoles were treated the same way except that we bathed them in
tap water rather than in Itraconazole solution. Tadpoles were fed ad libitum
with fish food (Sera Spirulina Tabs, Sera GmbH, Heinsberg, Germany) all
through the 7 days of their stage in the laboratory. After the treatment
tadpoles were released in their original mesocosm.
Measurements We swabbed each individual at the beginning of the ex-
periment, after the Itraconazole treatment and at Gosner (1960) stage 46 (or
upon death in case that an individual died before reaching stage 46). This
allowed us to test for Bd infection at the three time points “beginning”, “af-
ter” and “metamorphosis”. “Metamorphosis” were pooled data of the dead
metamorphs (developmental stage of 45-46 and two dead individuals with
stage 42) and survivors at stage 46. To assess whether antifungal treatments
affects tadpole size, we recorded the body mass and body length of tadpoles
at the beginning of the experiment and at stage 46. Mass was measured to
the nearest 0.01g on a Scaletec Scale (Scaletec Instruments, Heiligenstadt,
Germany) after blotting animals dry on a paper tissue. Body length was
measured to the nearest 0.1 mm from the tip of the snout to the beginning
of the tail muscle using a sliding caliper. We registered the developmental
stage (Gosner, 1960) at the beginning of the experiment. We recorded the
date of reaching stage 42 and the date of death or their survival until the
end of the experiment (30 days after the last individual reached stage 42).
Response variables and statistical analyses of mesocosm experi-
ment To test for effects of Itraconazole treatment and population of ori-
gin on prevalence (which was 100% at the beginning of the experiment),
we used a generalized linear mixed effects model (glmer) with a binomial
error distribution taking infection status of individuals (infected, not in-
fected) as dependent variable and time, treatment, population and interac-
tion treatment-by-population as explanatory variables (fixed effects). Meso-
cosm was included as grouping (random) effect (Tab. 4.1).
We used the logarithm of Bd loads to quantify infection intensity. To
test for effects of Itraconazole treatment and population of origin on the
logarithm of loads we used a linear mixed effects model (lme) time, treat-
ment, population and interaction treatment-by-population as explanatory
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Table 4.1: Mesocosm experiment. Effects of treatment, time, population
and interaction treatment-by-population on Bd prevalence and Bd loads. P-
values in bold type show differences among factors, while p-values in normal
type size show contrasts in Bd prevalence and Bd loads between a certain
level of a factor and the control level. Estimates and their standard errors
(SE) show how strong and in which direction prevalence or loads are affected
by a certain level. Significant values are marked with ∗ (α = 0.05).
Factor Bd:prevalence Bd:loads
level estimate:±:SE p-value estimate ±:SE p-value
treatment <0.001* <0.001*
half -1.937 ± 0.703 0.006* -2.325 ± 0.563 0.001*
all -3.514 ± 0.770 <0.001* -2.450 ± 0.552 0.001*
time <0.001* <0.001*
after treat. -3.354 ± 0.602 <0.001* -4.729 ± 0.355 <0.001*
stage 46 -3.897 ± 0.630 <0.001* -4.681 ± 0.368 <0.001*
population 0.964 0.045*
Zunzgen -0.355 ± 0.755 0.638 -1.019 ± 0.562 0.095
treatment:population 0.926 0.216
variables (fixed effects) and mesocosm as grouping (random) effect (Tab.
4.1).
To analyze effects of the treatment on mortality we used a generalized
linear mixed model (glmer) with a binomial error distribution taking mor-
tality at the end of the experiment as dependent variable. As explanatory
variables we included treatment and population as fixed effects and meso-
cosm as grouping (random) effect (Tab. 4.2).
To test for effects of Itraconazole treatment and population of origin on
size at metamorphosis, we checked for differences in size at stage 46 among
treatments and among populations (individuals that did not reach meta-
morphosis were excluded from this analysis). We used principal component
analysis to combine mass and length of individuals into a single variable
(Schmidt et al. 2012). We did one PCA for size at the beginning of the
experiment and one PCA for size at stage 46. The first principal component
axis (PC1) explained 97% (at the beginning of the experiment) and 85% (at
stage 46) of the variance. We used the first principal component of responses
at stage 46 as our measure of size at metamorphosis. We tested for an effect
of treatment and population on PC1 at stage 46 using a linear mixed effects
model (lme) where PC1 at stage 46 was the dependent variable and treat-
ment, population and PC1 at the beginning were the explanatory variables
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Table 4.2: Mesocosm experiment. Parameter estimates of treatment, pop-
ulation and density showing effects on mortality of tadpoles and on size of
tadpoles at Gosner stage 46. P-values in bold type show differences among
factors, p-values in normal type size show contrasts in Bd prevalence and Bd
loads among levels. Estimates indicate strength and direction of an effect.
Significant values are marked with * (α = 0.05).
Factor mortality PC15stage546
level estimate5±5SE p-value estimate5±5SE p-value
treatment <0.001* 0.405
half -1.825 ± 0.649 0.005* -0.252 ± 0.703 0.727
all -4.289 ± 1.135 <0.001* 0.561 ± 0.684 0.428
population 0.360 0.071
Zunzgen -0.562 ± 0.619 0.363 1.462 ± 0.601 0.032
PC15at5beginning - - -0.234 ± 0.157 0.147
(fixed effects) and we included mesocosm as grouping (random) effect (Tab.
4.2).
Field experiment in natural ponds
We conducted two experiments in natural ponds. In the first experiment, we
used Itraconazole to clear tadpoles of Alytes obstetricans from Bd infection
whereas we used General Tonic® in the second experiment. In the first
experiment, we treated tadpoles against Bd only once in April 2010 while in
the second experiment we treated tadpoles against Bd once a month from
May to September 2011. The dynamics of Bd infection were then monitored
until the following spring.
Throughout both experiments we followed standard biosafety protocols
to avoid spreading Bd or other pathogens (Schmidt et al., 2009b).
Experimental design Both experiments had a two-by-one factorial de-
sign. The two levels of the factor treatment (treatment and control) were
randomly assigned to 7 ponds. This assignment was not changed between
the Itraconazole and the General Tonic® experiment. However one site in
the treatment group was dropped after the first experiment because of a lack
of tadpoles. Thus in the Itraconazole experiment the level “treatment” was
replicated 4 times and “control” was replicated 3 times while in the Gen-
eral Tonic® experiment we had 3 replicates in the level “treatment” and 3
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replicates in the level “control”.
Study sites The two experiments in natural ponds were carried out in the
canton Lucerne in central Switzerland. This is an area where Bd does not
appear to negatively affect populations despite high prevalence (Tobler et
al. 2012). We selected 7 ponds located at 5 different sites: Sagerhu¨sli upper
pond (hereafter SagO), Sagerhu¨sli lower pond (SagU), Ra¨schenhaus (Rae)
(only in the Itraconazole experiment), Hergiswald (Her), Hinter Rohren
(HiR), Schauensee upper pond (SchO), Schauensee lower pond (SchU). The
selection of the ponds was based on criteria that are exclusively related
to the feasibility of the experiment: i) the sites sustain large numbers of
Alytes obstetricans tadpoles, ii) tadpoles of Alytes obstetricans hibernate in
the pond, iii) amphibians are positive for Bd and iv) annual counts of the
number of calling males are available (Tobler et al. 2012, A. Borgula, per-
sonal communication) for an eventual evaluation of long-term effects of the
treatments on population size.
The first site consists of the two ponds SagO (8.01641◦E, 47.22083◦N, 689
masl) and SagU (8.01740◦E, 47.2210◦, 672 masl). Both ponds are man-made
ponds that are at a distance of about 70 m on a SE-exposed grassland. A
spring supplies the water for SagO, from which it flows down to SagU. SagO
is approximately 12 m2 in size and 0.7 m in depth and is little vegetated.
SagU is about 30 m2 in size and 1.4 m in depth. One half of it is densely
vegetated while the other half is nearly not vegetated. Rae (8.19382◦E,
47.0152◦N, 818 masl), is a former quarry in a W-exposed topographic de-
pression. The pond is about 8 m2 in size and 1.5 m deep, it is surrounded
by reed and the ground is densely vegetated. Her (8.01740◦E, 47.22101◦N,
798 masl) is a static fire tank which is 15 m2 in size and 2.5m in depth.
The tank is located on a E-exposed meadow and sparely vegetated because
it gets cleaned out regularly. HiR (8.18041◦E, 47.00922◦N, 773 masl) is a
totally natural site on a W-exposed slightly afforested hillside with an ag-
gregation of several tiny water bodies and one big pond which we included
in the experiment. The pond is approximately 30 m2 in size and 0.5 m deep.
One half is in the forest where the ground is densely vegetated, the other
half is in a swamp with little vegetation on the ground. SchO (8.28156◦E,
47.0274◦N, 570 masl) and SchU (8.28208◦E, 47.0275◦N, 558 masl) are two
man-made ponds located 30 m from each other on a SE-exposed hillside.
A fountain ensures the water supply for SchO from where it flows down to
SchU. SchO is about 6 m2 in size and about 0.5 m in depth. It is located in
a concrete basin under a birch tree (Betula pendula) which causes the pond
to have a layer of leaf litter that is cleaned out regularly by the pond owner.
SchU is approximately 10 m2 in size, 0.8 m deep and densely vegetated.
SchU as well is cleaned out regularly by the pond owner.
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Antifungal treatment in Itraconazole experiment We started the
Itraconazole experiment in early April 2010. At the ponds where tadpoles
were treated against Bd, we captured tadpoles using dipnets. A sample of
n=30 was swabbed over the mouthparts with a sterile rayon tipped plain
swab (Copan, Brescia, Italy) to test for Bd. All tadpoles were placed in PET
bottles that were filled up to two-thirds with pond water and we transported
to the laboratory at the University of Zurich. At the university, we placed
tadpoles in groups of 30 in 100 L tanks filled with aged tap water. After 2
days we started the 7-day Itraconazole treatment by giving the tadpoles a
daily bath for 5 minutes in a solution of 1 mg L-1 Itraconazole (Garner et al.
2009). To increase efficiency, tadpoles were treated in groups of 15 animals
in tubs of 6 L volume that contained 4 L of the antifungal solution. After the
5 minute treatment tadpoles were placed back in a clean and disinfected 100
L tank that was filled up with 80 L of aged tap water. Tadpoles were fed ad
libitum with fish food all through the 10 days of their stay in the laboratory.
1 day after the last treatment we swabbed 10 randomly chosen individuals
to control for the success of the treatment. We marked each individual with
a red VIE tag. Thereafter, tadpoles were placed for transport in clean and
disinfected PET bottles that were filled up to two-thirds with tab water. All
tadpoles were released at the pond of capture. These treated and marked
tadpoles are hereafter called “treated tadpoles”. Tadpoles from the same
ponds that were not treated against Bd are called “untreated tadpoles”. At
the control ponds, we caught 30 individuals, swabbed and released them
right after the swabbing (hereafter “control pond tadpoles”). We applied
the Itraconazole treatment only once in April on tadpoles that hibernated
in the ponds. This treated generation of tadpoles left the pond in summer.
Consequently we do not have data of treated tadpoles for the Itraconazole
treatment across years.
In order to monitor the dynamics of Bd infection after the treatment we
visited each pond repeatedly (May 2010, June 2010, July 2010, September
2010, January 2011 and April 2011) and swabbed at the treated ponds
30 treated and 30 untreated tadpoles and at the control ponds 30 control
tadpoles. In case that not 30 animals were available, we swabbed as many
as possible. The numbers of tadpoles that were captured at each occasion
is given in Tab. 4.3.
Antifungal treatment in the General Tonic® experiment We started
with the General Tonic® experiment in early May 2011. At the ponds where
tadpoles were treated against Bd, we captured tadpoles using dipnets. A
sample of n=30 was swabbed to test for Bd. Thereafter we marked all tad-
poles with pink VIE tags and placed them in groups of 50 in 100 L tanks
that were filled with 50 L of tap water. Tanks were placed close to the pond
and covered with green shade cloth. Tadpoles were treated against Bd using
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General Tonic® in the tanks (see Geiger and Schmidt 2013). The antifungal
treatment lasted eight days. During the first two days of treatment we kept
concentration of General Tonic® at 1.25 ml L−1 . All following treatments
were done with a General Tonic® concentration of 0.6 ml L−1 , because 13
tadpoles died during the first two days (10 in SagO and 3 in Herg). After
4 days in the tanks with General Tonic® we changed the water of all tanks
and refilled them with fresh solution of 0.6 ml L−1 General Tonic® . 4 days
later tadpoles were released into their original pond. At the control ponds
we caught 30 individuals out and released them after swabbing. This pro-
cedure of treating, marking and swabbing was done in May, June, July and
September 2011. At every occasion, we used a different color for the VIE
tag marking. In August 2011, October 2011, January 2012 and April 2012
we monitored Bd infection of the tadpoles by swabbing 30 treated tadpoles
and 30 untreated tadpoles in the treatment ponds and 30 control tadpoles in
the control ponds. In case that not 30 animals were available, we swabbed
as many as possible.
Measures of habitat characteristics We measured different environ-
mental variables to explain differences in prevalence of Bd among different
ponds. All ponds were equipped with one HOBO H8 temperature data log-
ger (Onset Computer Corporation, Bourne MA, USA) that recorded water
temperature 6 times a day between May 2011 and April 2012. The sensors
of the loggers were placed at the deepest spot in the pond where tadpoles
were found during winter 2010. Salinity, pH and oxygen concentration of the
pond water were measured on the 1st of June 2012 with a HQ30d portable
Multiparameter Meter (HACH Company, Loveland, Colorado, USA). We
measured each parameter at three different places in each pond, each 5 cm
under the water surface and approximately 0.5 m from the pond edge. We
used the mean of the three measurements for statistical analysis.
Response variables and statistical analyses of field experiments
in natural ponds We tested four main responses to the experimental
treatments: 1) reduction of Bd loads and prevalence in the short run and 2)
in the long run, 3) side effect of the monthly General Tonic® treatment on
whether an individual is metamorphosing or not and 4) effect of ecological
factors and experimental treatment on Bd loads and Bd prevalence.
We took June as reference month when we calculated contrasts of Bd
infection among treatments because this month was available in all data
sets.
1) Analysis of treatment efficiency within season in the short run: To test
for the effects of experimental antifungal treatments on prevalence, we used
a generalized linear mixed model (glmer) with a binomial error distribution
including infection status as dependent variable and treatment, month and
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interaction treatment-by-month as explanatory variables. In the General
Tonic® experiment mean temperature per month was also included as an
explanatory variable. Pond was included as grouping (random) variable. We
used this model to compare three different results of the experiment. First,
we compared “treated tadpoles” and “control pond tadpoles”. Second, we
compared “untreated tadpoles” and “control pond tadpoles”. Third we com-
pared “treated tadpoles” and “untreated tadpoles”. The third comparison
is a comparison within those ponds where some, but not all, tadpoles were
treated against Bd. We ran all three analyses for the short-term time peri-
ods May to July 2010 (treated and control pond tadpoles in the Itraconazole
experiment), April to September 2010 (untreated and control pond tadpoles
in the Itraconazole experiment), June to October 2011 (treated and control
pond tadpoles in the General Tonic® experiment) and May to September
2011 (untreated and control pond tadpoles in the General Tonic® experi-
ment) (Tab. 4.4).
Log-transformed Bd loads of infected individuals were analysed in the
same way. For the General Tonic® experiment, we included monthly mean
temperature as explanatory variable.
2) Analysis of treatment efficiency across years: To analyze efficiency of
agents in reducing prevalence a year after the treatment we used a general-
ized linear mixed model (glmer) with a binomial error distribution includ-
ing infection status in April of the year following the treatment as depen-
dent variable and treatment as explanatory variable. Pond was included as
grouping (random) variable (Tab. 4.4). We followed the same approach as
in the analysis within seasons comparing three different results of the ex-
periment (first comparing “treated tadpoles” and “control pond tadpoles”,
second “untreated tadpoles” and “control pond tadpoles” and third com-
paring “treated tadpoles” and “untreated tadpoles”).
Log-transformed Bd loads of infected individuals were analysed in the
same way.
3) Effect of ecological factors on Bd loads and Bd prevalence: We used a
model selection approach (Burnham and Anderson, 2001) to identify whether
stage, salinity, pH, oxygen concentration of the pond water (O2) and mean
temperature per month explained differences in Bd loads and Bd preva-
lence. We ranked models within 2 ∆AICc units of the best model based on
Akaike’s information criterion for small sample sizes (AICc) (Burnham and
Anderson 2001). Because there was model selection uncertainty, we used
model averaging methods to calculate parameter estimates. (Burnham and
Anderson, 2002).
All statistical analyses were done in R version 2.15.0 (RDevelopment-
CoreTeam, 2012).
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4.3 Results
Mesocosm experiment
One animal died during the treatment with Itraconazole. In the control 4
tadpoles cleared infections, in the half treatment 3 tadpoles cleared infection
and 5 got re-infected. In the all treatment none of the tadpoles got re-
infected.
Infection status was significantly affected by antifungal treatment (Tab.
4.1, Fig. 4.1). Comparison of each treatment level with the control group
showed significant effects of the half as well as of the all treatment on preva-
lence (Tab. 4.1, Fig. 4.1). Prevalence declined significantly through the
course of the experiment (Fig. 4.1, Tab. 4.1). We found no significant ef-
fect of population on infection status (Tab. 4.1). The interaction antifungal
treatment-by-population was not significant (Tab. 4.1).
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Figure 4.1: Mesocosm experiment: Effect of Itraconazole treatment on Bd
prevalence and on the logarithm of Bd loads at the beginning of the experi-
ment, after the treatment and at Gosner stage 46. Error bars represent the
standard error of the mean per mesocosm.
Bd loads were significantly different among treatment groups (Tab. 4.1,
Fig. 4.1). Loads differed significantly among all time periods and among
populations (Tab. 4.1). Comparison of each treatment level with the control
group showed significant effects of the half as well as of the all treatment
on Bd loads (Tab. 4.1, Fig. 4.1). Through the course of the experiment
Bd loads declined significantly (Fig. 4.1, Tab. 4.1). We found a significant
effect of population on Bd loads (Tab. 4.1). The interaction antifungal
treatment-by-population was not significant (Tab. 4.1).
Mortality until 30 days after stage 42 was significantly affected by treat-
ment. Both the half treatment and the all treatment reduced mortality of
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tadpoles significantly in comparison with the control (Tab. 4.2, Fig. 4.2).
Population of origin had no effect on mortality (Tab. 4.2).
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Figure 4.2: Mesocosm experiment: Effect of the different itraconazole treat-
ments on mortality of Alytes obstetricans. The black line represents the
median, the box represents the interquartile range containing 50% of the
values. Outliers are marked with circles.
Size at metamorphosis (PC1) was neither affected by the antifungal
treatment nor by population of origin and size at the start of the exper-
iment had no significant effect either (Tab. 4.2, Fig. 4.3).
Field Experiment in natural ponds
In the course of the Itraconazole experiment in April 2010 we caught, treated
and marked 580 tadpoles in the four treatment ponds (Herg: 370, SagO: 79,
SagU: 51 and Rae: 80). Three tadpoles died during the Itraconazole treat-
ment. After treatment, all tadpoles that were tested for Bd had cleared
the Bd infection. The number of marked (=treated) and unmarked (=un-
treated) animals during the capture occasions in May, are listed in Tab.
4.3.
Numbers of treated, untreated and control tadpoles that were captured,
treated and released during the General Tonic® experiment are listed in
Tab. 4.3.
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Figure 4.3: Mesocosm experiment: Effect of treatment on size of Alytes
obstetricans at stage 46. The black line represents the median, the box
represents the interquartile range containing 50% of the values and whiskers
mark the 1.5 fold interquartile range. Outliers are marked with circles.
1) Analysis of treatment efficiency within season: The Itraconazole treat-
ment caused no significant difference in Bd loads or prevalence between
treated and control tadpoles (Fig. 4.4, Tab. 4.4). Bd prevalence and Bd
loads of treated and control tadpoles varied significantly among months
(Fig. 4.4, Tab. 4.4). The interaction between antifungal treatment and
month significantly affected both prevalence and loads (Fig. 4.4, Tab. 4.4).
Comparisons of Bd loads and prevalence between untreated and control
tadpoles in the Itraconazole experiment showed no difference between these
two groups. Both prevalence and loads varied among months but there
was no interaction between month and group (i.e., untreated vs. control
tadpoles) (Fig. 4.4, Tab. 4.4).
Treated and untreated tadpoles had significantly different Bd prevalence
and Bd loads. Both prevalence and loads varied among months and there
was an interaction between month and group (Fig. 4.4, Tab. 4.4).
We compared Bd loads and prevalence of treated tadpoles with control
tadpoles in the General Tonic® experiment. We found no significant effect
of the treatment on Bd loads and Bd prevalence. Both temperature and
month had a significant effect on Bd loads and on prevalence (Fig. 4.4, Tab.
4.4). The interaction between antifungal treatment and month significantly
affected loads but prevalence was not affected (Fig. 4.4, Tab. 4.4).
The General Tonic® treatment did not cause a statistically significant
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difference in prevalence between untreated and control tadpoles. The model
returned significant effects of temperature on Bd loads and on prevalence of
untreated and control tadpoles (Fig. 4.4, Tab. 4.4). Prevalence and loads
were significantly different among (Fig. 4.4, Tab. 4.4). The interaction be-
tween antifungal treatment and month significantly affected both prevalence
and loads (Fig. 4.4, Tab. 4.4).
Comparisons of Bd loads and prevalence between treated and untreated
tadpoles in the General Tonic® experiment showed no difference between
these two groups. Both temperature and month had a significant effect on
Bd loads and on prevalence (Fig. 4.4, Tab. 4.4). The interaction between
antifungal treatment and month significantly affected both prevalence and
loads (Fig. 4.4, Tab. 4.4).
2) Analysis of treatment efficiency across years: We compared Bd loads
and prevalence among untreated and control tadpoles (all treated tadpoles
had metamorphosed and therefore left the pond) to test whether the Itra-
conazole antifungal treatment had a persistent effect one year after the treat-
ment. We found that neither prevalence nor loads differed between these
two groups of tadpoles (Fig. 4.4, Tab. 4.4).
We compared Bd loads and prevalence of treated tadpoles with control
tadpoles in the General Tonic® experiment. We found no significant effect
of the treatment on Bd loads and Bd prevalence (Fig. 4.4, Tab. 4.4). The
General Tonic® treatment did not cause a statistically significant difference
in prevalence between untreated and control tadpoles (Fig. 4.4, Tab. 4.4).
Comparisons of Bd loads and prevalence between treated and untreated
tadpoles in the General Tonic® experiment showed no difference between
these two groups (Fig. 4.4, Tab. 4.4).
3) Effects of ecological factors on Bd loads and Bd prevalence: Differ-
ences in Bd loads were best explained by stage and by temperature with in-
dividuals in a higher developmental stage having lower Bd loads (Tab. 4.5)
and individuals in higher temperature having lower Bd loads (Tab. 4.5).
Differences in Bd prevalence were best explained by oxygen concentration
of the pond water (O2). Individuals in ponds with low oxygen concentration
had lower prevalence (Tab. 4.5).
4.4 Discussion
If there are no political, economic or social constraints, then conservation
action can have a beneficial effect on threatened species (Donald et al.,
2007; Hoffmann et al., 2010; Sodhi et al., 2011). Emerging diseases are
a relatively new threat to biodiversity (Daszak et al., 2000; Greger, 2007;
Smith et al., 2009) but there are no solutions yet how to preserve species
threatened by emerging diseases (Chauvenet et al., 2011; Woodhams et al.,
2011). Our aim was to develop and test a mitigation method that can be
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used to treat amphibian populations against chytridiomycosis, a fungal dis-
ease which threatens amphibian diversity on many continents(Fisher et al.,
2009). Our motivation to use chemical agents was inspired by agriculture
where chemical agents are used to treat fungal diseases of crops (Wood-
hams et al., 2011). The present experiment is of the only few that tested
chemical treatments in natural habitats. Similar experiments were done by
Jaime Bosch in Spain on Alytes obstetricans (Bosch et al., 2010) or on Alytes
muletensis in Mallorca (Jaime Bosch, personal communication). Further ex-
periments in natural habitats were undertaken by R. A. Knapp and V. T.
Vredenburg (personal communication).
Our mesocosm experiment showed that antifungal treatments in the lar-
val stage can reduce Bd prevalence and load and that the effects persist
through metamorphosis (Fig. 4.1). As a consequence, there was reduced
mortality after metamorphosis (Fig. 4.2). The field experiments showed
that antifungal treatments can temporarily reduce Bd prevalence and loads
but have no long-term effects of pathogen prevalence and infection intensity.
The dynamics of infection were not only affected by antifungal treatments
but also by abiotic conditions in the pond.
The mesocosm experiment mimicked a natural pond ecosystem and am-
phibian community as they are commonly observed at our study sites. The
treatment with Itraconazole reduced Bd prevalence and Bd loads. This effect
persisted through metamorphosis and reduced post-metamorphic mortality
of juveniles (Fog. 2). Post-metamorphic mortality of juveniles can be very
high (Tobler and Schmidt, 2010) and may regulate amphibian population
dynamics (Lampo and De Leo, 1998; Hels and Nachman, 2002; Conroy and
Brook, 2003). The antifungal treatments did not affect juvenile fitness (i.e.,
size at metamorphosis;(Schmidt, 2012)). These results imply that treating
tadpoles shortly before metamorphosis can be an efficient way to reduce
chytridiomycosis-induced mortality.
The aim of the field experiments in natural ponds was to check whether
the findings of the mesocosm experiment and a previous laboratory experi-
ment (Geiger and Schmidt, 2013) can be transferred to natural ponds. Ad-
ditionally, we wanted to learn whether antifungal treatments can depress Bd
infection temporarily or permanently.
The efficiency of the Itraconazole treatment in reducing Bd infection
was confirmed in natural ponds. We treated animals in April 2010 and
measurements of Bd infection in May 2010 showed that Bd loads and Bd
prevalence were still clearly reduced. However, the effect of the Itraconazole
treatment disappeared after two months and Bd infection of treated tadpoles
was similar to infections of the control group and untreated animals (Fig.
4.4). Bd infection of untreated animals in the pond was unaffected by the
Itraconazole treatment despite that a subsample of infected tadpoles was
absent for 7 days (Fig. 4.4). Briggs et al. (2010) suggested that temporarily
removing tadpoles might be a strategy to reduce Bd loads. How many
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animals we need to remove in order to reduce loads is difficult to predict. In
the Itraconazole experiment we removed roughly 30% of the tadpoles from
the ponds for the treatment (this value was estimated from the recapture
data). The other question is how long tadpoles need to be out of pond.
The treatment with Itraconazole took ten days, which might be too short to
affect Bd infection of those tadpoles that remained in the pond. Whether
percentage of removed animals, the time of the removal or a combination of
both factors led to the result, is difficult to predict.
The Itraconazole field experiment showed that the effects of the antifun-
gal treatment disappeared within months if tadpoles were treated only once.
One year after the treatment we found no difference between Bd infection
of tadpoles in control ponds and in ponds where tadpoles were treated. Our
main motivation for the General Tonic® experiment in natural ponds was to
test the effect of repeated treatments with an antifungal agent on Bd preva-
lence and Bd loads. The choice of the antifungal agent General Tonic® was
based on results of previous experiments in laboratory (Geiger and Schmidt,
2013) and in mesocosms (chapter 3) where we found that General Tonic® re-
duces Bd loads significantly. The advantage of General Tonic® is the very
simple application which made it possible to treat large numbers of animals
repeatedly in a reasonable amount of time. In the course of the experiment
with General Tonic® in mesocosms we found some side effects of the anti-
fungal agent on non-target organisms. For this purpose we did not apply
the antifungal agent directly in the pond but treated tadpoles in tanks next
to the pond.
Prevalence of treated tadpoles was not reduced by the repeated General
Tonic® treatments which is consistent with our findings in chapter 3. How-
ever, we found that untreated tadpoles had a lower prevalence than control
tadpoles. This implies that treating a subsample of animals in the pond has
an effect on those tadpoles that were not treated against Bd. It has not only
an effect on prevalence but also on loads. The effect on prevalence implies
that the treatment might affect transmission of the pathogen from infected
to uninfected individuals. The effect on loads is difficult to interpret but
might be a consequence of the effect on transmission.
Bd loads of treated and untreated tadpoles were reduced in the short
term but this effect disappeared when the treatment was stopped. Shortly
after the last treatment, loads of treated tadpoles leveled to the Bd loads of
control tadpoles (Fig. 4.4). Results show furthermore that repeated treat-
ments were not effective across years. Our motivation for repeated treat-
ments was, that they might eventually reduce Bd loads permanently and
might lead to the eradication of the pathogen (Lubick, 2010). Our results
however returned no effect of the treatments across years. This implies that
a treatment has to be applied not only during a season, but again in the
next year in order to keep Bd loads in a low level.
Whether the reduction of loads with the General Tonic® treatment has
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an effect on survival is difficult to predict. From our experiment with General
Tonic® in mesocosms (chapter 3) we know that Bd loads of treated tadpoles
remain on a low level even after metamorphosis (mean GE ± SE = 174.21
± 65.40). This range of Bd loads is still below the Bd loads of surviving
Alytes obstetricans metamorphs documented in Tobler and Schmidt (2010)
(mean GE ± SE of surviving Alytes obstetricans metamorphs: = 282 ±
1132). We carefully conclude that mortality rate among metamorphosing
individuals might be reduced by treating tadpoles with General Tonic® in
natural ponds.
Effect of the repeated treatment was restricted to months in spring and
summer. In fall Bd infection increases while temperature decreases (Fig.
4.4). This pattern was already suggested by John Bielby (personal commu-
nication) who said that high loads may be induced by low temperatures in
winter. One reason for this pattern might be that cool temperature extend
the time of activity of motile zoospores from 8 days (at 23◦C) to 35 days (at
4◦C) (Voyles et al., 2012). Zoospores encounter rates might thus be higher
in low temperatures. Another reason may be that the amphibian immune
system is decreased in fall, which may lead to increased susceptibility to
parasites and pathogens (Raffel et al., 2006).
Taken together, a treatment with antifungal agents may reduce Bd loads
and Bd prevalence of individuals in natural ponds. If loads stay on a low
level over the time of metamorphosis animals might survive, as we have seen
it in the Itraconazole experiment in mesocosms. In general, treatments with
antifungal agents may be useful to mitigate Bd in natural ponds albeit with
reasonable time and effort.
Our approach was treating tadpoles in spring shortly before metamor-
phosis in order to have reduced Bd infection when susceptibility of animals
is highest, i.e. after metamorphosis. The mesocosm experiment showed that
this approach is effective. In the course of the field experiments in natural
ponds we observed that prevalence and loads were lowest in fall. A new
approach might thus be to treat animals in fall in order to keep Bd infec-
tion on a low level. Another observation was that ecological factors affect
Bd infection. Individuals in high temperatures have low Bd loads. This
brings us to another approach which is the treatment with elevated temper-
ature. This idea was already tested in the laboratory and is an effective way
to reduce loads or even to clear individuals from Bd (Geiger et al., 2011;
Woodhams et al., 2011). This idea might be worth testing in natural ponds
either by treating individuals in tanks with warm water next to the pond or
by creating shallow water zones in order to provide warmer water. Warmer
water speeds up larval development which implies that fewer tadpoles will
hibernate (Thiesmeier, 1992) and therefore population growth rate will in-
crease (Govindarajulu et al., 2005). Speeding up larval development might
additionally reduce Bd loads because analysis of Bd infection under different
ecological factors showed that individuals in a higher developmental stage
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have lower Bd loads.
The drawback of course is that Bd will persist and repeated treatments
are necessary to keep Bd infection on a low level. In some sites repeated
treatments are a possibility to reduce Bd infection i.e. at sites where tadpoles
are easy accessible. In many cases tadpoles are very difficult to access and
the approach might thus be difficult to apply or only with a considerable
amount of time and manual effort. Yet in an emergency case like after a
Bd-induced collapse of a population we have a method in hand which allows
reducing Bd prevalence and Bd loads in natural habitats.
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Table 4.3: Field Experiment in natural ponds: Number of Alytes obstetricans
tadpoles that got sampled during the two experiments in natural ponds.
treat = treated tadpoles, untreat = untreated tadpoles.
treatment ponds control ponds
SagO SagU Herg Rae SchO SchU HiR
treat untreat treat untreat treat untreat treat untreat control control control
Itraconazole
experiment 2010
Aprils10 79 0 51 0 370 0 80 0 30 29 31
Mays10 30 7 18 11 30 25 25 11 30 30 30
Junes10 35 5 14 16 30 11 21 8 19 31 27
Julys10 32 14 3 15 36 8 9 4 15 29 13
Septembers10 0 28 0 29 0 32 1 32 32 33 30
Januarys11 0 30 0 30 0 30 2 19 30 30 30
Aprils11 0 30 0 31 0 30 0 12 30 30 29
General Tonic®
experiment 2011
Mays11 111 0 187 0 363 0 - - 30 31 13
Junes11 74 37 58 66 187 355 - - 30 30 22
Julys11 74 6 16 9 97 115 - - 29 30 21
Augusts11 5 31 0 30 13 906 - - 20 20 30
Septembers11 3 278 0 461 0 912 - - 30 28 30
Octobers11 24 3 20 10 17 25 - - 30 30 29
Januarys12 66 9 30 30 63 30 - - 30 30 30
Aprils12 63 8 31 43 76 34 - - 30 30 26
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Table 4.4: Field Experiment in natural ponds. Differences in Bd prevalence
and Bd loads among treatment, month and temperature within seasons. We
analyzed three different data sets which included i) treated and control pond
tadpoles, ii) untreated and control pond tadpoles and iii) treated and un-
treated tadpoles. P-values show differences among factors, Significant values
are marked with* for a significance level of α = 0.05. Itra = Itraconazole,
GT = General Tonic.
factor treated-control untreated-control treated-untreated
loads prevalence loads prevalence loads prevalence
within season
Itraconazole 0.208 0.365 0.517 0.689 0.002* 0.039*
month <0.001* <0.001* <0.001* <0.001* <0.001* <0.001*
Itra:month <0.001* <0.001* 0.255 0.053 <0.001* <0.001*
General Tonic® 0.193 0.738 0.952 0.355 0.494 0.122
temp <0.001* 0.011* <0.001* 0.006* <0.001* 0.042*
month <0.001* 0.004* <0.001* <0.001* <0.001* 0.009*
GT:month <0.001* 0.654 <0.001* <0.001* 0.597 0.970
across years
Itraconazole - - 0.134 0.232 - -
GT 0.139 0.205 0.307 0.724 0.135 0.394
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Figure 4.4: Effect of itraconazole treatment and General Tonic treatment
on Bd prevalence and on the logarithm of Bd loads over the time period of
one year. Error bars represent the standard error of the means per pond.
Arrows indicate in which month a treatment was done. Temperatures are
shown as a mean water temperature over all ponds.
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Table 4.5: Effect of ecological factors on Bd loads and prevalence. Model se-
lection results of linear mixed effects model (lme) for loads and of generalized
linear models (glmer) for Bd prevalence.
estim
atesv±vSE
df
∆AICc
w
eight
likelihood
O
2
pH
salinity
stage
tem
perature
treatm
ent
Bdvloads
stage + salinity
6
0
0.204
1.000
10.100
±
4.281
-0.048
±
0.012
stage + salinity + tem
perature
7
0.01
0.203
0.995
8.292
±
4.488
-0.047
±
0.012
-0.100
±
0.049
stage + tem
perature
6
1.24
0.110
0.538
-0.046
±
0.012
-0.122
±
0.047
stage + tem
perature + pH
7
1.4
0.102
0.497
-1.523
±
1.109
-0.046
±
0.012
-0.125
±
0.047
stage + salinity + pH
7
1.96
0.077
0.375
0.353
±
1.380
11.040
±
5.638
-0.048
±
0.012
stage + salinity + tem
perature + treatm
ent
8
1.96
0.077
0.375
7.719
±
4.917
-0.047
±
0.012
-0.100
±
0.050
0.105
±
0.368
stage +
salinity + treatm
ent
7
1.97
0.076
0.373
9.656
±
4.698
-0.048
±
0.012
0.082
±
0.356
stage + salinity + O
2
7
1.99
0.076
0.370
0.012
±
0.066
9.754
±
4.698
-0.048
±
0.012
stage + salinity + tem
perature + pH
8
2.00
0.075
0.368
-0.307
±
1.466
7.421
±
6.067
-0.047
±
0.012
-0.103
±
0.050
m
odelvaveragedvparam
etervestim
ates
10
-
1.000
0.565
0.012v±v0.067
-0.594v±v1.533
9.162v±v4.948
-0.047v±v0.012
-0.109v±
0.050
0.093v±v0.363
Bdvprevalence
tem
perature + O
2 + stage + salinity
5
0
0.136
1.000
-0.089
±
0.024
0.000
3.887
±
1.790
-0.021
±
0.012
-0.025
±
0.014
tem
perature + stage + pH + treatm
ent
5
0.1
0.129
0.951
-1.092
±
0.398
-0.020
±
0.012
-0.026
±
0.014
-0.318
±
0.122
tem
perature + O
2 + stage + pH
5
0.5
0.106
0.779
-0.060
±
0.023
-0.842
±
0.409
-0.020
±
0.012
-0.029
±
0.014
tem
perature + pH + treatm
ent
4
0.74
0.094
0.691
-1.066
±
0.397
-0.023
±
0.014
-0.314
±
0.122
tem
perature + O
2 + salinity
4
0.89
0.087
0.641
-0.087
±
0.024
3.609
±
1.780
-0.022
±
0.014
tem
perature + O
2 + pH
4
1.03
0.081
0.598
-0.060
±
0.024
-0.817
±
0.409
-0.025
±
0.014
O
2 + stage + salinity
4
1.26
0.072
0.533
-0.091
±
0.024
3.932
±
1.786
-0.018
±
0.012
O
2 + salinity
3
1.43
0.066
0.489
-0.089
±
0.024
3.687
±
1.775
pH +
treatm
ent
3
1.53
0.063
0.465
-1.013
±0.396
-0.340
±
0.121
stage + pH + treatm
ent
4
1.62
0.060
0.445
-1.028
±
0.396
-0.017
±
0.012
-0.347
±
0.122
tem
perature + O
2 + stage + pH + salinity
6
1.76
0.056
0.415
-0.078
±
0.031
-0.354
±
0.691
2.644
±
3.019
-0.021
±
0.012
-0.027
±
0.014
tem
perature + O
2 + stage + salinity + treatm
ent
6
2.01
0.050
0.366
-0.093
±
0.054
3.860
±
1.820
-0.021
±
0.012
-0.025
±
0.014
0.024
±
0.291
m
odelvaveragedvparam
etervestim
ates
7
-
1.000
0.614
-0.080
±v0.031
-0.920
±
0.486
3.661
±v2.017
-0.020
±v0.012
-0.025
±v0.014
-0.282
±v0.193
Chapter 5
Learning from failed trials
(Diseases of Aquatic Organisms 98: 11-25 DOI: 10.3354/dao02429)
Douglas C. Woodhams, Corina C. Geiger, Laura K. Reinert, Louise A.
Rollins-Smith, Brianna Lam, Reid N. Harris, Cheryl J. Briggs, Vance T.
Vredenburg, Jamie Voyles
Abstract Amphibian conservation goals depend on effective disease-treatment
protocols. Desirable protocols are species, life stage, and context specific,
but currently few treatment options exist for amphibians infected with the
chytrid fungus Batrachochytrium dendrobatidis (Bd). Treatment options, at
present, include antifungal drugs and heat therapy, but risks of toxicity and
sideeffects make these options untenable in some cases. Here, we report on
the comparison of several novel treatments with a more generally accepted
antifungal treatment in experimental scientific trials to treat Bd-infected
frogs including Alytes obstetricans tadpoles and metamorphs, Bufo bufo and
Limnodynastes peronii metamorphs, and Lithobates pipiens and Rana mus-
cosa adults. The experimental treatments included commercial antifungal
products (itraconazole, mandipropamid, steriplantN, and PIP Pond Plus),
antimicrobial skin peptides from the Bd-resistant Pelophylax esculentus, mi-
crobial treatments (Pedobacter cryoconitis), and heat therapy (35◦C for 24
h). None of the new experimental treatments were considered successful
in terms of improving survival; however, these results may advance future
research by indicating the limits and potential of the various protocols. Cau-
tion in the use of itraconazole is warranted because of observed toxicity in
metamorphic and adult frogs, even at low concentrations. Results suggest
that rather than focusing on a single cure-all, diverse lines of research may
provide multiple options for treating Bd infection in amphibians. Learning
from failed treatments’ is essential for the timely achievement of conserva-
tion goals and one of the primary aims for a publicly accessible treatment
database under development.
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5.1 Introduction
Amphibians are more threatened than any other vertebrate taxon (Stuart
et al., 2004; Hoffmann et al., 2010). One significant factor contributing to
population declines is an emerging infectious disease called chytridiomycosis
caused by the fungus Batrachochytrium dendrobatidis (Bd) (Berger et al.,
1998; Daszak et al., 2000; Skerratt et al., 2007). Chytridiomycosis causes
death to amphibians both in the laboratory (Parker et al., 2002; Tobler
and Schmidt, 2010) and in natural habitats (Berger et al., 1998; Bosch,
2001; Lips et al., 2006; Pounds et al., 2006). The disease is associated
with mass mortality events, population declines (Vredenburg et al., 2010),
the loss of amphibian biodiversity (Daszak et al., 2003; Lips et al., 2006;
Smith et al., 2009), and subsequent ecosystem changes (Whiles et al., 2006).
Chytridiomycosis was charactereized in the IUCN Amphibian Conservation
Action Plan as ”the worst infectious disease ever recorded among vertebrates
in terms of the number of species impacted, and its propensity to drive them
to extinction” (Gascon et al., 2007). Hence, it is of particular importance
to develop effective methods to mitigate Bd (Woodhams et al., 2011) and
also to cure infected amphibians (Mendelson et al., 2006).
The urgent development of antifungal treatment protocols has resulted
in several reports (Nichols and Lamiranda, 2000; Berger et al., 2010; Bower-
man et al., 2010; Pessier and Mendelson, 2010; Martel et al., 2011; Tamukai
et al., 2011). Successful trials have been documented in peer-reviewed jour-
nals. These reports include treatment with elevated temperature (Wood-
hams et al., 2003; Chatfield and Richards-Zawacki, 2011; Geiger et al., 2011),
treatment with salt (White, 2006), and also treatments with different anti-
fungals (Hadfield and Whitaker, 2005; Garner et al., 2009a; Bowerman et al.,
2010; Martel et al., 2011). Unfortunately, information about unsuccessful
trials is scarce (Berger et al., 2009). Anecdotal reports of both successful and
unsuccessful treatments used in the pet trade, zoos, and for captive assur-
ance colonies are becoming more numerous. These unpublished reports may
help to guide future clinical studies. To be efficient in developing successful
mitigation methods against Bd, intuitive yet unsuccessful trials should not
be needlessly repeated. Thus, documentation of failed trials is important
for future research planning.
Here, we report on 5 experiments that were considered unsuccessful
treatments in terms of improving amphibian survival, and we also outline
what can be learned from these unsuccessful treatment attempts. First,
we examine treatments of newly metamorphosed common toads Bufo bufo.
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This species is common, yet susceptible to chytridiomycosis (Bosch and Rin-
con, 2008; Fisher et al., 2009; Garner et al., 2009b, 2010) and, therefore, a
good model species for development of treatment protocols. Since the species
does not appear to produce conventional cationic antimicrobial skin peptides
(Roseghini et al., 1989), we chose to examine the effects of adding anti-Bd
skin peptides from a disease- resistant species. If the added antimicrobial
peptides reduce the pathogen load, the adaptive immunesystem may be bet-
ter able to clear infections. Second, adult mountain yellow-legged frogs Rana
muscosa were treated with either itraconazole or the anti-Bd bacterium Pe-
dobacter cryoconitis. Third, itraconazole and heat treatments were tested
on infected adult northern leopard frogs Lithobates pipiens. Successful treat-
ment of this infection-tolerant reservoir host (Woodhams et al., 2008) could
be implemented by commercial suppliers to reduce the spread of Bd. Meta-
morphosing striped marsh frogs Limnodynastes peronii and midwife toads
Alytes obstetricans show a typical pattern of chytridiomycosis development
at metamorphosis (Marantelli et al., 2004; Tobler and Schmidt, 2010), and
treatments with several antifungal compounds were tested. Treatment at
the tadpole stage may reduce the incidence of disease in later stages of host
development. These experiments test a broad range of potential treatment
protocols across a variety of life stages and contexts important for mitigating
the emerging amphibian disease chytridiomycosis.
5.2 Material and Methods
Treating newly metamorphosed Bufo bufo with antimicrobial
peptides
Animal husbandry Four amplexing pairs of common toads Bufo bufo
were collected at the pond on the Fa¨rberwiesli, near Schaffhausen, Switzer-
land (47◦ 42’ 1.19” N, 8◦ 35’ 42.45” E) in March 2010, and kept in captivity
overnight for egg collection. Tadpoles were reared in outdoor artificial ponds
(0.28 m2 plastic tubs containing 80 L of water) at the University of Zurich.
Artificial ponds were disinfected before use with Virkon S (DuPont), cov-
ered with shade cloth, provided with leaves and zooplankton to establish
semi-natural conditions, and irregularly supplemented with fish feed (Sera
Spirulina Tabs; Sera GmbH). Upon metamorphosis, toadlets were trans-
ferred to tubs with access to land and water and fed crickets, aphids, and
fruit flies. Temperature in the tubs fluctuated naturally and reached 30◦C
on several occasions. On July 12, 2010, 75 B. bufo metamorphs (mean ± SD:
0.094 ± 0.029 g) were placed in a controlled environment room kept between
17 and 18.5◦C on a 14 h light:10 h dark schedule with full-spectrum lighting.
Each toadlet was given a new plastic enclosure tipped to one side containing
approximately 25 ml of aged tap water, and fed crickets 2 to 3 times weekly
during the laboratory experiment. Relative humidity was consistently 100%
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in both outdoor tubs and laboratory enclosures. Temperature and humidity
were recorded with LogTag Recorders. Under these husbandry conditions,
the toads were considered to be free of Bd infections at the beginning of the
treatments.
Experimental design The toadlets were randomly allocated to 1 of 5
treatment regimes and placed in a randomized block design. Initial mass
did not significantly differ among treatments (ANOVA: F = 0.907, df = 4,
p = 0.465). Toadlets were exposed 1 time to either Bd (7 105 zoospores
mixed from UK Bufo bufo isolate and Swiss Alytes obstetricans isolate 0739)
or a sham solution of water washed from sterile plates by placing in a sterile
15 ml tube with 1 ml solution for 1 h. Peptides were rinsed from Pelophylax
esculentus skin after norepinephrine induction (40 nmol g-1 body mass) of
granular gland secretions. Peptide treatment consisted of a 2 min bath
in 1 ml solution containing 400 µg ml-1 peptide mixtures collected from
15 P. esculentus and partially purified over C-18 Sep-Paks (Waters Corp.)
and combined. This peptide concentration was approximately the minimal
concentration needed to completely inhibit growth of Bd
(D.C. Woodhams unpubl. data). In Treatment 1, toad lets (n = 12) were
unexposed controls. In Treatment 2 toadlets (n = 12) were not exposed
to Bd but treated with peptides. In Treatment 3 toadlets (n = 17) were
exposed to Bd. In Treatment 4 toadlets (n = 17) were exposed to Bd
immediately after treatment with peptides. In Treatment 5 toadlets (n =
17) were exposed to Bd and then treated with peptides on Days 8 and 9
after exposure. Toadlets were monitored daily for clinical signs of disease
and weighed 2 and 5 wk after exposure. At the end of the experiment on
Day 35, the skin of toadlets was swabbed for quantitative real time PCR
(qPCR) diagnostic analysis of Bd infection according to Hyatt et al. (2007).
Standard statistical analyses were carried out using IBM SPSS Statistics 19
(SPSS Inc.) for this and the following experiments.
Treating adult Rana muscosa with itraconazole and biother-
apy
Animal husbandry Forty-four adult Rana muscosa (mean ± SD: 8.8 ±
2.1 g) were collected from Sixty Lake Basin in the Sierra Nevada mountains
of California, USA, transported by helicopter out of the park in individual
plastic containers, and shipped overnight to James Madison University, Har-
risonburg, Virginia, USA, arriving on July 13, 2007. These lakes were known
to be heavily infected with Bd and were thought to be in imminent danger
of population collapse caused by chytridiomycosis. One frog was moribund
upon collection in the field and died 2 d after arrival. Upon arrival at the
laboratory, each frog was swabbed on the left side only for qPCR diagnostic
analysis of Bd, as above. Each frog was then rinsed in sterile artificial pond
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water (Provisoli medium, Wyngaard and Chinnappa 1982) to remove debris
and transient microbes, and swabbed on the right side for analysis of skin
microbiota by denaturing gradient gel electrophoresis (DGGE, described in
DGGE’). Next the frogs were weighed, treated, and placed individually into
2 L plastic containers containing a 5 cm plastic saucer and approximately
200 ml of artificial pond water. All containers were randomly assigned a
position on metal racks in a controlled environment room set at 17◦C with
a 12 h light:12 h dark cycle. Containers were cleaned with 10% bleach and
autoclaved twice per week. Artificial pond water was autoclaved and cooled
before use. Frogs were fed crickets twice per week.
Experimental design Frogs were randomly allocated to 3 treatments:
control (n = 13), biotherapy (n = 20), and itraconazole (n = 10). Analy-
sis of variance showed no significant differences among treatments in initial
mass (mean ± SD: 8.8 ± 2.1 g, F = 0.72, df = 2, p = 0.493) or Bd load
(mean ± SD: 46 888 ± 92 716 zoospore equivalents, F = 0.371, df = 2,
p = 0.692). Four days after arrival, control frogs were treated by placing
them in 25 ml of artificial pond water for 2 h and swishing’ every 30 min.
Biotherapy frogs were treated similarly, except that the water contained
Pedobacter cryoconitis at a concentration of approximately 1.57 108 cells
ml-1. The P. cryoconitis strain used was originally isolated from a wild
adult Rana muscosa from Sixty Lake Basin in August, 2005, and found to
inhibit Bd growth in co-culture assays (Woodhams et al. 2007). A pure
culture was incubated for 24 h at room temperature in 1% tryptone with
continuous stirring. The culture was then centrifuged at 4500 g for 10 min
at 10◦C, and the supernatant was discarded. The cells were then washed by
re-suspending the pellet in artificial pond water and repeating the centrifu-
gation twice. A third group of frogs was treated for 11 d with itraconazole
by placing each frog in a plastic container for 5 min with 25 ml artificial
pond water containing 250 ul of Sporonox oral solution at 10 mg ml-1 (final
concentration: 100 mg L−1 ; Nichols et al. 2000). All frogs were weighed
and swabbed for Bd each week, and microbiota swabs were taken 7 and 13
d after beginning the experiment.
Measuring skin pH and Bd infection The dorsal and ventral skin
pH of Rana muscosa (n = 24) was measured with a flat glass probe. The
intensity of infection measured in zoospore equivalents was determined by
quantitative PCR according to Boyle et al. (2004). Both of these measure-
ments were repeated 7 times at weekly intervals. We tested for a difference
between the dorsal and ventral skin pH at the initial timepoint with a paired
t-test, and for an overall correlation between infection intensity and ventral
or dorsal skin pH by Pearson correlation. Since these frogs were all initially
infected in the wild, no comparisons between infected and uninfected skin
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pH or accurate analysis of skin pH through the time course of infection was
possible.
DGGE Bacterial DNA was extracted from skin swabs using Qiagen DNEasy
Blood and Tissue kit (Qiagen) and amplified with bacterial specific 16S
rRNA gene primers 357F and 907R (Muyzer and Smalla 1998) designed to
amplify the V4 and V5 regions of the 16S rRNA gene. Amplicons from PCR
were analyzed by DGGE with a Bio-Rad D-Code System (Bio-Rad Labo-
ratories) on 8% (w/v) polyacrylamide gels using gradients ranging from 30
to 60% (where 100% denaturant contains 7 M urea and 40% formamide).
Electrophoresis was carried out in 1 TAE (40 mM Tris, 20 mM acetic acid, 1
mM EDTA) buffer at 70 V for 18 h at 60◦C. Gels were stained with ethidium
bromide (1:10 000 dilution) for 30 min and visualized on a UV transillumi-
nator. Community profiles were aligned with pure isolates of Pedobacter
cryoconitis for probable identification.
Treating adult Lithobates pipiens with itraconazole and heat
therapy
Animal husbandry Adult Lithobates pipiens were purchased from a com-
mercial supplier (J. M. Hazen Frog Company) and kept in groups until ini-
tiating the experiment. Frogs were placed into individual plastic enclosures
(approximately 2 L) with access to water and were fed with crickets 2 to 3
times weekly after water changes. All frogs were weighed and swabbed for
Bd at the beginning of the experiment and again on Day 17 after treatments
and then changed to clean housing. Natural infections ranged from 0 to 4330
zoospore equivalents before beginning treatments.
Experimental design In February, 2007, 12 frogs were treated with itra-
conazole as above according to Nichols et al. (2000), except that daily
treatments extended for only 5 d. Frogs were rinsed and placed into a
new container after each treatment. A second treatment consisted of 10
frogs given heat therapy. Individual plastic enclosures containing frogs were
placed in an incubator at 30◦C overnight, and then the temperature was
raised to 35◦C for 24 h. The water was then changed, and frogs resumed
feeding the next day. Control frogs were kept in larger plastic containers in
groups of 3 and 4 individuals and kept at room temperature (about 23◦C)
without special treatment.
Treating newly metamorphosed Limnodynastes peronii with
itraconazole
Animal husbandry Striped marsh frog Limnodynastes peronii larvae (n
= 26) were collected from Tasmania’s northwest coast, at sites where Bd-
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infection status was unknown. Frog collections occurred in January and
February 2009. Each animal was collected by hand using clean vinyl gloves,
transferred to an individual plastic container (200 240 330 mm3) and
transported to temperature (18 to 23◦C) and light (12 h light:12 h dark)
controlled facilities at the Department of Primary Industries, Parks, Water
and the Environment (DPIPWE), Newtown Laboratories in Hobart, Tasma-
nia, Australia. These individuals were originally collected for an exposure
experiment. However, 12/26 (46%) of the newly metamorphosed L. peronii
frogs died within 6 wk of metamorphosis, before the experiment had be-
gun. Clinical signs were consistent with other studies reporting mortality
due to chytridiomycosis occurring shortly after metamorphosis (Rachowicz
and Vredenburg 2004, Garner et al. 2009a). Postmortem examinations
on a subset of L. peronii metamorphs that died early determined that 4/5
(80%) of these individuals had Bd infections, one of which was confirmed
with histopathology to be consistent with cases of severe chytridiomycosis
(Berger et al. 1998, Pessier et al. 1999, see Fig. 5.4), and all had epidermal
necrosis of an unknown etiology.
Experimental design We assumed that all metamorphs were infected
with Bd; however, this could not be confirmed with PCR testing at the
time. Metamorphs were monitored closely for clinical signs of chytridiomy-
cosis. Two individuals displayed clinical signs of severe chytridiomycosis
(loss of righting reflex, irregular skin sloughing and epidermal erythmia; see
Fig. 5.4) and were therefore included in the treatment group. The remain-
ing metamorphs (n = 12) were randomly assigned to control and treatment
groups. Froglets were placed in round (5.5 cm diameter) clean plastic con-
tainers. Itraconazole (1%: 10 mg mL−1 Sporonox oral solution; Symbion)
was diluted to 0.1% in 0.6% saline solution for a final concentration of 100
mg L−1 (Nichols and Lamiranda, 2000). Treated froglets were exposed to a
bath of itraconazole solution (10 ml) for 5 min for 3 consecutive days before
treatment was discontinued because of high mortality. Control froglets were
exposed to an identical solution with no itraconazole. At the end of the 5
min period, the metamorphs were rinsed with tap water and returned to
their individual containers with fresh tap water.
Treating larval Alytes obstetricans with commercial antifun-
gals
Animal husbandry Tadpoles of Alytes obstetricans (n = 77) were col-
lected in November 2009 (33 of them in Itingen, Switzerland (47◦ 27’ 35.17”
N, 7◦ 47’ 2.12” E, 410 m above sea level [masl]) and 44 in Zunzgen, Switzer-
land (47◦ 26’ 5.44” N, 7◦ 47’ 56.73” E, 480 masl). For a separate experi-
ment, Bd-infected tadpoles were captured from Zunzgen, and 89 were raised
through metamorphosis between summer 2010 and spring 2011. Tadpoles
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were reared in the laboratory in 0.28 m2 plastic containers containing 80 L of
tap water. The room was equipped with full-spectrum sunlight lamps on a
12 h photoperiod. Temperature was kept at 18 to 20◦C. Water was changed
once a week, and tadpoles were fed ad libitum with fish feed (Sera Spirulina
Tabs, Sera GmbH). From January 2010, tadpoles were kept individually in
1.5 L plastic tubs using the same husbandry care. In the week before the
experiment, we recorded the mass (Scaletec Instruments), the length from
the snout to the beginning of the tail muscle, the developmental stage (Gos-
ner, 1960), and we swabbed the mouthpart of the tadpoles with a sterile
rayon-tipped plain swab with a plastic applicator (Copan). We used sep-
arate latex gloves for handling each tadpole to avoid cross contamination.
These measurements were repeated after the experiments. We analyzed the
swabs for the presence of Bd using qPCR following the protocol by Boyle
et al. (2004). We ran samples in duplicate and repeated the analysis when
the 2 results were inconsistent. For statistical analyses, we used counts of
genomic equivalents (zoospore counts) to compare effectiveness of agents.
For each individual the experiment was finished after a week of treatment.
After the experiment, all tadpoles were successfully treated for 7 d with
itraconazole according to Garner et al. (2009a) and brought back to their
original pond according to per- mit specifications. Additionally, 89 meta-
morphs were treated with itraconazole diluted to 0.01% aqueous solution (10
mg L−1 ; (Garner et al., 2009a; Tamukai et al., 2011), for 3 consecutive days
before treatment was discontinued because of high mortality. The surviving
frogs were returned near their pond of origin.
Experimental design Tadpoles were randomly allocated to 3 treatments,
each testing a different agent for efficiency against Bd. One tested agent
was PIP Pond Plus (Chrisal). PIP Pond Plus contains a mixture of unde-
fined probiotic bacteria (Bacillus sp.), enzymes, and 0.5 to 2.4% isopropanol.
However, the exact composition of the agent is a corporate secret of Chrisal.
To be sure that we were not erroneously measuring the effect of isopropanol
alone, we conducted a small pilot study in which an equivalent dosage of
isopropanol was added. No effect of isopropanol on Bd loads or on tadpole
condition was detected. The second agent tested was Steriplant N (Swiss
Steriplant AG). Steriplant N is electrochemically activated water. It con-
tains 99.96% water (drinking water quality) and 0.04% oxidants (NaOCl-,
ClO2, NaClO3, O3). Disinfection is thought to work through oxidation of
microbes. The third tested agent was mandipropamid (Syngenta Crop Pro-
tection AG). Mandipropamid was developed by the derivatization of phenyl-
glycinamides and mandelamides (Lamberth et al. 2008). It was developed
as an effective agent against oomycetes. Mandipropamid is soluble in water
up to a concentration of 4.2 mg L−1 .
(1) Efficiency test with PIP Pond Plus: infected tadpoles (n = 28) were
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assigned to 3 different treatment groups and a control group (n = 7 in each
group, housed individually). The agent was mixed into the water (1 L)
daily over a period of 7 d. Depending on the treatment group the following
dosages were applied: 0 µL (control, only stirring the water), 25, 50, and
100 µL. After 7 d the water was changed, and tadpoles were individually
housed 7 d without treatment but with 2 water changes before swabbing
them.
(2) Efficiency test with Steriplan N: infected tadpoles (n = 28) were
assigned to 3 different treatment groups and a control group (n = 7 in each
group, housed individually). We added 5 ml of the agent daily into the
water (5 ml into 1 L = 5 ppm daily). Depending on the treatment group
this treatment was applied 0 d (control, 0 ppm), 1 d (5 ppm), 2 d (10 ppm),
or 3 d (15 ppm). After 7 d, the water was changed. Tadpoles were swabbed
after 7 additional days of individual housing with 2 water changes.
(3) Efficiency test with mandipropamid: infected tadpoles (n = 21) were
treated with different dosages of mandipropamid mixing different amounts
of the agent into the water. The following dosages were tested: 0.01, 0.02,
0.04, 0.06, 0.08, 0.1, 0.15, 0.2, 0.4, 0.6, 0.8, 1, 1.2, 1.4, 1.6, 1.8, 2, and 4
mg L−1 , and 3 controls. As mandipropamid is hardly soluble in water, we
dissolved it in acetone (300 g L−1 ) before applying it to the water. Hence,
we tested 4 tadpoles with different dosages of acetone that were equivalent
to the 0.01, 0.1, 1, and 4 mg dosages (not shown in the figure). Standard
statistical analyses were done using R 2.10.1 for all experiments.
5.3 Results
Treating newly metamorphosed Bufo bufo with antimicrobial
peptides
Survival and infection status The rationale for this experiment was
to determine whether bath exposure to amphibian antimicrobial peptides
would significantly reduce the level of detectable Bd infection in a suscepti-
ble species. Bd exposure reduced survival compared to unexposed toadlets
5.1(A).
Initial mass was a significant covariate with larger toadlets surviving
longer (Cox regression, p < 0.001). Survival of toadlets in each treatment for
the 35 d experiment was as follows. In Treatment 1 (unexposed controls),
survival was 58.3% (mean: 27.3 d). In Treatment 2 (unexposed controls
treated with peptides), survival was 63.6% (mean: 27.5 d). In Treatment 3
(Bd-exposed controls), survival was 17.6% (mean: 17.9 d). In Treatment 4
(exposed after prophylactic treatment with antimicrobial peptides), survival
was 11.8% (mean: 15.6 d). In Treatment 5 (Bd exposed and treated with
antimicrobial peptides 7 and 8 d after exposure), survival was 11.8% (mean:
20.9 d). Peptide treatment alone (Treatment 2) did not reduce survival
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compared to unexposed controls (Treatment 1); however, both groups expe-
rienced approximately 40% mortality, typical for the species (Garner et al.,
2009b; Loman and Madsen, 2010). Neither prophylactic (Treatment 4) nor
remedial peptide treatments (Treatment 5) improved survival compared to
infected controls (Treatment 3). However, of the surviving toadlets, 3 of
3 exposed controls were Bd positive at the end of the experiment, and 0
of 3 exposed toadlets that were treated with peptides were infected by the
end of the experiment, indicating a potential benefit of peptide treatments
(Fisher’s exact test, p = 0.05). Thus, although treatment with peptides
did not improve survival, it may have prevented or induced the clearance of
infection in a small number of individuals.
Weight changes An analysis of variance of the rate of weight change
throughout the experiment showed significant differences among treatments
(F = 3.632, df = 4, p = 0.012). Unexposed toadlets had the highest rate of
growth, peptide-treated toadlets showed intermediate growth rate, and Bd-
exposed toadlets had the slowest rate of growth (Fig. 5.1B). Thus, treatment
with Pelophylax esculentus peptides did not seem to negatively affect toad
survival or growth; rather, peptide treatments before or after Bd exposure
had similar beneficial effects on growth.
Treating adult Rana muscosa with itraconazole or biotherapy
Survival Bd infection loads on adult Rana muscosa indicated relatively
heavy infections in all frogs at the beginning of the experiment (Fig. 5.2).
Thus, it was not possible to observe development of Bd infections in the
frogs as in previous studies (Harris et al., 2009; Briggs et al., 2010), and
mortalities began 3 d into the 51 d experiment. Survival of infected control
frogs was 38.5% (mean: 31.5 d). Survival of infected control frogs was
38.5% (mean: 31.5 d). Survival of frogs treated with Pedobacter cryoconitus
was 50.0% (mean: 38.5 d). Survival of frogs treated with itraconazole was
30.0% (mean: 25.4 d). A log-rank test on censored survival data did not
demonstrate a significant difference among treatments (χ2 = 1.494, df = 2,
p = 0.474; Fig. 5.2A). Controlling for initial frog mass and initial Bd load as
covariates in a Cox regression did not show a significant effect of treatment
(p = 0.381). All 17 frogs that died in either the infected control treatment
or the biotherapy treatment were severely infected with Bd at death. Of the
frogs that died in the itraconazole treatment, 2 of 7 were infected with Bd at
death; thus, most frogs cleared infections before death. Three frogs survived
the itraconazole treatment: Bd was initially undetectable from swabs on Day
60, but small zoospore loads were detected at a later time point, indicating
incomplete clearance of Bd with itraconazole.
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Weight changes Frogs in all 3 treatment groups lost weight. Pedobacter
cryoconitis treatment reduced weight loss due to Bd infection compared to
infected controls, and itraconazole-treated frogs had intermediate weight loss
(ANOVA: F = 3.455, df = 2, p = 0.041; Fig. 5.2B). A general linear model
did not indicate initial Bd load as a significant cofactor in weight loss (p ¿
0.05).
Bd and skin pH Most frogs were heavily infected at the initiation of
the experiment (Fig. 5.2B). Itraconazole quickly cleared Bd infections in
surviving frogs, treatment with Pedobacter cryoconitis did not. Immediately
after exposure to the bacterium (Day 2), zoospore loads were significantly
reduced. At all later timepoints, infection intensity and prevalence were
similar to values in infected controls (Fig. 5.2B). The skin pH of adult Rana
muscosa naturally infected with Bd hovered around neutral (Fig. 5.3A),
but the dorsal surface had a significantly lower pH than the ventral surface
(paired t-test: p < 0.0001). Infection load was not significantly correlated
with dorsal skin pH (Pearson’s correlation: p = 0.542), but was weakly
correlated with ventral skin pH (Pearson’s correlation: p = 0.0056; Fig.
5.3B).
DGGE Microbial community analysis showed that 63% of Rana muscosa
were naturally colonized by Pedobacter cryoconitis at the initiation of the
experiment, and this did not significantly differ among treatments (Pearson
χ2 = 0.084, df = 2, p = 0.959). One group of 20 frogs was given a bath
treatment in the bacterium. At 7 d after treatment, the bacterium had
not become established on previously P. cryoconitis-negative frogs, and the
bacterium was cleared from 1 of 12 initially P. cryoconitis-positive frogs.
After 13 d, 1 of 15 surviving frogs treated with P. cryoconitis retained the
bacterium on its skin. This frog was not initially colonized. Of the surviving
control frogs on Day 13 of the experiment, 0 of 9 showed P. cryoconitis colo-
nization despite initial colonization on 6 of these frogs. Thus, this bacterium
does not appear to be a good candidate for bioaugmentation because it does
not persist after exposure of potential hosts.
Treating adult Lithobates pipiens with heat therapy in com-
parison with itraconazole
The short-term heat treatment was ineffective in clearing the infection in
a small group of infected individuals, whereas itraconazole was effective
in this experiment. Tab. 5.1 summarizes the results of diagnostic qPCR
for each of the 3 treatments in comparison with untreated controls. Each
treatment group included some frogs that were infected initially and some
that were uninfected. All frogs had previously been exposed to infected
conspecifics. The itraconazole treatment cleared infections for the 4 infected
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frogs; however, 1 initially uninfected frog became Bd positive, and 1 frog died
showing clinical signs of toxicity rather than acute chytridiomycosis. Heat
therapy (24 h at 35◦C) did not help clear infections. All control frogs kept
in group enclosures were infected at the end of the experiment.
Table 5.1: Lithobates pipiens. Effects of itraconazole and elevated tempera-
ture on infection status of naturally infected adults. Bd: Batrachochytrium
dendrobatidis.
Treatment No. of frogs Initial infection
status
Treatment outcome
Itraconazole
(100hmghL−1)
4 Bdhpositive 4/4hlosthinfections
8 Bdhnegative 1/7 becamehinfected,h1hdeath
Heat
(35°Chforh24hh)
4 Bdhpositive 4/4hlosthinfections
6 Bdhnegative 1/6hbecamehinfected
Control
(23°C)
4 Bdhpositive 0/4hlosthinfections
3 Bdhnegative 3/3hbecamehinfected
Treating newly metamorphosed Limnodynastes peronii with
itraconazole
The standard high-dose itraconazole treatment (100 mg L−1 ) appeared
to be highly toxic to these young metamorphs. Two froglets developed
clinical signs of severe chytridiomycosis (Fig. 5.4) and died after 2 d of
itraconazole treatment. Clinical signs of chytridiomycosis were noted in 2
additional treatment frogs on the same day. On the third day of treatment,
we discovered that an additional 4 treatment and 2 control froglets had died.
Treatments were discontinued at this point. The remaining froglets were
sent to Lee Berger (James Cook University, Townsville, QLD, Australia) for
isolation of Bd.
Treating larval Alytes obstetricans with commercial antifun-
gals
Three commercial antifungals were tested on Bdinfected Alytes obstetricans
tadpoles that had naturally acquired infections. There was no survival ef-
fect of any of the tested agents. The probiotic agent PIP Pond Plus was
used in 3 different dosages with no significant effect on zoospore counts (Fig.
5A). Electrochemically activated water (Steriplant N) was used in 3 differ-
ent dosages with no significant effect on zoospore counts (Fig. 5B). Doses
of mandipropamid between 0.01 and 4 mg L−1 did not significantly affect
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zoospore counts of infected A. obstetricans tadpoles (Fig. 5C). Infection
prevalence effects are summarized in Tab. 5.2. We analyzed our data from
the PIP Pond Plus treatment with different thresholds of zoospore equiva-
lents to calculate infection prevalence (Fig. 5D). We analyzed the data with
a factorial analysis of variance considering different thresholds factors and
different treatments levels. We found that different thresholds (no thresh-
old, 0.1, and 1 zoospore equivalent) produced different results (from 100%
infection prevalence without a threshold to < 60% infection prevalence at a
threshold of 1 zoospore equivalent, p < 0.001; Fig. 5D).
Table 5.2: Alytes obstetricans. Commercial antifungal treatments tested on
infected tadpoles.
Treatment Summary
PIP1Pond1Plus® Infected A. obstetricans tadpoles1Bn1=128M1were1treated1with131different
dosages1of1the1probiotic1agent PIP1Pond1Plus®61All1individuals1but111were1still
infected1at1low1levels1after1the1treatment61No1significant effect1of1the
treatments1on1zoospore1counts1could1be1shown1BFig61565 AM6
Steriplant1N Infected A. obstetricans tadpoles1Bn1=128M1were1treated1with131different
dosages of1electrochemically activated1water1BSteriplant1NM61All1individuals
were1still1infected1after1the1treatment61No1significant effect1of1the1treatments
on1zoospore1counts1could1be1shown1BFig6 565 BM6
Mandipropamid Infected A. obstetricans tadpoles1Bn1=121M1were1treated1with1a range1of
dosages1of1mandipropamid6 Five1animals1were1cured1afterwards:1the1061,1164,
and11661mg1l−1 and12 animals1from1the1control1group6 All1other1animals1were
still1infected1after1the1treatments61No1significant1effect1of1the1treatment1on
Bd loads1could be1shown1BFig61565 CM6
Juvenile Alytes obstetricans were raised from naturally Bd-infected tad-
poles in a separate experiment. They were never experimentally exposed
to Bd in the laboratory. Collecting permits specified the return of these
animals to the wild; thus, we began treatment with 0.01% itraconazole (10
mg L−1 ) before release. Although the dose of itraconazole was reduced
from the standard adult treatment dose, 10, 5, and 2 individuals out of
the 89 metamorphs died after the first,second, and third days of treatment,
respectively, and then treatment with itraconazole was stopped.
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5.4 Discussion
Understanding the mechanisms by which chytridiomycosis can be suppressed
is one of the first steps toward developing effective strategies to mitigate
chytridiomycosis. Manipulation of temperature regime, microbiota, and an-
tifungal compounds including peptides are all strategies based on a growing
ecological understanding of the disease chytridiomycosis (Woodhams et al.,
2011). Although the results of experimental treatments presented here do
not demonstrate significant survival benefits, they will be instrumental in
the development of effective treatment protocols. To briefly summarize the
lessons learned. (1) Low doses of itraconazole or alternatives should be
tested in future treatments of adult frogs to avoid lethal side-effects, and
treatment should be applied early, before damage from disease accrues. (2)
Antimicrobial peptide applications may reduce or eliminate Bd infection in
hosts such as Bufo bufo, a species that does not produce skin defense pep-
tides. (3) A minimum elevated temperature regime should be developed for
a range of species and life stages. For example, a treatment period of longer
than 24 h at temperatures between 30 and 35◦C appears to be necessary.
(4) The probiotic Pedobacter cryoconitis had beneficial effects on heavily in-
fected Rana muscosa; however, the effects were transient (Fig. 5.2) because
this bacterium did not persist on the host skin. (5) A commercially available
probiotic treatment (PIP Pond Plus) added to water at recommended and
higher doses against fish disease did not improve survival of infected Alytes
obstetricans tadpoles either (Tab. 5.2, Fig. 5). In vitro sensitivity tests
against Bd may reduce animal use for experimental treatments that are not
known to be antifungal a priori. To date there are 2 published methods
with apparent efficacy in clearing Bd infections in some species: antifun-
gal drugs (itraconazole, voriconazole, terbinafine hydrochloride, and others)
and temperature treatments (review in Berger et al. 2010, Bowerman et
al. 2010, Martel et al. 2011, Woodhams et al. 2011). Itraconazole can be
used to treat infected adults or larvae of some species; however, harmful
side-effects including depigmentation of tadpoles have been noted (Garner
et al. 2009). We showed here that lethal side-effects occur when using the
commonly applied itraconazole treatment regimes at high or reduced doses
(Nichols et al. 2000, Garner et al. 2009a) on adult Rana muscosa, Alytes
obstetricans, and Limnodynastes peronii. Thus, we suggest testing of lower
doses on a range of species and life-history stages with controlled pharma-
cokinetic safety trials as outlined by Berger et al. (2010). To date, few
studies have examined the dose-related effects of itraconazole. Increasing
evidence (review in Woodhams et al. 2011) indicates that elevated tem-
perature can reduce the prevalence and intensity of Bd infections. Thus,
elevated temperature may be used therapeutically for infected amphibians.
However, the treatment regimes to minimize the temperatures and durations
of treatment, in order to prevent unnecessary stress on the amphibians, has
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not been systematically tested. Our preliminary experiment with Lithobates
pipiens adults was not a systematic test of heat treatment, but it did indicate
that temperature treatments longer than 24 h may be needed to clear Bd
infection. If the zoospore stage is primarily affected by temperature or other
treatments, then treatment regimes should continue throughout the life cy-
cle of the pathogen. A life cycle is about 4 to 5 d in laboratory culture, but
could be longer in amphibian skin or at suboptimal temperatures. A 10 d
treatment at 30◦C was more successful in the clearance of Bd in Rana cates-
beiana and Acris crepitans adults (Chatfield and Richards-Zawacki 2011). A
concern with the use of high temperature is that it may impair reproductive
success. Examination of heat-treatment effects on egg and sperm quality
should precede recommended protocols for elevated temperature.
In addition to these more traditional treatments, we provide results from
alternative treatments, such as the application of beneficial microbes or an-
timicrobial skin peptides. Recent studies have demonstrated that biother-
apy can effectively prevent the establishment of Bd and increase survival of
mountain yellowlegged frogs Rana muscosa (Harris et al. 2009). In our ex-
periment, treated frogs initially limited Bd proliferation and slowed weight
loss compared to Bd-infected controls. DGGE microbial community analysis
showed that although 63% (27/43) of R. muscosa were naturally colonized
by Pedobacter cryoconitis, even after an additional bath treatment in the
bacterium, only 1 of 15 frogs retained the bacterium on their skin 13 d post-
treatment with individual housing in clean laboratory conditions. Although
anti-Bd microbiota were previously shown to provide prophylactic benefits
to R. muscosa and other amphibians (Harris et al. 2009, Becker and Harris
2010), treatment of heavily infected frogs may require more frequent anti-
fungal treatment or more persistent and strongly protective skin microbes.
Probiotic treatments of human and veterinary diseases, as well as applica-
tions in agriculture and aquaculture, are often applied continuously or in
pulses for the greatest benefit (Yang et al., 2006; Nikoskelainen et al., 2003;
Frohmader et al., 2010; Magnadottir, 2010; Thomas et al., 2010). Thus, a
future research focus on prophylactic rather than remedial disease treatment
may be warranted. Alternatively, more natural conditions, including hous-
ing frogs in groups in terrariums with soil may increase bacterial persistence.
Since a reduction of microbial diversity may be a function of time in cap-
tivity, future trials should avoid this potential pitfall by using more natural
conditions such as outdoor mesocosms. Microbes compete for resources and
may alter the micro-environment indirectly through triggering host immune
defences or directly by oxygen and nutrient utilization, biofilm formation,
or by production of antagonistic substances or altering skin pH (Wilson
2005). Here, we show that the Bd infection load was weakly correlated with
ventral skin pH in Rana muscosa (Fig. 5.3). This could be the result of
immunopathology. Bd prefers a pH of 6 to 7, but growth is dramatically re-
duced at a of pH 4 to 5 or pH 8 (Piotrowski et al. 2004). Secretion of cationic
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antimicrobial peptides may decrease the pH of the skin to create a hostile
micro-environment. Lower pH on the dorsal surface, particularly during
peptide discharge, may be a factor limiting infection there (Weldon and Du
Preez 2006, North and Alford 2008, Sheafor et al. 2008). Here, higher pH
on the ventral surface with higher Bd loads may be a cause or consequence
of infection. Future studies on the effects of pH on skin infections may prove
useful for disease management. We make the following recommendations:
(1) Develop additional animal models. The experiments with Bufo bufo il-
lustrate the potential for this model system in understanding the role of
antimicrobial skin defenses against Bd. A recurring question is whether an-
timicrobial peptides on amphibian skin act as a protective mantle to resist
infection, or as a first-aid kit to help deal with infection. Although we do not
yet have a clear answer, ongoing studies suggest that some species are better
protected than others by the constitutive release of antimicrobial peptides
into the skin mucus. In our experiment, antimicrobial peptides may have
prevented or eliminated Bd infection in 3 of 3 surviving toadlets that were
exposed to Bd. One drawback to experiments with B. bufo metamorphs is
their typically low survival under seemingly benign laboratory and natural
conditions (Garner et al., 2009b; Loman and Madsen, 2010). (2) Attention to
quality control of experimental protocols. Protocols to detect Bd infection in
field surveys are often conservative to avoid false positives by using a qPCR
detection threshold of 1 zoospore equivalent (Kriger et al. 2007, Vredenburg
et al. 2010). In contrast, experimental treatments of Bd-in fected animals
require protocols that are conservative to avoid false negatives. Thus, we
do not recommend using a qPCR threshold infection intensity to dia gnose
infection. Rather, here, we compare zoo spore equivalents among treatment
and control groups to determine treatment effects on infection because esti-
mates of in fection prevalence can be misleading. Working with prevalence
requires the arbitrary definition of a threshold of zoospore equivalents above
which an animal is considered infected or below which an animal is consid-
ered uninfected. This can generate inaccuracies when a treatment reduces
Bd loads strongly but does not completely clear Bd infection. After such a
treatment many animals could have zoospore counts below the threshold and
hence be considered uninfected. Yet these could be false negatives. Com-
municating these results in terms of prevalence might give a very promising
im pression of the treatment, but, in fact, all animals might still be infected
at a low level. Our analysis of the PIP Pond Plus treatment with different
zoospore equivalent thresholds illustrates this problem (Fig. 5D). A second
recommendation, to reiterate Hyatt et al. (2007), is to swab treated ani-
mals at least twice after completion of the treatment, several weeks apart,
to be sure that the infection was cleared. A third consideration is group
size. Individual housing of amphibians may be important. In our prelimi-
nary experiment with Lithobates pipiens, transmission of Bd from infected
to uninfected control frogs housed together emphasizes the importance of
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individual housing unless several groups are used with group as the level of
replicate to avoid pseudo-replication. However, group housing may stabilize
infection status (if microbial populations fluctuate on individuals and re-
colonization can occur via trans mission from group members) and be more
indicative of disease dynamics in natural settings for some systems. (3)
Share information with a public database. We are currently developing a
public database of amphibian disease treatments that will incorporate both
published and unpublished accounts of such treatments. We welcome contri-
butions and suggestions. One portion of the database will be de dicated to
microbes detected on the skin of various amphibians, including the methods
of identification and results of growth-inhibitory activity of the microbes or
their metabolites. Such a database, in addition to the published literature
on primarily successful disease treatments, will be valuable to inform future
research and to alleviate the threat of chytridiomycosis.
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Figure 5.1: Bufo bufo. Newly metamorphosed B. bufo treated with antimi-
crobial peptides (AMPs) either before exposure to Batrachochytrium dendro-
batidis (Bd) or after experimental infection. Peptides were harvested non-
destructively from the skin of the chytridiomycosis-resistant species Pelo-
phylax esculentus (see Materials and methods’). (A) Kaplan-Meier survival
curve of toads in each treatment throughout the experiment (log-rank test
on censored survival data: χ2 = 15.179, df = 2, p = 0.004). (B) Mean
(±SE) change in weight throughout the experiment in all frogs weighed at
least twice (ANOVA: F = 3.632, df = 4, p = 0.012). Identical letters above
bars indicate homogeneous subsets (Tukey test).
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Figure 5.2: Rana muscosa. Results of treating adult R. muscosa natu-
rally infected with Batrachochytrium dendrobatidis (Bd) with the antifungal
itraconazole or the probiotic bacterium Pedobacter cryoconitis. (A) Kaplan-
Meier survival curve of frogs after treatments (log-rank test on censored
survival data: χ2 = 1.494, df = 2, p = 0.474). (B) Intensity of infection
with Bd throughout the experiment. (C) Mean (±SE) change in weight
throughout the experiment in all frogs weighed at least twice (ANOVA: F =
3.455, df = 2, p = 0.041). Identical letters below bars indicate homogeneous
subsets (Tukey test).
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Figure 5.3: Rana muscosa. Skin pH of R. muscosa infected with Batracho-
chytrium dendrobatidis (Bd). (A) Mean (±SE) pH of ventral and dorsal
skin surfaces. (B) Infection intensity shows a slight but significant correla-
tion with ventral skin pH (light gray line) but not dorsal skin pH (dark gray
line).
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Figure 5.4: Limnodynastes peronii. Striped march frogs that had naturally
acquired infections with Batrachochytrium dendrobatidis (Bd) as tadpoles
remained infected upon metamorphosis. (A) A histological section of the
skin of an infected L. peronii stained with hematoxalin and eosin, showing
clear hyperkeratosis of the epidermis and typical Bd zoosporangia. (B) A
newly metamorphosed L. peronii with clinical signs of chytridiomycosis.
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Figure 5.5: Alytes obstericans. The effects of 3 commercial antifungal treat-
ments applied to larval A. obstericans on Batrachochytrium dendrobatidis
(Bd) infection intensities (Bd load = log zoospore equivalents. (A) No sig-
nificant effect of the PIP Pond Plus® treatment on Bd load (ANOVA: F
= 0.7148, df = 24, p = 0.5528). (B) No significant effect of the Steriplant
N treatment on Bd load (ANOVA: F = 0.3056, df = 24, p = 0.8210). Box
plots show the medium value (line), 25 and 75% quantiles (box), 5 and
95% quantiles (whiskers), and outliers (◦). (C) No significant effect of the
mandipropamid treatment on the Bd load (linear regression: p = 0.0638).
Five animals cleared infection, including 2 in the control group. The tadpole
with the highest possible water-soluble dosage (4 mg L−1 ) was still infected
with Bd. (D) Thresholds of Bd zoospore intensity affect the interpretation
of treatment results. All individuals with zoospore counts smaller than the
threshold are considered uninfected. When no threshold is employed, al-
most all frogs regardless of treatment are considered infected. At higher
thresholds, treatment seems to have a larger effect. Here, Treatments P100,
P50, and P25 represent different dosages of the agent PIP Pond Plus® (see
Treating Alytes obstericans with commercial antifungals’).
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Accumulation of
Batrachochytrium
dendrobatidis and bacteria
on the regressing tail of
metamorphosing individuals
(Submitted to Amphibia-Reptilia)
Corina C. Geiger, Francesco C. Origgi and Benedikt R. Schmidt
Abstract Batrachochytrium dendrobatidis (Bd) is a fungus infecting the
skin of amphibians. On metamorphosing animals infection is difficult to
detect because of the limited information concerning the location of Bd on
the animals during this stage. Histological investigation revealed that Bd
and bacteria accumulate on the reabsorbing tail of metamorphosing animals.
Keywords amphibian, chytridiomycosis, disease, tadpole
6.1 Introduction
Batrachochytrium dendrobatidis (hereafter Bd) is a fungus that infects the
skin of amphibians. Bd is a generalist pathogen that has contributed to
amphibian declines and extinctions worldwide (Stuart et al., 2004; Fisher
et al., 2009). Bd was discovered in 1997 (Berger et al., 1998) and formally
described in 1999 (Longcore et al., 1999). Bd causes the disease chytrid-
iomycosis (Nichols et al., 2001; Voyles et al., 2009). Occurrence of Bd in the
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amphibian host is highly associated with the keratinized cells of the epider-
mis of the skin (Berger et al., 2005b). The distribution of keratinized cells
changes according to the life stage of the amphibian and infection with Bd
usually parallels these changes (Marantelli et al., 2004). During the tadpole
life-stage, keratin is usually found only on the mouthparts. At metamor-
phosis the keratinized mouthparts are shed before keratin is layered on the
skin of the entire body (Marantelli et al., 2004). Hence, detecting Bd on a
metamorphosing animal can be challenging since the dynamic of the tissue
changes occurring in the skin might influence the attachment and distri-
bution of Bd (Marantelli et al., 2004). Here we report the results of a
histological study which shows that Bd and bacteria can accumulate also on
the reabsorbing tail of metamorphosing midwife toads (Alytes obstetricans).
6.2 Material and Methods
The detection of the accumulation of Bd on the regressing tail was observed
in the context of a larger experiment on Bd mitigation (Woodhams et al.
2011; C. C. Geiger et al., unpublished manuscript). Part of this experiment
was a histological investigation on metamorphosing individuals of the mid-
wife toad Alytes obstetricans aiming to evaluate the spectrum of changes
which different antifungal compounds might have induced on the tissues of
the toads. Seventy tadpoles of Alytes obstetricans naturally infected with
Bd were caught in early spring in Zunzgen, a site located in the canton
Baselland in northwestern Switzerland (7.801185◦E, 47.436677◦N, 480 masl)
for the experiment. Tadpoles were raised in 10 outdoor mesocosms, all of
them containing 650 L of water, leaf litter, plankton and a self-sustaining
aquatic community composed of zooplankton and microorganisms (Wilbur,
1987). Upon metamorphosis the tadpoles were caught and housed individu-
ally indoors in clear plastic containers, containing leaf litter and some water.
Containers were tilted so that water and land were both available. The room
was equipped with full spectrum sunlight lamps set for a 12 h day length.
Room temperature was maintained at 19 - 21◦C. Once the toadlets reached
Gosner stage 44 (Gosner, 1960), 11 individuals were randomly selected and
euthanized with MS 222 that was buffered to pH 7. The tadpoles were fixed
in 10% buffered formalin and sectioned cranio-caudally along the midline.
The two symmetrical portions of the body were then layered flat in the his-
tocassette, processed as such and embedded in paraffin. Five micron-thick
sections were obtained from each specimen and stained routinely with hema-
toxylin and eosion (H&E). All the sections obtained were screened before
full histological examination and additional deep cuts were performed until
the major organs were visible in the examined sections, if necessary. Ad-
ditionally, special stains including Grocott, Gram, PAS, and Zihel-Neelsen
were applied as appropriate. Slides were observed under light microscopy
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by a single veterinary pathologist and the detected integument changes were
recorded for each specimen. Abundance of Bd zoosporangia was ranked ac-
cording to a subjective scoring system into five categories (0, 1, 2, 3, 4; see
Fig. 6.1).
6.3 Results
We found variable thickening of the epidermal layer (hyperplasia) with hy-
perkeratosis (parakeratotic). Presence of Bd was variable, from very few
fungal organisms to myriads forming thick “pseudo-membranes” with the
superficial devitalized layers of the epidermis (Fig. 6.1). While we observed
variable amounts of Bd on most body parts, the most severe skin lesions,
almost invariably associated with accumulation of Bd, were observed more
frequently in the caudal portion of the body, and almost regularly occur-
ring in correspondence of the “wrinkling” and “bending” of the epidermis
of the regressing tail. Significant collections of bacteria were also observed
in correspondence with the most severe skin lesions. More specifically, six
out of the 11 individuals from the control group showed more severe lesions
in the caudal part of the body. Five of the six animals with more severe
lesions on the tail showed a correspondent higher amount of Bd on the tail.
For one animal, despite the most severe lesion was observed on the tail, a
higher number of fungal organisms was observed on the caudal aspect of the
abdominal skin.
6.4 Discussion
We do not know why Bd and bacteria accumulate on the regressing tail
and what the consequences of this accumulation might be (e.g. for host-
pathogen interactions). Marantelli et al. (2004) suggested that there are
accumulations of sloughing keratin on the degenerating epidermis of the
tail. It is possible that the accumulation of Bd in this area of the skin might
be secondary to the indirect formation of recesses in the integument of the
regressing tail providing ideal “collection sites” for the fungus to attach and
grow. Here, Bd would be less likely to undergo easy mechanical removal.
Considering that the life cycle of Bd takes 4 to 5 days (Berger et al., 2005a)
and the re-absorption of the tail takes between 3 and 6 days (Walsh et al.,
2008), it is consequential that Bd can persist at least for one but probably
for several generations on the regressing tail. Accumulation of Bd on the
regressing tail may allow Bd to persist through host metamorphosis.
The tail would then seem to be a part of the body where Bd likely occurs
during metamorphosis. This was previously reported by Marantelli et al.
(2004) for the Australian frog Myxophyes fasciolatus and we confirm the
pattern for the European toad Alytes obstetricans. The detection of Bd on
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metamorphosing amphibians could then benefit from this observation. For
studies concerning the epidemiology and disease ecology of Bd, we therefore
suggest to swab not only feet and belly of metamorphosing anurans (Garner
et al., 2009) but also the tail. By doing so, we believe that the number of
false negatives can be reduced.
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Figure 6.1: (1) Skin. A histological section of normal skin from Alytes
obstetricans is shown. Scoring for presence of Bd=0. Size bar= 50 µm (H&E
stain). (2) Skin. There is patchy collection of fungi (asterisk) within the
keratin layer of the epidermis, which is also mildly thickened. The epidermis
is thickened (hyperplasia) and infiltrated by few numbers of mononuclear
cells. Scoring for presence of Bd=1. Size bar= 50 µm (H&E stain). (3) Skin.
There is more pronounced hyperkeratosis (parakeratotic) than that observed
in (2) with more abundant fungal organisms, piling up to 3 layer thick. There
is mild to moderate hyperplasia of the epidermis with vacuolization and
infiltration by mononuclear cells. Scoring for presence of Bd=2. Size bar=
50 µm (H&E stain). (4) Skin. A thick mat of fungal organisms is embedded
within the thickened keratin layer of the epidermis. Bd piles up to 12 layer
thick. Mild infiltration of mononuclear cells is observed in the hyperplastic
epidermis. Scoring for presence of Bd=3. Size bar= 50 µm (H&E stain).
(5) Skin. A very thick layer of fungal organisms admixed with bacteria
(asterisk) is overlaying the necrotic and degenerating epidermis. Scoring for
presence of Bd=4. Size bar= 50 µm (H&E stain). (6) Regressing tail. A
thick mat of fungal organisms is present over the stump of the regressing
tail (asterisk). Other less prominent but abundant collections of Bd are seen
in the clefts of the bending epidermis. Size bar= 1mm; the arrow shows the
orientation of the body (H&E stain).
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General Discussion
Amphibians are more threatened than any other vertebrate taxon (Stuart et
al. 2004, Hoffmann et al. 2010). Reasons for this threat are mainly overuti-
lization and habitat loss (Stuart et al., 2004). Only recently a new severe
threat to amphibians appeared which contributes to population declines
and drives species to extinction: the emerging infectious disease chytrid-
iomycosis caused by the fungus Batrachochytrium dendrobatidis (hereafter
Bd) ((Berger et al., 1998; Daszak et al., 2000; Stuart et al., 2004; Sker-
ratt et al., 2007). Hence, successful amphibian conservation depends beside
habitat restoration and reduction of amphibian exploitation also on effective
mitigation of chytridiomycosis.
While it is in principle easy to reduce population declines due to habitat
loss, habitat fragmentation or traffic, reduction of disease induced threats is
a challenging issue. Problems might be centered around obstacles concerning
politics and law, lack of knowledge about many diseases of wildlife, the
absence of basic data on wildlife populations, difficulties with monitoring,
as well as logistical limitations ((Keesing et al., 2006). In the search for a
mitigation strategy against chytridiomycosis one way could be to build on
the experiences that were made during the mitigation of other infectious
diseases. This approach might work in some cases however as mitigation of
wildlife diseases is a new topic in species conservation we face new problems
and might need new solutions for them.
A glance at the mitigation methods and experiences in the context of
infectious diseases in human and life stock reveals that mitigating infectious
diseases is a difficult endeavor. Among all diseases ever recorded on this
planet there are only two where a global eradication was successful: 1980
the smallpox were declared eradicated and 2011 the rinderpest. The key
to success was in both cases a large-scale vaccination program (Mayr, 2003;
Mariner et al., 2012).
There are other cases where disease mitigation was to a greater extent
successful but the pathogens got reintroduced into previously disease-free
areas (Fevre et al., 2006). This was the case for rabies, which was mit-
igated by culling and oral vaccination programs, for bovine tuberculosis
where the spread of disease could be predicted through knowledge of the net-
work among cattle dealers. It was the case for trypanosomiasis in domestic
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animals and humans where the disease was managed in an integrated way
by treatment of animals to prevent disease spread to humans. Mitigation of
the foot and mouth disease was as well to a large extent successful where
sources of infection were identified through DNA sequencing techniques so
that these sources could have been eliminated quickly (Fevre et al., 2006).
Mitigation of other infectious diseases proved to be very difficult and
was less successful for multiple reasons. This relates for instance to the
influenza virus, AIDS, cholera or malaria. The methods used to control
these diseases involve vaccination, reduction of transmission, treatment of
diseased patients, early diagnosis, prevention programs and communication
of mitigation strategies (Inglesby et al., 2006; Mukherjee, 2007; Woodborne
et al., 2008; IWMI, 2010). Problems mainly arise thorough lack of money,
rapidity of spread, inaccessibility to vaccines or drugs, structural violence,
resistances and lack of knowledge about how the disease is embedded into
the environment (Inglesby et al., 2006; Mukherjee, 2007; Woodborne et al.,
2008; IWMI, 2010).
Similar difficulties have also been experienced regarding mitigation of
infectious diseases in agriculture. Mitigation of rapidly spreading fungal dis-
eases known as wheat rusts are so far limited to fungicide sprays to which
resistance may evolve (Hovmoller et al., 2010). The most promising ap-
proach in this case is currently the breeding of plants that are resistant to
the fungus (Hovmoller et al., 2010). Other mitigation strategies that cur-
rently come into play are focused on the investigation of different pathogen
strains to identify the geographic source of the pest or pathogen and reveal
interactions with other pests, pathogens or environmental factors (Kim and
Sappington, 2006; Martin et al., 2012).
Mirroring these strategies and experiences that exist in the context with
human diseases and livestock and considering that we need a mitigation
method against a wildlife disease to protect endangered species the following
approaches emerged: One approach is to stop the human induced dissemina-
tion of Bd by controlling the world trade in amphibians (Fisher and Garner,
2007) or by developing standard biosafety protocols to avoid spreading Bd
on a smaller scale (Schmidt et al., 2009b). This approach proved to be
effective as we have seen it with bovine tuberculosis or foot and mouth dis-
ease. A second approach is the establishment of captive breeding programs.
This approach is not a mitigation method but it preserves the most sus-
ceptible species from disease-induced extinction (Zippel et al., 2011). The
third approach is the development of a mitigation strategy against Bd. In
the context of the third approach different ideas were suggested or tested
experimentally and valuable results were achieved. These ideas were to a
certain degree borrowed from agriculture and from mitigation of human and
livestock diseases but some of them are new.
One idea was to use amphibian skin microbiota and antimicrobial pep-
tides with Bd inhibitory activity to combat chytridiomycosis (Woodhams
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et al., 2011). Here, the most promising strategies are mitigation by intro-
duction of bacteria into the soil which inhibits colonization by Bd on the skin
of the amphibian (Muletz et al., 2012). Moreover bacteria and antimicrobial
skin peptides were found to suppress disease in some amphibians (Garner
et al., 2009b; Woodhams et al., 2011). A further idea was to find natural
enemies of Bd or ecological conditions that are unfavorable for the pathogen
(Woodhams et al., 2003). In this context treatments with elevated tempera-
ture were very successful. Keeping amphibians in elevated temperature has
the potential to clear or drastically reduce infection burdens (Woodhams
et al., 2011). Finally, an idea is borrowed from agriculture where fungal
diseases of crops are treated using chemical antifungal agents (Woodhams
et al., 2011). In this regard a very successful treatment was found by Garner
et al. (2009a), who cleared tadpoles with the antifungal agent Itraconazole.
What has been missing until now is a strategy to mitigate Bd in natural
habitats potentially including a method which not only reduces Bd infection
but transmission of the pathogen from infected to non-infected individuals.
Most of the mitigation methods that were developed so far were conducted in
the laboratory and none of them proved to be an implementable and effective
strategy to mitigate Bd in natural habitats. Some of these methods were
simply not tested yet in natural habitats but have the potential to be very
effective. Other strategies might not satisfy the demands of a mitigation
method in natural habitats.
A mitigation method against Bd in natural habitats has to fulfill multi-
ple objectives: most importantly it should reduce Bd infection and possibly
Bd transmission not only under controlled conditions in the laboratory but
importantly also in the complex framework of a natural ecosystem. Fur-
thermore a treatment should be safe for individual amphibians as well as
for non-target organisms in the environment. A treatment should also be
simple to implement because it might be applied in remote areas. Finally, as
we need to treat whole or parts of a population it should be possible to treat
large numbers of amphibians. Hence, we need to explore new treatments
that seem promising for use in natural populations.
This was exactly the goal of my dissertation: Developing methods to mit-
igate chytridiomycosis in natural habitats. The approach I persuaded was
partly borrowed from agriculture by using antifungal agents for a treatment
against Bd and partly I tested ecological conditions that are unfavorable for
the pathogen.
In chapter 1 I describe an experiment in which an ecological condition
was used as mitigation method against Bd. As Bd is sensitive to high tem-
perature (Piotrowski et al., 2004), I exposed tadpoles of Alytes obstetricans
to low, medium and high temperatures. I found that most tadpoles lost the
infection, when they were kept for 5 days at temperatures higher than 26◦C.
When applying elevated temperature as treating method I recommend some
acclimatization of the tadpoles before the treatment and a pilot study when
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novel species are treated. As conservation measures I suggest to reduce
canopy cover and to construct shallow water zones which results in the rise
of temperatures in the ponds (Skelly et al., 2002) and perhaps prevalence
will drop. Additionally warmer water speeds up larval development which
implies that fewer tadpoles will hibernate (Thiesmeier, 1992) and therefore
population growth rate will increase (Govindarajulu et al., 2005). Warmer
ponds may thus boost population growth rate and reduce Bd prevalence.
In chapter 2 I used chemical agents to treat infected tadpoles against Bd.
I kept tadpoles of Alytes obstetricans for seven days individually in solutions
of the two chemical agents General Tonic® and Virkon Aquatic® . General
Tonic® reduced Bd infection efficiently while Virkon Aquatic® showed no
effect on Bd infections. Chapter 2 shows that chemical agents may be used
to treat amphibian larvae against Bd infection. I found a side effect of
General Tonic® on size of tadpoles and further experiments are necessary
to test side effects of this agent on the pond ecosystem and also to check
whether the side effect on tadpoles disappears in a more natural context.
In chapter 3 I set up semi-natural mesocosms to test for the effects of
antifungal chemicals in a broader ecological context. I introduced mollusks,
insects, plants, crustaceans, plankton and infected and uninfected tadpoles
of Alytes obstetricans and uninfected tadpoles of other species into the meso-
cosms. I added three different chemical agents (General Tonic® , Virkon
Aquatic® and PIP Pond Plus® ) to the mesocosms. I checked for the effi-
ciency of these compounds in reducing Bd infection of infected tadpoles and
transmission from infected to uninfected tadpoles. Furthermore, I also tested
for side effects of the antifungal treatment on amphibians, mollusks and on
different responses of the ecosystem. PIP Pond Plus® neither had an effect
on Bd infections, nor did I detect any side effects. General Tonic® reduced
Bd infection and had some negative short-term effects on mollusks and on
the structure of the ecosystem like plankton density, but the function of the
ecosystem was unaffected returning no effects on litter breakdown. Virkon
Aquatic® had no effect on Bd loads and Bd prevalence of infected individu-
als, but it blocked Bd transmission. Virkon Aquatic® caused no short-term
side effects on the ecosystem, but in the long run ecosystem structure was
affected by Virkon Aquatic® , mainly boosting snail reproduction and plank-
ton numbers. However, the crucial question is: what are the costs and the
benefits? While the benefit for amphibians seems clear, we know that there
are costs but the costs are much harder to quantify. In such a situation,
a precautionary approach is recommendet. That is, one should only use
antifungal agents in natural habitats when the expected benefit is large and
likely outweighs the costs. A benefit may be large if one is witnessing a
catastrophic Bd-induced population decline. In situations, where Bd does
not appear to have immediate catastrophic effects, e.g. Tobler et al. (2012),
the use of antifungal agents might not be recommended. Moreover costs of
antifungal treatments may be more admissible in simple habitat types like
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the gorges inhabited by the Mallorcan midwife toad Alytes muletensis or
man-made habitats such as gravel pits. In a next experiment I tested the
treatment with antifungal agents in natural habitats.
In chapter 4 I report on three experiments in which I tested chemical
antifungal treatments with Itraconazole and General Tonic® in mesocosms
and in natural ponds. I did not add the agent directly to the water. Instead I
caught tadpoles out and treated them in tanks next to the pond to avoid side
effects on non-target organisms. After the treatment tadpoles were released
into the pond. I did this procedure first in mesocosms using the chemical
agent Itraconazole (Garner et al., 2009a; Tobler and Schmidt, 2010). Here
I found that a treatment in the tadpole stage reduced Bd infection. Bd
infection stayed on a low level throughout metamorphosis and reduced the
mortality of metamorphosed individuals. Subsequently I tested this method
in the second experiment in natural ponds by treating tadpoles once with
the chemical agent Itraconazole; in a last experiment I treated tadpoles
monthly with General Tonic® . Both experiments in ponds were followed
by a monitoring of Bd infection over the period of one year. I found that
treating tadpoles with chemical agents outside the pond and releasing them
after the treatment reduced Bd infection in the short term. However the
effect disappeared after two months. A part of the tadpoles were not caught
out and thus not treated. These untreated tadpoles showed as well reduced
Bd infection. Finally I found that Bd infection is lowest in fall. A treatment
in fall might thus be a new approach in order to keep Bd infection in a low
level. These results suggest that antifungal agents can reduce infection but
cannot eradicate Bd from natural environments. However, treatments are
effective for a short time and thus might serve as an emergency measure in
the case of a Bd-induced mass die-off.
Chapter 5 is a conglomeration of treatments that were not considered as
successful. The chapter includes treatments to treat Bd-infected frogs in-
cluding Alytes obstetricans tadpoles and metamorphs, Bufo bufo and Limno-
dynastes peronii metamorphs, and Lithobates pipiens and Rana muscosa
adults. The experimental treatments included commercial antifungal prod-
ucts (itraconazole, mandipropamid, steriplantN, and PIP Pond Plus® ),
antimicrobial skin peptides from the Bd-resistant Pelophylax esculentus, mi-
crobial treatments (Pedobacter cryoconitis), and heat therapy (35◦C for 24
h). None of the new experimental treatments were considered successful in
terms of improving survival; however, these results may advance future re-
search by indicating the limits and potential of the various protocols. Learn-
ing from failed treatments’ is essential because the time we lose by doing
the same failures twice is valuable time we lose in the development of an
urgently needed mitigation method against Bd.
Chapter 6 is a notice about the observation that Bd and bacteria ac-
cumulate on the reabsorbing tail of metamorphosing animals. So far it
was difficult to detect Bd infection on metamorphosing individuals because
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of lack of information about the position of Bd on the animal during this
developmental stage. The notice in chapter 6 helps to find Bd also on meta-
morphosing individuals.
If we now go back to the mitigation methods that are available we can
summarize that there are methods to treat infected individuals in the lab-
oratory with skin microbiota, with antimicrobial peptides or with chemical
agents. A promising strategy for treatments in natural habitats might be in-
troduction of bacteria into the soil which inhibits colonization by Bd on the
skin of the amphibian (Muletz et al., 2012) as well as elevated temperature.
None of these methods was tested in the field. My dissertation provides
methods of which we know how they work under controlled conditions in
the laboratory, we know their effects on Bd infection and transmission and
their side effects on non-target organisms under semi-natural conditions in
mesocosms and we know how they work in the complex framework of a
natural ecosystem.
A new and ecologically compatible approach might be to reduce canopy
cover and to create shallow water zones in order to provide warmer water
which may result in lower Bd prevalence and higher population growth rate.
Another new finding was that transmission can be blocked by adding anti-
fungal agents to the water. If we add such an agent when Bd prevalence is
low, for instance when tadpoles hatch, might ensure that prevalence stays
low. Further experiments should be done to find how long this treatment is
effective.
New was the finding, that commercially available antifungal agents have
the potential to reduce Bd loads and Bd prevalence under semi-natural con-
ditions. Negative side effects on amphibians were, in my opinion, context-
and species-specific but overall relatively benign. Yet, antifungal agents
have a number of side effects on the ecosystem. I thus recommend chemi-
cal treatments of ponds exclusively if a catastrophic Bd-induced population
decline is foreseeable and I also recommend to careful assess the costs and
benefits of such a treatment in advance. In general I advise against adding
the chemicals directly into the pond water because of side effects on the
aquatic ecosystem. I rather recommend catching animals and treating them
outside the pond in groups, at best shortly before metamorphosis because
treating tadpoles is effective throughout metamorphosis. This leads us to
a further new outcome of my dissertation: catching tadpoles out of a pond
and treating them with a chemical agent in tanks next to the pond reduces
not only Bd loads of the treated tadpoles but also prevalence of those tad-
poles that remained in the pond and were never treated. In the course of
the experiments in natural ponds I observed that Bd infection is lowest in
fall. This is an interesting finding in the disease dynamics of Bd and help
to define the right time for a treatment. A treatment in fall might help to
keep Bd infection on a low level.
Future problems could arise through development of new and more vir-
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ulent strains of Bd or through resistances of Bd against the treatments.
Resistances however might also be developed among susceptible amphibian
species to Bd. Researchers suggest that Bd-infection may initially cause a
reduction in population abundance but thereafter, populations remain sta-
tionary or can even increase (Briggs et al., 2010; Tobler and Schmidt, 2010)
implying that enzootic Bd not necessarily causes population declines.
The drawback of course is that Bd will persist and what we have in hand
are some emergency strategies to confine the pathogen for a short term on a
very limited area. What we can do is go on with research to find mitigation
strategies that reduce Bd infection and transmission in whole populations,
like blocking transmission, vaccination, culturing antimicrobial skin bacteria
and importantly also more integrated strategies including habitat restora-
tion. What remains finally is hope; the hope that our mitigation strategies
help to avoid extinction of susceptible species so that we get more time
to develop mitigation methods against Bd with permanent effects and one
day, hopefully, chytridiomycosis disappears from the long list of threats to
amphibians.
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